<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.0//EN" "http://www.w3.org/TR/2001/REC-SVG-20010904/DTD/svg10.dtd">
<svg width="2400" height="2400" xmlns="http://www.w3.org/2000/svg" style="background-color:black">
<circle cx="1200" cy="1200" r="1045" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="1041" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="1040" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="1002" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="1001" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="990" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="986" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="975" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="974" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="969" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="968" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="948" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="946" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="939" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="939" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="913" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="913" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="795" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="795" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="140" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<text font-size="4.0em" x="50" y="60" fill="white">SARS-CoV-2 mutations 2021 timemap</text>
<text font-size="2.8em" x="50" y="105" fill="white">Genbank MN908947 vs 4,663 GISAID genomes</text>
<line x1="1200" y1="82.9384615384615" x2="1200" y2="132.938461538462" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="1176" y="72.9384615384615" fill="white">Winter</text>
<line x1="2267" y1="1200" x2="2317" y2="1200" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="2267" y="1245" fill="white">Spring</text>
<line x1="1200" y1="2267" x2="1200" y2="2317" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="1045" y="2352" fill="white">Summer</text>
<line x1="133" y1="1200" x2="73" y2="1200" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="59" y="1185" fill="white">Fall</text>
<g>	<title>orf1ab gene (266-21555)</title>
	<line x1="1208" y1="1060" x2="1208" y2="405" style="stroke:grey;stroke-width:8" />
</g><g>	<title>S gene (21563-25384)</title>
	<line x1="1208" y1="405" x2="1208" y2="287" style="stroke:gainsboro;stroke-width:8" />
</g><g>	<title>ORF3a gene (25393-26220)</title>
	<line x1="1208" y1="287" x2="1208" y2="261" style="stroke:grey;stroke-width:8" />
</g><g>	<title>E gene (26245-26472)</title>
	<line x1="1208" y1="261" x2="1208" y2="254" style="stroke:gainsboro;stroke-width:8" />
</g><g>	<title>M gene (26523-27191)</title>
	<line x1="1208" y1="252" x2="1208" y2="232" style="stroke:grey;stroke-width:8" />
</g><g>	<title>ORF6 gene (27202-27387)</title>
	<line x1="1208" y1="231" x2="1208" y2="226" style="stroke:gainsboro;stroke-width:8" />
</g><g>	<title>ORF7a gene (27394-27759)</title>
	<line x1="1208" y1="225" x2="1208" y2="214" style="stroke:grey;stroke-width:8" />
</g><g>	<title>ORF8 gene (27894-28259)</title>
	<line x1="1208" y1="210" x2="1208" y2="199" style="stroke:gainsboro;stroke-width:8" />
</g><g>	<title>N gene (28274-29533)</title>
	<line x1="1208" y1="198" x2="1208" y2="160" style="stroke:grey;stroke-width:8" />
</g><g>	<title>ORF10 gene (29558-29674)</title>
	<line x1="1208" y1="159" x2="1208" y2="155" style="stroke:gainsboro;stroke-width:8" />
</g><line x1="1200" y1="147.938461538462" x2="1200" y2="1068" style="stroke:white;stroke-width:3" />
<line x1="1204" y1="147.938461538462" x2="1210" y2="147.938461538462" style="stroke:white;stroke-width:2" />
<line x1="1210" y1="147.938461538462" x2="1215" y2="122.938461538462" style="stroke:white;stroke-width:2" />
<line x1="1204" y1="1068" x2="1210" y2="1068" style="stroke:white;stroke-width:2" />
<line x1="1210" y1="1068" x2="1215" y2="1093" style="stroke:white;stroke-width:2" />
<text font-size="2.0em" x="1215" y="122.938461538462" fill="white">29.9 kb</text>
<text font-size="2.0em" x="1215" y="1113" fill="white">1</text>
<text font-size="2.5em" x="75" y="175" fill="white">Continents</text>
<circle cx="60" cy="205" r="8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="215" fill="white">Europe</text>
<circle cx="60" cy="235" r="8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="245" fill="white">North America</text>
<circle cx="60" cy="265" r="8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="275" fill="white">Oceania</text>
<circle cx="60" cy="295" r="8" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="305" fill="white">Asia</text>
<circle cx="60" cy="325" r="8" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="335" fill="white">Africa</text>
<circle cx="60" cy="355" r="8" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="365" fill="white">South America</text>
<circle cx="60.0" cy="410.0" r="1.2" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="100.0" cy="410.0" r="4.2" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="140.0" cy="410.0" r="8.0" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<text font-size="2.0em" x="50" y="455" fill="white">1      10        100% daily</text>
<text font-size="2.0em" x="50" y="485" fill="white">sample fraction</text>
<g>
	<title>2021-01-01 Europe: 61 samples</title>
	<line x1="1200.3" y1="1180.0" x2="1200.6" y2="1165.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-01 North America: 23 samples</title>
	<line x1="1200.6" y1="1165.7" x2="1200.8" y2="1154.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-01 Oceania: 11 samples</title>
	<line x1="1200.8" y1="1154.6" x2="1200.9" y2="1146.0" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-01 Asia: 7 samples</title>
	<line x1="1200.9" y1="1146.0" x2="1201.1" y2="1138.8" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-01  C1059T  North America=14 [60.9%]  orf1ab polyprotein, T265I</title>
	<circle cx="1202.9" cy="1035.2" r="7.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C1059T  Oceania=6 [54.5%]  orf1ab polyprotein, T265I</title>
	<circle cx="1202.9" cy="1035.2" r="7.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C1572T  Oceania=3 [27.3%]  orf1ab polyprotein, T436I</title>
	<circle cx="1203.2" cy="1019.4" r="5.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G3231T  Oceania=5 [45.5%]  orf1ab polyprotein, G989V</title>
	<circle cx="1204.0" cy="968.3" r="6.7" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C3602T  Europe=4 [6.6%]  orf1ab polyprotein, H1113Y</title>
	<circle cx="1204.2" cy="956.9" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  A5011C  North America=3 [13.0%]  orf1ab polyprotein, Q1582H</title>
	<circle cx="1205.0" cy="913.6" r="4.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C6990T  Oceania=3 [27.3%]  orf1ab polyprotein, S2242F</title>
	<circle cx="1206.1" cy="852.7" r="5.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  T7767C  Europe=3 [4.9%]  orf1ab polyprotein, I2501T</title>
	<circle cx="1206.5" cy="828.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G8083A  North America=8 [34.8%]  orf1ab polyprotein, M2606I</title>
	<circle cx="1206.6" cy="819.1" r="6.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  A8703C  Oceania=5 [45.5%]  orf1ab polyprotein, D2813A</title>
	<circle cx="1207.0" cy="800.0" r="6.7" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G9526T  Europe=4 [6.6%]  orf1ab polyprotein, M3087I</title>
	<circle cx="1207.4" cy="774.7" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C10319T  North America=10 [43.5%]  orf1ab polyprotein, L3352F</title>
	<circle cx="1207.8" cy="750.3" r="6.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C11018A  Oceania=5 [45.5%]  orf1ab polyprotein, L3585I</title>
	<circle cx="1208.2" cy="728.8" r="6.7" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C11396T  Europe=5 [8.2%]  orf1ab polyprotein, L3711F</title>
	<circle cx="1208.4" cy="717.2" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G11417T  Oceania=5 [45.5%]  orf1ab polyprotein, V3718F</title>
	<circle cx="1208.4" cy="716.5" r="6.7" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  A11781G  Europe=4 [6.6%]  orf1ab polyprotein, K3839R</title>
	<circle cx="1208.6" cy="705.3" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C12525T  North America=3 [13.0%]  orf1ab polyprotein, T4087I</title>
	<circle cx="1209.0" cy="682.4" r="4.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G12988T  Europe=3 [4.9%]  orf1ab polyprotein, M4241I</title>
	<circle cx="1209.3" cy="668.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G13993T  Europe=5 [8.2%]  orf1ab polyprotein, A4577S</title>
	<circle cx="1209.8" cy="637.3" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C14408T  North America=23 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1210.0" cy="624.5" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C14408T  North America=23 [100.0%] Oceania=11 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1210.0" cy="624.5" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C14408T  North America=23 [100.0%] Oceania=11 [100.0%] Asia=7 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1210.0" cy="624.5" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C14408T  North America=23 [100.0%] Oceania=11 [100.0%] Asia=7 [100.0%] Europe=60 [98.4%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1210.0" cy="624.5" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G15598A  Europe=3 [4.9%]  orf1ab polyprotein, V5112I</title>
	<circle cx="1210.7" cy="587.9" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G15766T  Europe=4 [6.6%]  orf1ab polyprotein, V5168L</title>
	<circle cx="1210.8" cy="582.7" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  A16889G  Europe=4 [6.6%]  orf1ab polyprotein, K5542R</title>
	<circle cx="1211.4" cy="548.2" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G17019T  Europe=4 [6.6%]  orf1ab polyprotein, E5585D</title>
	<circle cx="1211.4" cy="544.2" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C17104T  Europe=3 [4.9%]  orf1ab polyprotein, H5614Y</title>
	<circle cx="1211.5" cy="541.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G18028T  Europe=3 [4.9%]  orf1ab polyprotein, A5922S</title>
	<circle cx="1212.0" cy="513.1" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  A18424G  North America=10 [43.5%]  orf1ab polyprotein, N6054D</title>
	<circle cx="1212.2" cy="500.9" r="6.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C19718T  Oceania=5 [45.5%]  orf1ab polyprotein, T6485I</title>
	<circle cx="1212.9" cy="461.1" r="6.7" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C20762T  Oceania=3 [27.3%]  orf1ab polyprotein, T6833I</title>
	<circle cx="1213.5" cy="429.0" r="5.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C21304T  North America=10 [43.5%]  orf1ab polyprotein, R7014C</title>
	<circle cx="1213.7" cy="412.3" r="6.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C21364T  Oceania=5 [45.5%]  orf1ab polyprotein, P7034S</title>
	<circle cx="1213.8" cy="410.5" r="6.7" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C21614T  Europe=21 [34.4%]  surface glycoprotein, L18F</title>
	<circle cx="1213.9" cy="402.8" r="6.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C21855T  Europe=3 [4.9%]  surface glycoprotein, S98F</title>
	<circle cx="1214.0" cy="395.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C22227T  Europe=42 [68.9%]  surface glycoprotein, A222V</title>
	<circle cx="1214.2" cy="383.9" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C22879A  Europe=3 [4.9%]  surface glycoprotein, N439K</title>
	<circle cx="1214.6" cy="363.9" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G22992A  Europe=4 [6.6%]  surface glycoprotein, S477N</title>
	<circle cx="1214.7" cy="360.4" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  A23064C  Oceania=3 [27.3%]  surface glycoprotein, N501T</title>
	<circle cx="1214.7" cy="358.2" r="5.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  A23403G  Oceania=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1214.9" cy="347.8" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  A23403G  Oceania=11 [100.0%] Europe=60 [98.4%]  surface glycoprotein, D614G</title>
	<circle cx="1214.9" cy="347.8" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  A23403G  Oceania=11 [100.0%] Europe=60 [98.4%] North America=22 [95.7%]  surface glycoprotein, D614G</title>
	<circle cx="1214.9" cy="347.8" r="7.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  A23403G  Asia=6 [85.7%]  surface glycoprotein, D614G</title>
	<circle cx="1214.9" cy="347.8" r="7.8" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C23604A  North America=3 [13.0%]  surface glycoprotein, P681H</title>
	<circle cx="1215.0" cy="341.6" r="4.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C23604A  Europe=3 [4.9%]  surface glycoprotein, P681H</title>
	<circle cx="1215.0" cy="341.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  A25505G  Europe=3 [4.9%]  ORF3a protein, Q38R</title>
	<circle cx="1216.0" cy="283.1" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G25563T  Asia=6 [85.7%]  ORF3a protein, Q57H</title>
	<circle cx="1216.0" cy="281.3" r="7.8" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G25563T  North America=14 [60.9%]  ORF3a protein, Q57H</title>
	<circle cx="1216.0" cy="281.3" r="7.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G25563T  Oceania=6 [54.5%]  ORF3a protein, Q57H</title>
	<circle cx="1216.0" cy="281.3" r="7.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G25563T  Europe=6 [9.8%]  ORF3a protein, Q57H</title>
	<circle cx="1216.0" cy="281.3" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G25906C  Europe=3 [4.9%]  ORF3a protein, G172R</title>
	<circle cx="1216.2" cy="270.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G25907T  North America=10 [43.5%]  ORF3a protein, G172V</title>
	<circle cx="1216.2" cy="270.7" r="6.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G25996T  Europe=3 [4.9%]  ORF3a protein, V202L</title>
	<circle cx="1216.3" cy="268.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C26060T  Oceania=3 [27.3%]  ORF3a protein, T223I</title>
	<circle cx="1216.3" cy="266.0" r="5.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G26654T  Oceania=5 [45.5%]  membrane glycoprotein, R44S</title>
	<circle cx="1216.6" cy="247.7" r="6.7" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C27145T  Oceania=5 [45.5%]  membrane glycoprotein, T208I</title>
	<circle cx="1216.9" cy="232.6" r="6.7" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C27964T  North America=10 [43.5%]  ORF8 protein, S24L</title>
	<circle cx="1217.3" cy="207.4" r="6.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G28300T  North America=3 [13.0%]  nucleocapsid phosphoprotein, Q9H</title>
	<circle cx="1217.5" cy="197.1" r="4.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C28472T  North America=10 [43.5%]  nucleocapsid phosphoprotein, P67S</title>
	<circle cx="1217.6" cy="191.8" r="6.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C28677T  North America=3 [13.0%]  nucleocapsid phosphoprotein, T135I</title>
	<circle cx="1217.7" cy="185.5" r="4.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C28854T  Asia=4 [57.1%]  nucleocapsid phosphoprotein, S194L</title>
	<circle cx="1217.8" cy="180.1" r="7.1" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C28854T  North America=6 [26.1%]  nucleocapsid phosphoprotein, S194L</title>
	<circle cx="1217.8" cy="180.1" r="5.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C28854T  Europe=3 [4.9%]  nucleocapsid phosphoprotein, S194L</title>
	<circle cx="1217.8" cy="180.1" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C28869T  North America=10 [43.5%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1217.8" cy="179.6" r="6.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C28869T  Europe=3 [4.9%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1217.8" cy="179.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C28890T  Oceania=5 [45.5%]  nucleocapsid phosphoprotein, S206F</title>
	<circle cx="1217.8" cy="179.0" r="6.7" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C28893T  North America=3 [13.0%]  nucleocapsid phosphoprotein, P207L</title>
	<circle cx="1217.8" cy="178.9" r="4.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C28932T  Europe=43 [70.5%]  nucleocapsid phosphoprotein, A220V</title>
	<circle cx="1217.8" cy="177.7" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G28975C  Europe=4 [6.6%]  nucleocapsid phosphoprotein, M234I</title>
	<circle cx="1217.9" cy="176.3" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G29399A  Europe=4 [6.6%]  nucleocapsid phosphoprotein, A376T</title>
	<circle cx="1218.1" cy="163.3" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G29402T  North America=8 [34.8%]  nucleocapsid phosphoprotein, D377Y</title>
	<circle cx="1218.1" cy="163.2" r="6.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  C29445T  North America=4 [17.4%]  nucleocapsid phosphoprotein, T391I</title>
	<circle cx="1218.1" cy="161.9" r="5.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-01  G29645T  Europe=43 [70.5%]  ORF10 protein, V30L</title>
	<circle cx="1218.2" cy="155.7" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02 Europe: 179 samples</title>
	<line x1="1200.7" y1="1180.0" x2="1201.3" y2="1162.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-02 North America: 90 samples</title>
	<line x1="1201.3" y1="1162.0" x2="1201.9" y2="1146.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-02 Oceania: 5 samples</title>
	<line x1="1201.9" y1="1146.3" x2="1202.1" y2="1140.1" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-02  G374A  Europe=3 [1.7%]  orf1ab polyprotein, E37K</title>
	<circle cx="1205.0" cy="1056.3" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C593T  Europe=3 [1.7%]  orf1ab polyprotein, H110Y</title>
	<circle cx="1205.3" cy="1049.6" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C1059T  North America=71 [78.9%]  orf1ab polyprotein, T265I</title>
	<circle cx="1205.8" cy="1035.2" r="7.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C1059T  Europe=3 [1.7%]  orf1ab polyprotein, T265I</title>
	<circle cx="1205.8" cy="1035.2" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C1758T  Europe=3 [1.7%]  orf1ab polyprotein, A498V</title>
	<circle cx="1206.5" cy="1013.7" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G1820A  Europe=5 [2.8%]  orf1ab polyprotein, G519S</title>
	<circle cx="1206.6" cy="1011.8" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C2037T  Europe=3 [1.7%]  orf1ab polyprotein, A591V</title>
	<circle cx="1206.8" cy="1005.2" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G2258A  North America=3 [3.3%]  orf1ab polyprotein, V665I</title>
	<circle cx="1207.0" cy="998.4" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C2445T  North America=3 [3.3%]  orf1ab polyprotein, T727I</title>
	<circle cx="1207.2" cy="992.6" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C3140T  Europe=3 [1.7%]  orf1ab polyprotein, P959S</title>
	<circle cx="1208.0" cy="971.2" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C3176T  Europe=3 [1.7%]  orf1ab polyprotein, P971S</title>
	<circle cx="1208.0" cy="970.1" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C3177T  North America=3 [3.3%]  orf1ab polyprotein, P971L</title>
	<circle cx="1208.0" cy="970.1" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G3231T  North America=6 [6.7%]  orf1ab polyprotein, G989V</title>
	<circle cx="1208.1" cy="968.4" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C3267T  Europe=4 [2.2%]  orf1ab polyprotein, T1001I</title>
	<circle cx="1208.1" cy="967.3" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A3405G  Europe=6 [3.4%]  orf1ab polyprotein, E1047G</title>
	<circle cx="1208.3" cy="963.1" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C3602T  Europe=3 [1.7%]  orf1ab polyprotein, H1113Y</title>
	<circle cx="1208.5" cy="957.0" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C4113T  Europe=5 [2.8%]  orf1ab polyprotein, A1283V</title>
	<circle cx="1209.0" cy="941.3" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C5388A  Europe=4 [2.2%]  orf1ab polyprotein, A1708D</title>
	<circle cx="1210.4" cy="902.1" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C5622T  North America=3 [3.3%]  orf1ab polyprotein, P1786L</title>
	<circle cx="1210.7" cy="894.9" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A5747G  North America=4 [4.4%]  orf1ab polyprotein, T1828A</title>
	<circle cx="1210.8" cy="891.1" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A6441G  North America=3 [3.3%]  orf1ab polyprotein, K2059R</title>
	<circle cx="1211.5" cy="869.7" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G6618A  North America=3 [3.3%]  orf1ab polyprotein, G2118D</title>
	<circle cx="1211.7" cy="864.3" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  T6954C  Europe=4 [2.2%]  orf1ab polyprotein, I2230T</title>
	<circle cx="1212.1" cy="854.0" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  T7348A  North America=4 [4.4%]  orf1ab polyprotein, N2361K</title>
	<circle cx="1212.5" cy="841.8" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G8083A  North America=24 [26.7%]  orf1ab polyprotein, M2606I</title>
	<circle cx="1213.3" cy="819.2" r="5.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A9204G  North America=3 [3.3%]  orf1ab polyprotein, D2980G</title>
	<circle cx="1214.5" cy="784.8" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G9526T  Europe=8 [4.5%]  orf1ab polyprotein, M3087I</title>
	<circle cx="1214.8" cy="774.9" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G9928T  North America=12 [13.3%]  orf1ab polyprotein, M3221I</title>
	<circle cx="1215.3" cy="762.5" r="4.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C10029T  Europe=4 [2.2%]  orf1ab polyprotein, T3255I</title>
	<circle cx="1215.4" cy="759.4" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C10319T  North America=47 [52.2%]  orf1ab polyprotein, L3352F</title>
	<circle cx="1215.7" cy="750.5" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C10448T  Europe=5 [2.8%]  orf1ab polyprotein, P3395S</title>
	<circle cx="1215.8" cy="746.5" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G10996T  Europe=3 [1.7%]  orf1ab polyprotein, K3577N</title>
	<circle cx="1216.4" cy="729.7" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G11083T  Europe=10 [5.6%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1216.5" cy="727.0" r="3.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G11083T  Europe=10 [5.6%] North America=5 [5.6%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1216.5" cy="727.0" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G11132T  Europe=8 [4.5%]  orf1ab polyprotein, A3623S</title>
	<circle cx="1216.6" cy="725.5" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C11396T  Europe=9 [5.0%]  orf1ab polyprotein, L3711F</title>
	<circle cx="1216.9" cy="717.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G11417T  Europe=7 [3.9%]  orf1ab polyprotein, V3718F</title>
	<circle cx="1216.9" cy="716.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C11514T  North America=4 [4.4%]  orf1ab polyprotein, T3750I</title>
	<circle cx="1217.0" cy="713.7" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A11781G  Europe=3 [1.7%]  orf1ab polyprotein, K3839R</title>
	<circle cx="1217.3" cy="705.5" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A12075G  Europe=3 [1.7%]  orf1ab polyprotein, N3937S</title>
	<circle cx="1217.6" cy="696.5" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C12525T  North America=4 [4.4%]  orf1ab polyprotein, T4087I</title>
	<circle cx="1218.1" cy="682.7" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C12789T  Europe=3 [1.7%]  orf1ab polyprotein, T4175I</title>
	<circle cx="1218.3" cy="674.5" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C12809T  North America=4 [4.4%]  orf1ab polyprotein, L4182F</title>
	<circle cx="1218.4" cy="673.9" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A12878G  North America=9 [10.0%]  orf1ab polyprotein, I4205V</title>
	<circle cx="1218.4" cy="671.8" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G13993T  Europe=8 [4.5%]  orf1ab polyprotein, A4577S</title>
	<circle cx="1219.6" cy="637.5" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C14318T  North America=4 [4.4%]  orf1ab polyprotein, T4685I</title>
	<circle cx="1220.0" cy="627.5" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C14408T  Europe=179 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1220.1" cy="624.8" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C14408T  Europe=179 [100.0%] North America=90 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1220.1" cy="624.8" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C14408T  Europe=179 [100.0%] North America=90 [100.0%] Oceania=5 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1220.1" cy="624.8" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G14500T  North America=3 [3.3%]  orf1ab polyprotein, V4746L</title>
	<circle cx="1220.2" cy="621.9" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G15766T  Europe=8 [4.5%]  orf1ab polyprotein, V5168L</title>
	<circle cx="1221.5" cy="583.0" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A16889G  Europe=7 [3.9%]  orf1ab polyprotein, K5542R</title>
	<circle cx="1222.8" cy="548.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C16952T  North America=3 [3.3%]  orf1ab polyprotein, T5563I</title>
	<circle cx="1222.8" cy="546.5" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G17014T  North America=9 [10.0%]  orf1ab polyprotein, D5584Y</title>
	<circle cx="1222.9" cy="544.6" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G17019T  Europe=7 [3.9%]  orf1ab polyprotein, E5585D</title>
	<circle cx="1222.9" cy="544.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G17259T  North America=4 [4.4%]  orf1ab polyprotein, E5665D</title>
	<circle cx="1223.1" cy="537.1" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C18131T  North America=4 [4.4%]  orf1ab polyprotein, T5956I</title>
	<circle cx="1224.1" cy="510.3" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A18424G  North America=47 [52.2%]  orf1ab polyprotein, N6054D</title>
	<circle cx="1224.4" cy="501.3" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A19655G  Europe=3 [1.7%]  orf1ab polyprotein, K6464R</title>
	<circle cx="1225.7" cy="463.4" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C20132T  Europe=4 [2.2%]  orf1ab polyprotein, A6623V</title>
	<circle cx="1226.2" cy="448.7" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C21304T  North America=46 [51.1%]  orf1ab polyprotein, R7014C</title>
	<circle cx="1227.5" cy="412.7" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C21364T  North America=5 [5.6%]  orf1ab polyprotein, P7034S</title>
	<circle cx="1227.6" cy="410.9" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C21431T  North America=4 [4.4%]  orf1ab polyprotein, A7056V</title>
	<circle cx="1227.6" cy="408.8" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C21575T  Europe=3 [1.7%]  surface glycoprotein, L5F</title>
	<circle cx="1227.8" cy="404.4" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C21597T  Europe=3 [1.7%]  surface glycoprotein, S12F</title>
	<circle cx="1227.8" cy="403.7" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G21600T  North America=9 [10.0%]  surface glycoprotein, S13I</title>
	<circle cx="1227.8" cy="403.6" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C21614T  Europe=79 [44.1%]  surface glycoprotein, L18F</title>
	<circle cx="1227.8" cy="403.2" r="6.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C21855T  Europe=4 [2.2%]  surface glycoprotein, S98F</title>
	<circle cx="1228.1" cy="395.8" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G21974T  Europe=3 [1.7%]  surface glycoprotein, D138Y</title>
	<circle cx="1228.2" cy="392.1" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  ATTA21993A  Europe=4 [2.2%]  surface glycoprotein, Y145H</title>
	<circle cx="1228.2" cy="391.5" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G22018T  North America=9 [10.0%]  surface glycoprotein, W152C</title>
	<circle cx="1228.3" cy="390.7" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G22205C  Europe=3 [1.7%]  surface glycoprotein, D215H</title>
	<circle cx="1228.5" cy="385.0" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C22227T  Europe=143 [79.9%]  surface glycoprotein, A222V</title>
	<circle cx="1228.5" cy="384.3" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C22329T  Europe=4 [2.2%]  surface glycoprotein, S256L</title>
	<circle cx="1228.6" cy="381.2" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G22346T  Europe=9 [5.0%]  surface glycoprotein, A262S</title>
	<circle cx="1228.6" cy="380.7" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C22377T  Europe=5 [2.8%]  surface glycoprotein, P272L</title>
	<circle cx="1228.6" cy="379.7" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  T22917G  North America=9 [10.0%]  surface glycoprotein, L452R</title>
	<circle cx="1229.2" cy="363.1" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G22992A  Europe=10 [5.6%]  surface glycoprotein, S477N</title>
	<circle cx="1229.3" cy="360.8" r="3.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A23063T  Europe=4 [2.2%]  surface glycoprotein, N501Y</title>
	<circle cx="1229.4" cy="358.6" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A23064C  North America=4 [4.4%]  surface glycoprotein, N501T</title>
	<circle cx="1229.4" cy="358.6" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C23271A  Europe=4 [2.2%]  surface glycoprotein, A570D</title>
	<circle cx="1229.6" cy="352.2" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G23311C  Europe=3 [1.7%]  surface glycoprotein, E583D</title>
	<circle cx="1229.6" cy="351.0" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A23403G  North America=90 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1229.7" cy="348.2" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A23403G  North America=90 [100.0%] Oceania=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1229.7" cy="348.2" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A23403G  North America=90 [100.0%] Oceania=5 [100.0%] Europe=178 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="1229.7" cy="348.2" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G23593T  North America=5 [5.6%]  surface glycoprotein, Q677H</title>
	<circle cx="1230.0" cy="342.3" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C23604A  North America=7 [7.8%]  surface glycoprotein, P681H</title>
	<circle cx="1230.0" cy="342.0" r="3.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C23604A  North America=7 [7.8%] Europe=10 [5.6%]  surface glycoprotein, P681H</title>
	<circle cx="1230.0" cy="342.0" r="3.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C23709T  Europe=5 [2.8%]  surface glycoprotein, T716I</title>
	<circle cx="1230.1" cy="338.7" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A23756G  Europe=3 [1.7%]  surface glycoprotein, T732A</title>
	<circle cx="1230.1" cy="337.3" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G24095T  North America=3 [3.3%]  surface glycoprotein, A845S</title>
	<circle cx="1230.5" cy="326.9" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  T24506G  Europe=4 [2.2%]  surface glycoprotein, S982A</title>
	<circle cx="1230.9" cy="314.2" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G24914C  Europe=4 [2.2%]  surface glycoprotein, D1118H</title>
	<circle cx="1231.4" cy="301.7" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G25049T  Europe=3 [1.7%]  surface glycoprotein, D1163Y</title>
	<circle cx="1231.5" cy="297.5" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A25505G  Europe=3 [1.7%]  ORF3a protein, Q38R</title>
	<circle cx="1232.0" cy="283.5" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G25563T  North America=72 [80.0%]  ORF3a protein, Q57H</title>
	<circle cx="1232.1" cy="281.7" r="7.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G25563T  Europe=19 [10.6%]  ORF3a protein, Q57H</title>
	<circle cx="1232.1" cy="281.7" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C25714T  Europe=3 [1.7%]  ORF3a protein, L108F</title>
	<circle cx="1232.2" cy="277.1" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C25844T  North America=4 [4.4%]  ORF3a protein, T151I</title>
	<circle cx="1232.4" cy="273.1" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G25906C  Europe=3 [1.7%]  ORF3a protein, G172R</title>
	<circle cx="1232.4" cy="271.2" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G25907T  North America=47 [52.2%]  ORF3a protein, G172V</title>
	<circle cx="1232.4" cy="271.2" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G25996T  Europe=3 [1.7%]  ORF3a protein, V202L</title>
	<circle cx="1232.5" cy="268.4" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C26060T  Europe=3 [1.7%]  ORF3a protein, T223I</title>
	<circle cx="1232.6" cy="266.4" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A26664G  North America=4 [4.4%]  membrane glycoprotein, I48V</title>
	<circle cx="1233.2" cy="247.9" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C26895T  Europe=3 [1.7%]  membrane glycoprotein, H125Y</title>
	<circle cx="1233.5" cy="240.8" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C27434T  North America=3 [3.3%]  ORF7a protein, T14I</title>
	<circle cx="1234.1" cy="224.2" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C27964T  North America=47 [52.2%]  ORF8 protein, S24L</title>
	<circle cx="1234.6" cy="207.9" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C27972T  Europe=4 [2.2%]  ORF8 protein, Q27*</title>
	<circle cx="1234.7" cy="207.7" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G28048T  Europe=4 [2.2%]  ORF8 protein, R52I</title>
	<circle cx="1234.7" cy="205.3" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C28087T  Europe=7 [3.9%]  ORF8 protein, A65V</title>
	<circle cx="1234.8" cy="204.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  A28111G  Europe=3 [1.7%]  ORF8 protein, Y73C</title>
	<circle cx="1234.8" cy="203.4" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G28300T  North America=3 [3.3%]  nucleocapsid phosphoprotein, Q9H</title>
	<circle cx="1235.0" cy="197.6" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C28310A  Europe=4 [2.2%]  nucleocapsid phosphoprotein, P13T</title>
	<circle cx="1235.0" cy="197.3" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C28311T  North America=5 [5.6%]  nucleocapsid phosphoprotein, P13L</title>
	<circle cx="1235.0" cy="197.2" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C28472T  North America=47 [52.2%]  nucleocapsid phosphoprotein, P67S</title>
	<circle cx="1235.2" cy="192.3" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C28677T  North America=3 [3.3%]  nucleocapsid phosphoprotein, T135I</title>
	<circle cx="1235.4" cy="186.0" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G28690T  North America=3 [3.3%]  nucleocapsid phosphoprotein, L139F</title>
	<circle cx="1235.4" cy="185.6" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G28690T  North America=3 [3.3%] Europe=5 [2.8%]  nucleocapsid phosphoprotein, L139F</title>
	<circle cx="1235.4" cy="185.6" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C28706T  Europe=3 [1.7%]  nucleocapsid phosphoprotein, H145Y</title>
	<circle cx="1235.4" cy="185.1" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G28727T  Europe=3 [1.7%]  nucleocapsid phosphoprotein, A152S</title>
	<circle cx="1235.5" cy="184.4" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C28854T  North America=11 [12.2%]  nucleocapsid phosphoprotein, S194L</title>
	<circle cx="1235.6" cy="180.5" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C28854T  Europe=5 [2.8%]  nucleocapsid phosphoprotein, S194L</title>
	<circle cx="1235.6" cy="180.5" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C28869T  North America=47 [52.2%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1235.6" cy="180.1" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C28869T  Europe=4 [2.2%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1235.6" cy="180.1" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C28887T  North America=14 [15.6%]  nucleocapsid phosphoprotein, T205I</title>
	<circle cx="1235.6" cy="179.5" r="4.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C28887T  Europe=3 [1.7%]  nucleocapsid phosphoprotein, T205I</title>
	<circle cx="1235.6" cy="179.5" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C28890T  North America=5 [5.6%]  nucleocapsid phosphoprotein, S206F</title>
	<circle cx="1235.6" cy="179.4" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C28893T  North America=3 [3.3%]  nucleocapsid phosphoprotein, P207L</title>
	<circle cx="1235.6" cy="179.3" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C28932T  Europe=143 [79.9%]  nucleocapsid phosphoprotein, A220V</title>
	<circle cx="1235.7" cy="178.1" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G28975T  North America=5 [5.6%]  nucleocapsid phosphoprotein, M234I</title>
	<circle cx="1235.7" cy="176.8" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G28975C  Europe=8 [4.5%]  nucleocapsid phosphoprotein, M234I</title>
	<circle cx="1235.7" cy="176.8" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C28977T  Europe=4 [2.2%]  nucleocapsid phosphoprotein, S235F</title>
	<circle cx="1235.7" cy="176.7" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G29399A  Europe=8 [4.5%]  nucleocapsid phosphoprotein, A376T</title>
	<circle cx="1236.2" cy="163.8" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G29402T  North America=16 [17.8%]  nucleocapsid phosphoprotein, D377Y</title>
	<circle cx="1236.2" cy="163.7" r="5.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G29402T  Europe=7 [3.9%]  nucleocapsid phosphoprotein, D377Y</title>
	<circle cx="1236.2" cy="163.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  C29445T  North America=5 [5.6%]  nucleocapsid phosphoprotein, T391I</title>
	<circle cx="1236.2" cy="162.4" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-02  G29645T  Europe=142 [79.3%]  ORF10 protein, V30L</title>
	<circle cx="1236.5" cy="156.2" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03 Europe: 91 samples</title>
	<line x1="1201.0" y1="1180.0" x2="1201.9" y2="1164.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-03 North America: 61 samples</title>
	<line x1="1201.9" y1="1164.3" x2="1202.6" y2="1150.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-03 Oceania: 4 samples</title>
	<line x1="1202.6" y1="1150.0" x2="1202.9" y2="1144.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-03  C936T  North America=6 [9.8%]  orf1ab polyprotein, T224I</title>
	<circle cx="1208.4" cy="1039.1" r="4.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C1059T  North America=36 [59.0%]  orf1ab polyprotein, T265I</title>
	<circle cx="1208.6" cy="1035.4" r="7.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C1758T  Europe=4 [4.4%]  orf1ab polyprotein, A498V</title>
	<circle cx="1209.8" cy="1013.9" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G2258A  North America=3 [4.9%]  orf1ab polyprotein, V665I</title>
	<circle cx="1210.6" cy="998.5" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  A2342G  North America=6 [9.8%]  orf1ab polyprotein, I693V</title>
	<circle cx="1210.7" cy="995.9" r="4.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G3259T  North America=6 [9.8%]  orf1ab polyprotein, Q998H</title>
	<circle cx="1212.2" cy="967.8" r="4.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  A3405G  Europe=4 [4.4%]  orf1ab polyprotein, E1047G</title>
	<circle cx="1212.4" cy="963.3" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C3773T  Europe=3 [3.3%]  orf1ab polyprotein, R1170C</title>
	<circle cx="1213.0" cy="952.0" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  T6023C  Europe=4 [4.4%]  orf1ab polyprotein, Y1920H</title>
	<circle cx="1216.6" cy="882.8" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C6026T  Europe=3 [3.3%]  orf1ab polyprotein, P1921S</title>
	<circle cx="1216.6" cy="882.7" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  A6441G  North America=3 [4.9%]  orf1ab polyprotein, K2059R</title>
	<circle cx="1217.3" cy="870.0" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G6618A  North America=4 [6.6%]  orf1ab polyprotein, G2118D</title>
	<circle cx="1217.6" cy="864.6" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  T7348A  North America=4 [6.6%]  orf1ab polyprotein, N2361K</title>
	<circle cx="1218.8" cy="842.1" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  T7767C  Europe=4 [4.4%]  orf1ab polyprotein, I2501T</title>
	<circle cx="1219.4" cy="829.2" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G8083A  North America=20 [32.8%]  orf1ab polyprotein, M2606I</title>
	<circle cx="1219.9" cy="819.5" r="6.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C9438T  Europe=3 [3.3%]  orf1ab polyprotein, T3058I</title>
	<circle cx="1222.1" cy="777.9" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C10319T  North America=28 [45.9%]  orf1ab polyprotein, L3352F</title>
	<circle cx="1223.5" cy="750.8" r="6.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C10448T  Europe=3 [3.3%]  orf1ab polyprotein, P3395S</title>
	<circle cx="1223.7" cy="746.9" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G11083T  Europe=3 [3.3%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1224.8" cy="727.4" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G11230T  Europe=3 [3.3%]  orf1ab polyprotein, M3655I</title>
	<circle cx="1225.0" cy="722.8" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C11396T  Europe=4 [4.4%]  orf1ab polyprotein, L3711F</title>
	<circle cx="1225.3" cy="717.7" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C11591T  North America=6 [9.8%]  orf1ab polyprotein, L3776F</title>
	<circle cx="1225.6" cy="711.7" r="4.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C14408T  Europe=91 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1230.1" cy="625.2" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C14408T  Europe=91 [100.0%] North America=61 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1230.1" cy="625.2" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C14408T  Europe=91 [100.0%] North America=61 [100.0%] Oceania=4 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1230.1" cy="625.2" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G17014T  North America=3 [4.9%]  orf1ab polyprotein, D5584Y</title>
	<circle cx="1234.3" cy="545.1" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C17104T  Europe=4 [4.4%]  orf1ab polyprotein, H5614Y</title>
	<circle cx="1234.5" cy="542.3" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G17122T  North America=6 [9.8%]  orf1ab polyprotein, A5620S</title>
	<circle cx="1234.5" cy="541.8" r="4.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C18131T  North America=4 [6.6%]  orf1ab polyprotein, T5956I</title>
	<circle cx="1236.1" cy="510.8" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  A18424G  North America=27 [44.3%]  orf1ab polyprotein, N6054D</title>
	<circle cx="1236.6" cy="501.8" r="6.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  A19655G  Europe=3 [3.3%]  orf1ab polyprotein, K6464R</title>
	<circle cx="1238.6" cy="464.0" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G19999T  Europe=4 [4.4%]  orf1ab polyprotein, V6579F</title>
	<circle cx="1239.1" cy="453.4" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G20995T  Europe=3 [3.3%]  orf1ab polyprotein, G6911C</title>
	<circle cx="1240.7" cy="422.8" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C21304T  North America=24 [39.3%]  orf1ab polyprotein, R7014C</title>
	<circle cx="1241.2" cy="413.3" r="6.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C21575T  Europe=3 [3.3%]  surface glycoprotein, L5F</title>
	<circle cx="1241.7" cy="405.0" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G21600T  North America=3 [4.9%]  surface glycoprotein, S13I</title>
	<circle cx="1241.7" cy="404.2" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C21614T  Europe=31 [34.1%]  surface glycoprotein, L18F</title>
	<circle cx="1241.7" cy="403.8" r="6.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C21621T  North America=3 [4.9%]  surface glycoprotein, T20I</title>
	<circle cx="1241.7" cy="403.6" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C21648T  North America=4 [6.6%]  surface glycoprotein, T29I</title>
	<circle cx="1241.8" cy="402.7" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G22018T  North America=3 [4.9%]  surface glycoprotein, W152C</title>
	<circle cx="1242.4" cy="391.4" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C22227T  Europe=74 [81.3%]  surface glycoprotein, A222V</title>
	<circle cx="1242.7" cy="384.9" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C22329T  Europe=3 [3.3%]  surface glycoprotein, S256L</title>
	<circle cx="1242.9" cy="381.8" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G22346T  Europe=9 [9.9%]  surface glycoprotein, A262S</title>
	<circle cx="1242.9" cy="381.3" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C22377T  Europe=5 [5.5%]  surface glycoprotein, P272L</title>
	<circle cx="1243.0" cy="380.3" r="3.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  T22917G  North America=4 [6.6%]  surface glycoprotein, L452R</title>
	<circle cx="1243.8" cy="363.7" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C23277T  North America=4 [6.6%]  surface glycoprotein, T572I</title>
	<circle cx="1244.4" cy="352.7" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  A23403G  Europe=91 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1244.6" cy="348.8" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  A23403G  Europe=91 [100.0%] North America=61 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1244.6" cy="348.8" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  A23403G  Europe=91 [100.0%] North America=61 [100.0%] Oceania=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1244.6" cy="348.8" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G23593T  North America=7 [11.5%]  surface glycoprotein, Q677H</title>
	<circle cx="1244.9" cy="343.0" r="4.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C23604A  North America=4 [6.6%]  surface glycoprotein, P681H</title>
	<circle cx="1244.9" cy="342.6" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G25555T  Europe=3 [3.3%]  ORF3a protein, V55F</title>
	<circle cx="1248.1" cy="282.7" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G25563T  North America=37 [60.7%]  ORF3a protein, Q57H</title>
	<circle cx="1248.1" cy="282.4" r="7.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G25617T  Europe=3 [3.3%]  ORF3a protein, K75N</title>
	<circle cx="1248.2" cy="280.8" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G25621T  Europe=3 [3.3%]  ORF3a protein, V77F</title>
	<circle cx="1248.2" cy="280.6" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C25624T  North America=4 [6.6%]  ORF3a protein, H78Y</title>
	<circle cx="1248.2" cy="280.6" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C25810T  Europe=3 [3.3%]  ORF3a protein, L140F</title>
	<circle cx="1248.5" cy="274.8" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C25844T  North America=3 [4.9%]  ORF3a protein, T151I</title>
	<circle cx="1248.5" cy="273.8" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C25889T  North America=4 [6.6%]  ORF3a protein, S166L</title>
	<circle cx="1248.6" cy="272.4" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G25907T  North America=27 [44.3%]  ORF3a protein, G172V</title>
	<circle cx="1248.6" cy="271.9" r="6.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  A26069G  North America=6 [9.8%]  ORF3a protein, E226G</title>
	<circle cx="1248.9" cy="266.9" r="4.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  TGTT26157T  Europe=3 [3.3%]  ORF3a protein, V256N</title>
	<circle cx="1249.0" cy="264.2" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C27964T  North America=28 [45.9%]  ORF8 protein, S24L</title>
	<circle cx="1252.0" cy="208.7" r="6.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C28310A  Europe=4 [4.4%]  nucleocapsid phosphoprotein, P13T</title>
	<circle cx="1252.5" cy="198.0" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C28472T  North America=27 [44.3%]  nucleocapsid phosphoprotein, P67S</title>
	<circle cx="1252.8" cy="193.0" r="6.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C28706T  Europe=4 [4.4%]  nucleocapsid phosphoprotein, H145Y</title>
	<circle cx="1253.1" cy="185.9" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C28854T  North America=9 [14.8%]  nucleocapsid phosphoprotein, S194L</title>
	<circle cx="1253.4" cy="181.3" r="4.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C28869T  North America=27 [44.3%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1253.4" cy="180.8" r="6.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C28887T  North America=6 [9.8%]  nucleocapsid phosphoprotein, T205I</title>
	<circle cx="1253.4" cy="180.3" r="4.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C28932T  Europe=74 [81.3%]  nucleocapsid phosphoprotein, A220V</title>
	<circle cx="1253.5" cy="178.9" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G28975T  North America=5 [8.2%]  nucleocapsid phosphoprotein, M234I</title>
	<circle cx="1253.6" cy="177.6" r="3.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C29253T  Europe=3 [3.3%]  nucleocapsid phosphoprotein, S327L</title>
	<circle cx="1254.0" cy="169.0" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  C29366T  Europe=4 [4.4%]  nucleocapsid phosphoprotein, P365S</title>
	<circle cx="1254.2" cy="165.6" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G29402T  North America=12 [19.7%]  nucleocapsid phosphoprotein, D377Y</title>
	<circle cx="1254.3" cy="164.5" r="5.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-03  G29645T  Europe=74 [81.3%]  ORF10 protein, V30L</title>
	<circle cx="1254.7" cy="157.0" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04 Europe: 2280 samples</title>
	<line x1="1201.4" y1="1180.0" x2="1203.3" y2="1153.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-04 North America: 251 samples</title>
	<line x1="1203.3" y1="1153.2" x2="1204.6" y2="1134.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-04 Oceania: 3 samples</title>
	<line x1="1204.6" y1="1134.1" x2="1204.9" y2="1129.3" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-04 Asia: 11 samples</title>
	<line x1="1204.9" y1="1129.3" x2="1205.5" y2="1120.7" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-04  C335T  Europe=30 [1.3%]  orf1ab polyprotein, R24C</title>
	<circle cx="1209.9" cy="1057.8" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G376T  Europe=3 [0.1%]  orf1ab polyprotein, E37D</title>
	<circle cx="1210.0" cy="1056.5" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A408G  Europe=5 [0.2%]  orf1ab polyprotein, D48G</title>
	<circle cx="1210.1" cy="1055.5" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C593T  Europe=45 [2.0%]  orf1ab polyprotein, H110Y</title>
	<circle cx="1210.5" cy="1049.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A605C  Europe=15 [0.7%]  orf1ab polyprotein, I114L</title>
	<circle cx="1210.5" cy="1049.5" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A642G  Europe=5 [0.2%]  orf1ab polyprotein, N126S</title>
	<circle cx="1210.6" cy="1048.3" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C690T  Europe=58 [2.5%]  orf1ab polyprotein, S142L</title>
	<circle cx="1210.7" cy="1046.9" r="2.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A761G  Europe=74 [3.2%]  orf1ab polyprotein, S166G</title>
	<circle cx="1210.9" cy="1044.7" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G806A  North America=4 [1.6%]  orf1ab polyprotein, A181T</title>
	<circle cx="1211.0" cy="1043.3" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C815T  Europe=7 [0.3%]  orf1ab polyprotein, R184C</title>
	<circle cx="1211.0" cy="1043.0" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C843T  Europe=5 [0.2%]  orf1ab polyprotein, P193L</title>
	<circle cx="1211.0" cy="1042.2" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C875T  Europe=3 [0.1%]  orf1ab polyprotein, L204F</title>
	<circle cx="1211.1" cy="1041.2" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C882T  Europe=52 [2.3%]  orf1ab polyprotein, A206V</title>
	<circle cx="1211.1" cy="1041.0" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C884T  Europe=12 [0.5%]  orf1ab polyprotein, R207C</title>
	<circle cx="1211.1" cy="1040.9" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C900T  Europe=9 [0.4%]  orf1ab polyprotein, S212L</title>
	<circle cx="1211.2" cy="1040.4" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C936T  North America=16 [6.4%]  orf1ab polyprotein, T224I</title>
	<circle cx="1211.2" cy="1039.3" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C1059T  North America=182 [72.5%]  orf1ab polyprotein, T265I</title>
	<circle cx="1211.5" cy="1035.5" r="7.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C1059T  Europe=9 [0.4%]  orf1ab polyprotein, T265I</title>
	<circle cx="1211.5" cy="1035.5" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A1163T  Europe=10 [0.4%]  orf1ab polyprotein, I300F</title>
	<circle cx="1211.7" cy="1032.3" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C1190T  Europe=3 [0.1%]  orf1ab polyprotein, P309S</title>
	<circle cx="1211.8" cy="1031.5" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C1191T  Europe=31 [1.4%]  orf1ab polyprotein, P309L</title>
	<circle cx="1211.8" cy="1031.5" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C1218T  Europe=15 [0.7%]  orf1ab polyprotein, S318L</title>
	<circle cx="1211.8" cy="1030.7" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C1346A  North America=3 [1.2%]  orf1ab polyprotein, P361T</title>
	<circle cx="1212.1" cy="1026.7" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G1358A  North America=3 [1.2%]  orf1ab polyprotein, V365I</title>
	<circle cx="1212.1" cy="1026.4" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G1358T  Europe=5 [0.2%]  orf1ab polyprotein, V365F</title>
	<circle cx="1212.1" cy="1026.4" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C1380T  Europe=9 [0.4%]  orf1ab polyprotein, A372V</title>
	<circle cx="1212.2" cy="1025.7" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C1392T  Europe=3 [0.1%]  orf1ab polyprotein, S376L</title>
	<circle cx="1212.2" cy="1025.3" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G1401A  Europe=3 [0.1%]  orf1ab polyprotein, G379E</title>
	<circle cx="1212.2" cy="1025.0" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G1408T  Europe=22 [1.0%]  orf1ab polyprotein, E381D</title>
	<circle cx="1212.2" cy="1024.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G1439T  Europe=3 [0.1%]  orf1ab polyprotein, G392C</title>
	<circle cx="1212.3" cy="1023.9" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G1464A  Europe=14 [0.6%]  orf1ab polyprotein, G400D</title>
	<circle cx="1212.4" cy="1023.1" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C1469T  Europe=6 [0.3%]  orf1ab polyprotein, R402C</title>
	<circle cx="1212.4" cy="1023.0" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C1473T  Europe=7 [0.3%]  orf1ab polyprotein, T403I</title>
	<circle cx="1212.4" cy="1022.8" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C1514T  Europe=8 [0.4%]  orf1ab polyprotein, H417Y</title>
	<circle cx="1212.5" cy="1021.6" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C1758T  Europe=9 [0.4%]  orf1ab polyprotein, A498V</title>
	<circle cx="1213.0" cy="1014.1" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G1820A  Europe=6 [0.3%]  orf1ab polyprotein, G519S</title>
	<circle cx="1213.1" cy="1012.2" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C1887T  Europe=46 [2.0%]  orf1ab polyprotein, A541V</title>
	<circle cx="1213.3" cy="1010.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A2015G  Europe=4 [0.2%]  orf1ab polyprotein, M584V</title>
	<circle cx="1213.6" cy="1006.2" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C2037T  North America=8 [3.2%]  orf1ab polyprotein, A591V</title>
	<circle cx="1213.6" cy="1005.5" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G2081A  Europe=37 [1.6%]  orf1ab polyprotein, V606I</title>
	<circle cx="1213.7" cy="1004.2" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C2106T  Europe=13 [0.6%]  orf1ab polyprotein, T614I</title>
	<circle cx="1213.7" cy="1003.4" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G2258A  North America=7 [2.8%]  orf1ab polyprotein, V665I</title>
	<circle cx="1214.1" cy="998.7" r="2.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C2334T  Europe=32 [1.4%]  orf1ab polyprotein, A690V</title>
	<circle cx="1214.2" cy="996.4" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A2342G  North America=16 [6.4%]  orf1ab polyprotein, I693V</title>
	<circle cx="1214.3" cy="996.2" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G2369T  Europe=8 [0.4%]  orf1ab polyprotein, A702S</title>
	<circle cx="1214.3" cy="995.3" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C2388T  Europe=3 [0.1%]  orf1ab polyprotein, T708I</title>
	<circle cx="1214.4" cy="994.7" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C2445T  North America=3 [1.2%]  orf1ab polyprotein, T727I</title>
	<circle cx="1214.5" cy="993.0" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C2445T  North America=3 [1.2%] Europe=5 [0.2%]  orf1ab polyprotein, T727I</title>
	<circle cx="1214.5" cy="993.0" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G2447T  Europe=22 [1.0%]  orf1ab polyprotein, G728C</title>
	<circle cx="1214.5" cy="992.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A2510G  Europe=48 [2.1%]  orf1ab polyprotein, T749A</title>
	<circle cx="1214.6" cy="991.0" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G2659T  Europe=3 [0.1%]  orf1ab polyprotein, K798N</title>
	<circle cx="1214.9" cy="986.4" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C2667T  Europe=3 [0.1%]  orf1ab polyprotein, A801V</title>
	<circle cx="1215.0" cy="986.2" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G2891A  Europe=4 [0.2%]  orf1ab polyprotein, A876T</title>
	<circle cx="1215.4" cy="979.3" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C2973T  Europe=3 [0.1%]  orf1ab polyprotein, A903V</title>
	<circle cx="1215.6" cy="976.8" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A2994G  Europe=7 [0.3%]  orf1ab polyprotein, E910G</title>
	<circle cx="1215.7" cy="976.1" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C3096T  Asia=6 [54.5%]  orf1ab polyprotein, S944L</title>
	<circle cx="1215.9" cy="973.0" r="7.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C3096T  North America=4 [1.6%]  orf1ab polyprotein, S944L</title>
	<circle cx="1215.9" cy="973.0" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C3096T  North America=4 [1.6%] Europe=4 [0.2%]  orf1ab polyprotein, S944L</title>
	<circle cx="1215.9" cy="973.0" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C3177T  North America=3 [1.2%]  orf1ab polyprotein, P971L</title>
	<circle cx="1216.0" cy="970.5" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C3177T  North America=3 [1.2%] Europe=5 [0.2%]  orf1ab polyprotein, P971L</title>
	<circle cx="1216.0" cy="970.5" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A3213G  Europe=4 [0.2%]  orf1ab polyprotein, D983G</title>
	<circle cx="1216.1" cy="969.4" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G3231T  North America=3 [1.2%]  orf1ab polyprotein, G989V</title>
	<circle cx="1216.2" cy="968.9" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G3239T  Europe=51 [2.2%]  orf1ab polyprotein, D992Y</title>
	<circle cx="1216.2" cy="968.6" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G3259T  North America=17 [6.8%]  orf1ab polyprotein, Q998H</title>
	<circle cx="1216.2" cy="968.0" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C3267T  North America=3 [1.2%]  orf1ab polyprotein, T1001I</title>
	<circle cx="1216.2" cy="967.8" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C3267T  North America=3 [1.2%] Europe=17 [0.7%]  orf1ab polyprotein, T1001I</title>
	<circle cx="1216.2" cy="967.8" r="1.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C3311T  Europe=75 [3.3%]  orf1ab polyprotein, L1016F</title>
	<circle cx="1216.3" cy="966.4" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A3329G  Europe=28 [1.2%]  orf1ab polyprotein, T1022A</title>
	<circle cx="1216.4" cy="965.9" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G3527A  North America=9 [3.6%]  orf1ab polyprotein, D1088N</title>
	<circle cx="1216.8" cy="959.8" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C3587T  North America=3 [1.2%]  orf1ab polyprotein, H1108Y</title>
	<circle cx="1216.9" cy="957.9" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C3602T  Europe=149 [6.5%]  orf1ab polyprotein, H1113Y</title>
	<circle cx="1217.0" cy="957.5" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C3653T  Europe=20 [0.9%]  orf1ab polyprotein, L1130F</title>
	<circle cx="1217.1" cy="955.9" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G3692T  Europe=20 [0.9%]  orf1ab polyprotein, V1143F</title>
	<circle cx="1217.2" cy="954.7" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C3738T  Europe=3 [0.1%]  orf1ab polyprotein, P1158L</title>
	<circle cx="1217.3" cy="953.3" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C3743T  Europe=10 [0.4%]  orf1ab polyprotein, H1160Y</title>
	<circle cx="1217.3" cy="953.2" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C3768T  Asia=6 [54.5%]  orf1ab polyprotein, T1168I</title>
	<circle cx="1217.3" cy="952.4" r="7.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C3828T  Europe=16 [0.7%]  orf1ab polyprotein, S1188L</title>
	<circle cx="1217.4" cy="950.5" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G3871T  Europe=26 [1.1%]  orf1ab polyprotein, K1202N</title>
	<circle cx="1217.5" cy="949.2" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G3955T  Europe=3 [0.1%]  orf1ab polyprotein, K1230N</title>
	<circle cx="1217.7" cy="946.6" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C4002T  Europe=10 [0.4%]  orf1ab polyprotein, T1246I</title>
	<circle cx="1217.8" cy="945.2" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A4040G  Europe=17 [0.7%]  orf1ab polyprotein, I1259V</title>
	<circle cx="1217.9" cy="944.0" r="1.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C4068T  Europe=38 [1.7%]  orf1ab polyprotein, A1268V</title>
	<circle cx="1218.0" cy="943.2" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G4399T  Europe=7 [0.3%]  orf1ab polyprotein, M1378I</title>
	<circle cx="1218.7" cy="933.0" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C4421T  Europe=7 [0.3%]  orf1ab polyprotein, R1386C</title>
	<circle cx="1218.7" cy="932.3" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G4474T  Europe=18 [0.8%]  orf1ab polyprotein, Q1403H</title>
	<circle cx="1218.8" cy="930.7" r="1.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G4486T  Europe=33 [1.4%]  orf1ab polyprotein, K1407N</title>
	<circle cx="1218.9" cy="930.4" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C4683T  Europe=4 [0.2%]  orf1ab polyprotein, A1473V</title>
	<circle cx="1219.3" cy="924.3" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C4752T  Europe=7 [0.3%]  orf1ab polyprotein, T1496I</title>
	<circle cx="1219.4" cy="922.2" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C4755T  Europe=4 [0.2%]  orf1ab polyprotein, P1497L</title>
	<circle cx="1219.4" cy="922.1" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C4893T  Europe=76 [3.3%]  orf1ab polyprotein, T1543I</title>
	<circle cx="1219.7" cy="917.9" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G4904T  Europe=4 [0.2%]  orf1ab polyprotein, D1547Y</title>
	<circle cx="1219.8" cy="917.5" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G4913T  Europe=46 [2.0%]  orf1ab polyprotein, V1550F</title>
	<circle cx="1219.8" cy="917.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  T4917C  Europe=73 [3.2%]  orf1ab polyprotein, I1551T</title>
	<circle cx="1219.8" cy="917.1" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C5007T  Europe=19 [0.8%]  orf1ab polyprotein, T1581M</title>
	<circle cx="1220.0" cy="914.4" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G5015A  North America=9 [3.6%]  orf1ab polyprotein, V1584M</title>
	<circle cx="1220.0" cy="914.1" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G5023T  Europe=3 [0.1%]  orf1ab polyprotein, M1586I</title>
	<circle cx="1220.0" cy="913.9" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C5055T  Europe=10 [0.4%]  orf1ab polyprotein, T1597I</title>
	<circle cx="1220.1" cy="912.9" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C5184T  Asia=6 [54.5%]  orf1ab polyprotein, P1640L</title>
	<circle cx="1220.4" cy="908.9" r="7.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C5184A  Europe=3 [0.1%]  orf1ab polyprotein, P1640H</title>
	<circle cx="1220.4" cy="908.9" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G5230T  Europe=6 [0.3%]  orf1ab polyprotein, K1655N</title>
	<circle cx="1220.5" cy="907.5" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C5310T  Europe=5 [0.2%]  orf1ab polyprotein, T1682I</title>
	<circle cx="1220.6" cy="905.1" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C5388A  Europe=15 [0.7%]  orf1ab polyprotein, A1708D</title>
	<circle cx="1220.8" cy="902.7" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C5526T  Europe=40 [1.8%]  orf1ab polyprotein, T1754I</title>
	<circle cx="1221.1" cy="898.4" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C5622T  North America=3 [1.2%]  orf1ab polyprotein, P1786L</title>
	<circle cx="1221.3" cy="895.5" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C5622T  North America=3 [1.2%] Europe=14 [0.6%]  orf1ab polyprotein, P1786L</title>
	<circle cx="1221.3" cy="895.5" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C5672T  Europe=7 [0.3%]  orf1ab polyprotein, P1803S</title>
	<circle cx="1221.4" cy="893.9" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C5724T  Europe=9 [0.4%]  orf1ab polyprotein, T1820I</title>
	<circle cx="1221.5" cy="892.4" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C5730T  Europe=7 [0.3%]  orf1ab polyprotein, T1822I</title>
	<circle cx="1221.5" cy="892.2" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A5747G  North America=7 [2.8%]  orf1ab polyprotein, T1828A</title>
	<circle cx="1221.6" cy="891.6" r="2.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C5826T  North America=3 [1.2%]  orf1ab polyprotein, T1854I</title>
	<circle cx="1221.7" cy="889.2" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C5826T  North America=3 [1.2%] Europe=3 [0.1%]  orf1ab polyprotein, T1854I</title>
	<circle cx="1221.7" cy="889.2" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A5877G  North America=9 [3.6%]  orf1ab polyprotein, N1871S</title>
	<circle cx="1221.8" cy="887.7" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A5949G  Europe=75 [3.3%]  orf1ab polyprotein, K1895R</title>
	<circle cx="1222.0" cy="885.4" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G5950T  Europe=30 [1.3%]  orf1ab polyprotein, K1895N</title>
	<circle cx="1222.0" cy="885.4" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C6027T  Europe=36 [1.6%]  orf1ab polyprotein, P1921L</title>
	<circle cx="1222.2" cy="883.1" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G6080A  Europe=24 [1.1%]  orf1ab polyprotein, D1939N</title>
	<circle cx="1222.3" cy="881.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C6195T  Europe=11 [0.5%]  orf1ab polyprotein, P1977L</title>
	<circle cx="1222.5" cy="877.9" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G6352T  Europe=5 [0.2%]  orf1ab polyprotein, K2029N</title>
	<circle cx="1222.9" cy="873.1" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G6404T  Europe=3 [0.1%]  orf1ab polyprotein, V2047F</title>
	<circle cx="1223.0" cy="871.5" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A6441G  North America=7 [2.8%]  orf1ab polyprotein, K2059R</title>
	<circle cx="1223.1" cy="870.3" r="2.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C6449T  Europe=4 [0.2%]  orf1ab polyprotein, L2062F</title>
	<circle cx="1223.1" cy="870.1" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G6476T  Europe=6 [0.3%]  orf1ab polyprotein, V2071F</title>
	<circle cx="1223.1" cy="869.3" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C6525T  Europe=3 [0.1%]  orf1ab polyprotein, T2087I</title>
	<circle cx="1223.2" cy="867.8" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C6539T  Europe=62 [2.7%]  orf1ab polyprotein, H2092Y</title>
	<circle cx="1223.3" cy="867.3" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C6543T  Europe=6 [0.3%]  orf1ab polyprotein, T2093I</title>
	<circle cx="1223.3" cy="867.2" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C6573T  North America=4 [1.6%]  orf1ab polyprotein, S2103F</title>
	<circle cx="1223.3" cy="866.3" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G6618A  North America=5 [2.0%]  orf1ab polyprotein, G2118D</title>
	<circle cx="1223.4" cy="864.9" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C6627T  Europe=3 [0.1%]  orf1ab polyprotein, T2121I</title>
	<circle cx="1223.5" cy="864.6" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C6636T  Europe=17 [0.7%]  orf1ab polyprotein, T2124I</title>
	<circle cx="1223.5" cy="864.4" r="1.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C6638T  Europe=4 [0.2%]  orf1ab polyprotein, H2125Y</title>
	<circle cx="1223.5" cy="864.3" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G6759T  Europe=6 [0.3%]  orf1ab polyprotein, C2165F</title>
	<circle cx="1223.7" cy="860.6" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C6807T  Europe=4 [0.2%]  orf1ab polyprotein, T2181I</title>
	<circle cx="1223.8" cy="859.1" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C6936T  Europe=7 [0.3%]  orf1ab polyprotein, S2224F</title>
	<circle cx="1224.1" cy="855.1" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A6948G  Europe=6 [0.3%]  orf1ab polyprotein, N2228S</title>
	<circle cx="1224.1" cy="854.8" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  T6954C  Europe=15 [0.7%]  orf1ab polyprotein, I2230T</title>
	<circle cx="1224.2" cy="854.6" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G7042T  Europe=3 [0.1%]  orf1ab polyprotein, M2259I</title>
	<circle cx="1224.3" cy="851.9" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C7044T  Europe=3 [0.1%]  orf1ab polyprotein, P2260L</title>
	<circle cx="1224.3" cy="851.8" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C7224T  Europe=72 [3.2%]  orf1ab polyprotein, A2320V</title>
	<circle cx="1224.7" cy="846.3" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  T7348A  North America=3 [1.2%]  orf1ab polyprotein, N2361K</title>
	<circle cx="1225.0" cy="842.5" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C7482T  Europe=11 [0.5%]  orf1ab polyprotein, S2406L</title>
	<circle cx="1225.3" cy="838.4" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C7764T  Europe=4 [0.2%]  orf1ab polyprotein, S2500F</title>
	<circle cx="1225.9" cy="829.7" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  T7767C  Europe=256 [11.2%]  orf1ab polyprotein, I2501T</title>
	<circle cx="1225.9" cy="829.6" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G7798T  North America=3 [1.2%]  orf1ab polyprotein, K2511N</title>
	<circle cx="1226.0" cy="828.7" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C7851T  Europe=11 [0.5%]  orf1ab polyprotein, A2529V</title>
	<circle cx="1226.1" cy="827.1" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C7869T  Europe=4 [0.2%]  orf1ab polyprotein, S2535L</title>
	<circle cx="1226.1" cy="826.5" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C7926T  Europe=5 [0.2%]  orf1ab polyprotein, A2554V</title>
	<circle cx="1226.2" cy="824.8" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C8016T  Europe=3 [0.1%]  orf1ab polyprotein, A2584V</title>
	<circle cx="1226.4" cy="822.0" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A8072G  Europe=8 [0.4%]  orf1ab polyprotein, N2603D</title>
	<circle cx="1226.6" cy="820.3" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G8083A  North America=99 [39.4%]  orf1ab polyprotein, M2606I</title>
	<circle cx="1226.6" cy="819.9" r="6.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G8131T  Europe=9 [0.4%]  orf1ab polyprotein, K2622N</title>
	<circle cx="1226.7" cy="818.5" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C8139T  Europe=21 [0.9%]  orf1ab polyprotein, S2625F</title>
	<circle cx="1226.7" cy="818.2" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G8264T  North America=10 [4.0%]  orf1ab polyprotein, G2667C</title>
	<circle cx="1227.0" cy="814.4" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C8327T  Europe=43 [1.9%]  orf1ab polyprotein, L2688F</title>
	<circle cx="1227.1" cy="812.5" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C8645T  Europe=6 [0.3%]  orf1ab polyprotein, H2794Y</title>
	<circle cx="1227.8" cy="802.7" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G8648A  Europe=26 [1.1%]  orf1ab polyprotein, V2795I</title>
	<circle cx="1227.8" cy="802.6" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C8664T  Europe=7 [0.3%]  orf1ab polyprotein, T2800I</title>
	<circle cx="1227.8" cy="802.1" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G8720A  Europe=70 [3.1%]  orf1ab polyprotein, D2819N</title>
	<circle cx="1227.9" cy="800.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G8872C  Europe=33 [1.4%]  orf1ab polyprotein, L2869F</title>
	<circle cx="1228.3" cy="795.7" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C8895T  Europe=8 [0.4%]  orf1ab polyprotein, T2877I</title>
	<circle cx="1228.3" cy="795.0" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C9120T  Europe=3 [0.1%]  orf1ab polyprotein, T2952I</title>
	<circle cx="1228.8" cy="788.1" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A9204G  North America=6 [2.4%]  orf1ab polyprotein, D2980G</title>
	<circle cx="1229.0" cy="785.5" r="2.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C9438T  Europe=3 [0.1%]  orf1ab polyprotein, T3058I</title>
	<circle cx="1229.5" cy="778.4" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C9474T  Europe=7 [0.3%]  orf1ab polyprotein, A3070V</title>
	<circle cx="1229.6" cy="777.2" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C9491T  Europe=5 [0.2%]  orf1ab polyprotein, H3076Y</title>
	<circle cx="1229.6" cy="776.7" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G9526T  Europe=223 [9.8%]  orf1ab polyprotein, M3087I</title>
	<circle cx="1229.7" cy="775.7" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C9693T  Europe=13 [0.6%]  orf1ab polyprotein, A3143V</title>
	<circle cx="1230.0" cy="770.5" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G9738C  North America=3 [1.2%]  orf1ab polyprotein, S3158T</title>
	<circle cx="1230.1" cy="769.1" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C9866T  Europe=11 [0.5%]  orf1ab polyprotein, L3201F</title>
	<circle cx="1230.4" cy="765.2" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C9891T  North America=9 [3.6%]  orf1ab polyprotein, A3209V</title>
	<circle cx="1230.5" cy="764.4" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G9928T  North America=7 [2.8%]  orf1ab polyprotein, M3221I</title>
	<circle cx="1230.5" cy="763.3" r="2.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G10097A  Europe=9 [0.4%]  orf1ab polyprotein, G3278S</title>
	<circle cx="1230.9" cy="758.1" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G10097T  Europe=58 [2.5%]  orf1ab polyprotein, G3278C</title>
	<circle cx="1230.9" cy="758.1" r="2.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G10265A  Europe=24 [1.1%]  orf1ab polyprotein, G3334S</title>
	<circle cx="1231.3" cy="753.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C10277T  Europe=4 [0.2%]  orf1ab polyprotein, L3338F</title>
	<circle cx="1231.3" cy="752.6" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C10319T  North America=151 [60.2%]  orf1ab polyprotein, L3352F</title>
	<circle cx="1231.4" cy="751.3" r="7.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C10319T  Europe=5 [0.2%]  orf1ab polyprotein, L3352F</title>
	<circle cx="1231.4" cy="751.3" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A10323G  North America=6 [2.4%]  orf1ab polyprotein, K3353R</title>
	<circle cx="1231.4" cy="751.2" r="2.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A10323G  North America=6 [2.4%] Europe=22 [1.0%]  orf1ab polyprotein, K3353R</title>
	<circle cx="1231.4" cy="751.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C10376T  Europe=6 [0.3%]  orf1ab polyprotein, P3371S</title>
	<circle cx="1231.5" cy="749.6" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C10448T  Europe=7 [0.3%]  orf1ab polyprotein, P3395S</title>
	<circle cx="1231.7" cy="747.4" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C10641T  Europe=13 [0.6%]  orf1ab polyprotein, T3459M</title>
	<circle cx="1232.1" cy="741.4" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G10793T  Europe=53 [2.3%]  orf1ab polyprotein, V3510F</title>
	<circle cx="1232.4" cy="736.8" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C10833T  Europe=18 [0.8%]  orf1ab polyprotein, A3523V</title>
	<circle cx="1232.5" cy="735.5" r="1.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  TT11083T  Europe=34 [1.5%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1233.0" cy="727.9" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G11083T  Asia=3 [27.3%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1233.0" cy="727.9" r="5.8" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G11083T  North America=7 [2.8%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1233.0" cy="727.9" r="2.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G11083T  North America=7 [2.8%] Europe=45 [2.0%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1233.0" cy="727.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C11109T  Europe=5 [0.2%]  orf1ab polyprotein, A3615V</title>
	<circle cx="1233.1" cy="727.1" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G11132T  Europe=4 [0.2%]  orf1ab polyprotein, A3623S</title>
	<circle cx="1233.1" cy="726.4" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C11195T  Asia=6 [54.5%]  orf1ab polyprotein, L3644F</title>
	<circle cx="1233.3" cy="724.4" r="7.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G11230T  Europe=4 [0.2%]  orf1ab polyprotein, M3655I</title>
	<circle cx="1233.3" cy="723.3" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C11396T  Europe=9 [0.4%]  orf1ab polyprotein, L3711F</title>
	<circle cx="1233.7" cy="718.3" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G11417T  North America=3 [1.2%]  orf1ab polyprotein, V3718F</title>
	<circle cx="1233.7" cy="717.6" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A11451G  Europe=5 [0.2%]  orf1ab polyprotein, Q3729R</title>
	<circle cx="1233.8" cy="716.6" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C11514T  Europe=3 [0.1%]  orf1ab polyprotein, T3750I</title>
	<circle cx="1233.9" cy="714.6" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G11540T  Europe=4 [0.2%]  orf1ab polyprotein, V3759F</title>
	<circle cx="1234.0" cy="713.8" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G11548T  Europe=6 [0.3%]  orf1ab polyprotein, M3761I</title>
	<circle cx="1234.0" cy="713.6" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G11557T  Europe=16 [0.7%]  orf1ab polyprotein, E3764D</title>
	<circle cx="1234.0" cy="713.3" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C11591T  North America=19 [7.6%]  orf1ab polyprotein, L3776F</title>
	<circle cx="1234.1" cy="712.3" r="3.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A11595G  Europe=6 [0.3%]  orf1ab polyprotein, Q3777R</title>
	<circle cx="1234.1" cy="712.1" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A11781G  Europe=7 [0.3%]  orf1ab polyprotein, K3839R</title>
	<circle cx="1234.5" cy="706.4" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A11991G  Europe=24 [1.1%]  orf1ab polyprotein, E3909G</title>
	<circle cx="1235.0" cy="700.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A12075G  Europe=6 [0.3%]  orf1ab polyprotein, N3937S</title>
	<circle cx="1235.1" cy="697.4" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C12116T  Europe=4 [0.2%]  orf1ab polyprotein, L3951F</title>
	<circle cx="1235.2" cy="696.2" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C12119T  Europe=13 [0.6%]  orf1ab polyprotein, P3952S</title>
	<circle cx="1235.2" cy="696.1" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  T12134C  Europe=209 [9.2%]  orf1ab polyprotein, F3957L</title>
	<circle cx="1235.3" cy="695.6" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C12242T  Europe=3 [0.1%]  orf1ab polyprotein, R3993C</title>
	<circle cx="1235.5" cy="692.3" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C12455T  Europe=99 [4.3%]  orf1ab polyprotein, L4064F</title>
	<circle cx="1236.0" cy="685.7" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C12459T  Europe=7 [0.3%]  orf1ab polyprotein, T4065I</title>
	<circle cx="1236.0" cy="685.6" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C12513T  Europe=14 [0.6%]  orf1ab polyprotein, T4083M</title>
	<circle cx="1236.1" cy="684.0" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C12525T  North America=3 [1.2%]  orf1ab polyprotein, T4087I</title>
	<circle cx="1236.1" cy="683.6" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C12809T  Europe=3 [0.1%]  orf1ab polyprotein, L4182F</title>
	<circle cx="1236.7" cy="674.9" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G12824A  Europe=3 [0.1%]  orf1ab polyprotein, D4187N</title>
	<circle cx="1236.8" cy="674.4" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A12878G  North America=5 [2.0%]  orf1ab polyprotein, I4205V</title>
	<circle cx="1236.9" cy="672.8" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G12988T  Europe=165 [7.2%]  orf1ab polyprotein, M4241I</title>
	<circle cx="1237.1" cy="669.4" r="3.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C13176T  Europe=4 [0.2%]  orf1ab polyprotein, T4304I</title>
	<circle cx="1237.5" cy="663.6" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C13197T  Europe=107 [4.7%]  orf1ab polyprotein, T4311I</title>
	<circle cx="1237.6" cy="663.0" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A13277G  Europe=22 [1.0%]  orf1ab polyprotein, N4338D</title>
	<circle cx="1237.7" cy="660.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C13335T  North America=5 [2.0%]  orf1ab polyprotein, A4357V</title>
	<circle cx="1237.8" cy="658.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C13517T  Europe=40 [1.8%]  orf1ab polyprotein, T4418I</title>
	<circle cx="1238.2" cy="653.2" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C13694T  Europe=5 [0.2%]  orf1ab polyprotein, T4477I</title>
	<circle cx="1238.6" cy="647.7" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C13730T  Europe=3 [0.1%]  orf1ab polyprotein, A4489V</title>
	<circle cx="1238.7" cy="646.6" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C13862T  Europe=5 [0.2%]  orf1ab polyprotein, T4533I</title>
	<circle cx="1239.0" cy="642.6" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G13993T  Europe=221 [9.7%]  orf1ab polyprotein, A4577S</title>
	<circle cx="1239.3" cy="638.5" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C14117T  Europe=12 [0.5%]  orf1ab polyprotein, T4618M</title>
	<circle cx="1239.5" cy="634.7" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C14120T  Europe=3 [0.1%]  orf1ab polyprotein, P4619L</title>
	<circle cx="1239.5" cy="634.6" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G14202T  Europe=8 [0.4%]  orf1ab polyprotein, E4646D</title>
	<circle cx="1239.7" cy="632.1" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C14230T  Europe=38 [1.7%]  orf1ab polyprotein, P4656S</title>
	<circle cx="1239.8" cy="631.3" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C14408T  North America=251 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1240.2" cy="625.8" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C14408T  North America=251 [100.0%] Asia=11 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1240.2" cy="625.8" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C14408T  North America=251 [100.0%] Asia=11 [100.0%] Oceania=3 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1240.2" cy="625.8" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C14408T  North America=251 [100.0%] Asia=11 [100.0%] Oceania=3 [100.0%] Europe=2275 [99.8%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1240.2" cy="625.8" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G14500T  North America=3 [1.2%]  orf1ab polyprotein, V4746L</title>
	<circle cx="1240.3" cy="623.0" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G14584A  Europe=19 [0.8%]  orf1ab polyprotein, A4774T</title>
	<circle cx="1240.5" cy="620.4" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C14786T  Europe=3 [0.1%]  orf1ab polyprotein, A4841V</title>
	<circle cx="1241.0" cy="614.2" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C15026T  Europe=15 [0.7%]  orf1ab polyprotein, A4921V</title>
	<circle cx="1241.5" cy="606.8" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G15243T  Europe=4 [0.2%]  orf1ab polyprotein, M4993I</title>
	<circle cx="1241.9" cy="600.2" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A15337G  Europe=10 [0.4%]  orf1ab polyprotein, M5025V</title>
	<circle cx="1242.1" cy="597.3" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G15598A  Europe=165 [7.2%]  orf1ab polyprotein, V5112I</title>
	<circle cx="1242.7" cy="589.3" r="3.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G15652T  Europe=6 [0.3%]  orf1ab polyprotein, D5130Y</title>
	<circle cx="1242.8" cy="587.6" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G15766T  Europe=222 [9.7%]  orf1ab polyprotein, V5168L</title>
	<circle cx="1243.1" cy="584.1" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C15848T  Europe=19 [0.8%]  orf1ab polyprotein, T5195I</title>
	<circle cx="1243.2" cy="581.6" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G15906T  Europe=31 [1.4%]  orf1ab polyprotein, Q5214H</title>
	<circle cx="1243.4" cy="579.8" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A16085G  Europe=51 [2.2%]  orf1ab polyprotein, H5274R</title>
	<circle cx="1243.8" cy="574.3" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C16349T  Europe=14 [0.6%]  orf1ab polyprotein, S5362L</title>
	<circle cx="1244.3" cy="566.2" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C16394T  North America=5 [2.0%]  orf1ab polyprotein, P5377L</title>
	<circle cx="1244.4" cy="564.8" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C16394T  North America=5 [2.0%] Europe=6 [0.3%]  orf1ab polyprotein, P5377L</title>
	<circle cx="1244.4" cy="564.8" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  T16456C  Europe=3 [0.1%]  orf1ab polyprotein, S5398P</title>
	<circle cx="1244.5" cy="562.9" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A16474G  Europe=5 [0.2%]  orf1ab polyprotein, S5404G</title>
	<circle cx="1244.6" cy="562.4" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G16528T  Europe=4 [0.2%]  orf1ab polyprotein, V5422F</title>
	<circle cx="1244.7" cy="560.7" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A16748G  North America=3 [1.2%]  orf1ab polyprotein, K5495R</title>
	<circle cx="1245.2" cy="554.0" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A16889G  Europe=219 [9.6%]  orf1ab polyprotein, K5542R</title>
	<circle cx="1245.5" cy="549.6" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G16935T  Europe=3 [0.1%]  orf1ab polyprotein, M5557I</title>
	<circle cx="1245.6" cy="548.2" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C17012T  Asia=6 [54.5%]  orf1ab polyprotein, S5583L</title>
	<circle cx="1245.7" cy="545.9" r="7.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C17012T  Europe=3 [0.1%]  orf1ab polyprotein, S5583L</title>
	<circle cx="1245.7" cy="545.9" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G17014T  North America=8 [3.2%]  orf1ab polyprotein, D5584Y</title>
	<circle cx="1245.7" cy="545.8" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G17014T  North America=8 [3.2%] Europe=3 [0.1%]  orf1ab polyprotein, D5584Y</title>
	<circle cx="1245.7" cy="545.8" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G17019T  Europe=222 [9.7%]  orf1ab polyprotein, E5585D</title>
	<circle cx="1245.8" cy="545.7" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G17058T  Europe=5 [0.2%]  orf1ab polyprotein, M5598I</title>
	<circle cx="1245.8" cy="544.5" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C17104T  Europe=257 [11.3%]  orf1ab polyprotein, H5614Y</title>
	<circle cx="1245.9" cy="543.1" r="4.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G17122T  North America=16 [6.4%]  orf1ab polyprotein, A5620S</title>
	<circle cx="1246.0" cy="542.5" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G17122A  Europe=62 [2.7%]  orf1ab polyprotein, A5620T</title>
	<circle cx="1246.0" cy="542.5" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G17259T  North America=8 [3.2%]  orf1ab polyprotein, E5665D</title>
	<circle cx="1246.3" cy="538.3" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G17259T  North America=8 [3.2%] Europe=5 [0.2%]  orf1ab polyprotein, E5665D</title>
	<circle cx="1246.3" cy="538.3" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G17278T  Europe=6 [0.3%]  orf1ab polyprotein, V5672L</title>
	<circle cx="1246.3" cy="537.7" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C17288T  North America=3 [1.2%]  orf1ab polyprotein, T5675I</title>
	<circle cx="1246.3" cy="537.4" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C17440T  Europe=15 [0.7%]  orf1ab polyprotein, P5726S</title>
	<circle cx="1246.7" cy="532.7" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G17572T  Europe=75 [3.3%]  orf1ab polyprotein, A5770S</title>
	<circle cx="1246.9" cy="528.7" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A17615G  Europe=12 [0.5%]  orf1ab polyprotein, K5784R</title>
	<circle cx="1247.0" cy="527.4" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C17747T  North America=3 [1.2%]  orf1ab polyprotein, P5828L</title>
	<circle cx="1247.3" cy="523.3" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C17747A  Europe=21 [0.9%]  orf1ab polyprotein, P5828H</title>
	<circle cx="1247.3" cy="523.3" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C17999T  Europe=11 [0.5%]  orf1ab polyprotein, T5912I</title>
	<circle cx="1247.9" cy="515.6" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G18028T  Europe=162 [7.1%]  orf1ab polyprotein, A5922S</title>
	<circle cx="1247.9" cy="514.7" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C18032T  Europe=3 [0.1%]  orf1ab polyprotein, T5923I</title>
	<circle cx="1247.9" cy="514.6" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C18131T  North America=4 [1.6%]  orf1ab polyprotein, T5956I</title>
	<circle cx="1248.1" cy="511.5" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C18176T  Europe=3 [0.1%]  orf1ab polyprotein, P5971L</title>
	<circle cx="1248.2" cy="510.1" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G18186T  Europe=6 [0.3%]  orf1ab polyprotein, M5974I</title>
	<circle cx="1248.3" cy="509.8" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G18255T  North America=5 [2.0%]  orf1ab polyprotein, M5997I</title>
	<circle cx="1248.4" cy="507.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G18255T  North America=5 [2.0%] Europe=3 [0.1%]  orf1ab polyprotein, M5997I</title>
	<circle cx="1248.4" cy="507.7" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A18424G  North America=145 [57.8%]  orf1ab polyprotein, N6054D</title>
	<circle cx="1248.8" cy="502.5" r="7.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C18458T  Europe=12 [0.5%]  orf1ab polyprotein, P6065L</title>
	<circle cx="1248.8" cy="501.5" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C18508T  Europe=3 [0.1%]  orf1ab polyprotein, L6082F</title>
	<circle cx="1249.0" cy="500.0" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G18651T  Europe=4 [0.2%]  orf1ab polyprotein, E6129D</title>
	<circle cx="1249.3" cy="495.6" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C18788T  Europe=4 [0.2%]  orf1ab polyprotein, T6175I</title>
	<circle cx="1249.6" cy="491.4" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G18951T  Europe=21 [0.9%]  orf1ab polyprotein, K6229N</title>
	<circle cx="1249.9" cy="486.4" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G18985T  Europe=4 [0.2%]  orf1ab polyprotein, V6241F</title>
	<circle cx="1250.0" cy="485.3" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C19018T  Europe=13 [0.6%]  orf1ab polyprotein, P6252S</title>
	<circle cx="1250.0" cy="484.3" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C19118T  Europe=3 [0.1%]  orf1ab polyprotein, A6285V</title>
	<circle cx="1250.3" cy="481.2" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C19273T  Europe=73 [3.2%]  orf1ab polyprotein, P6337S</title>
	<circle cx="1250.6" cy="476.5" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G19398T  Europe=3 [0.1%]  orf1ab polyprotein, E6378D</title>
	<circle cx="1250.9" cy="472.6" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G19542T  Europe=9 [0.4%]  orf1ab polyprotein, M6426I</title>
	<circle cx="1251.2" cy="468.2" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G19648T  Europe=16 [0.7%]  orf1ab polyprotein, V6462L</title>
	<circle cx="1251.4" cy="465.0" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A19655G  Europe=5 [0.2%]  orf1ab polyprotein, K6464R</title>
	<circle cx="1251.4" cy="464.7" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C19718T  Europe=34 [1.5%]  orf1ab polyprotein, T6485I</title>
	<circle cx="1251.5" cy="462.8" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G19732T  Europe=3 [0.1%]  orf1ab polyprotein, V6490F</title>
	<circle cx="1251.6" cy="462.4" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C19763T  North America=4 [1.6%]  orf1ab polyprotein, T6500I</title>
	<circle cx="1251.6" cy="461.4" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C19763T  North America=4 [1.6%] Europe=3 [0.1%]  orf1ab polyprotein, T6500I</title>
	<circle cx="1251.6" cy="461.4" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C19955T  Europe=7 [0.3%]  orf1ab polyprotein, T6564I</title>
	<circle cx="1252.1" cy="455.5" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G20060T  Europe=5 [0.2%]  orf1ab polyprotein, S6599I</title>
	<circle cx="1252.3" cy="452.3" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G20102T  Europe=4 [0.2%]  orf1ab polyprotein, S6613I</title>
	<circle cx="1252.4" cy="451.0" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C20233T  Europe=5 [0.2%]  orf1ab polyprotein, P6657S</title>
	<circle cx="1252.7" cy="447.0" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G20238T  Europe=11 [0.5%]  orf1ab polyprotein, R6658S</title>
	<circle cx="1252.7" cy="446.9" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C20389T  Europe=3 [0.1%]  orf1ab polyprotein, R6709C</title>
	<circle cx="1253.0" cy="442.2" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C20762T  Europe=8 [0.4%]  orf1ab polyprotein, T6833I</title>
	<circle cx="1253.8" cy="430.8" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G20995T  Europe=8 [0.4%]  orf1ab polyprotein, G6911C</title>
	<circle cx="1254.3" cy="423.6" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A21137G  Europe=14 [0.6%]  orf1ab polyprotein, K6958R</title>
	<circle cx="1254.6" cy="419.3" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  T21154G  Europe=3 [0.1%]  orf1ab polyprotein, S6964A</title>
	<circle cx="1254.6" cy="418.7" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G21220T  Europe=5 [0.2%]  orf1ab polyprotein, A6986S</title>
	<circle cx="1254.8" cy="416.7" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C21304T  North America=139 [55.4%]  orf1ab polyprotein, R7014C</title>
	<circle cx="1255.0" cy="414.1" r="7.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C21304T  Europe=5 [0.2%]  orf1ab polyprotein, R7014C</title>
	<circle cx="1255.0" cy="414.1" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C21364T  North America=4 [1.6%]  orf1ab polyprotein, P7034S</title>
	<circle cx="1255.1" cy="412.3" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C21365T  Europe=130 [5.7%]  orf1ab polyprotein, P7034L</title>
	<circle cx="1255.1" cy="412.3" r="3.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C21431T  North America=8 [3.2%]  orf1ab polyprotein, A7056V</title>
	<circle cx="1255.2" cy="410.2" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C21575T  North America=8 [3.2%]  surface glycoprotein, L5F</title>
	<circle cx="1255.5" cy="405.8" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C21575T  North America=8 [3.2%] Europe=44 [1.9%]  surface glycoprotein, L5F</title>
	<circle cx="1255.5" cy="405.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C21597T  Europe=16 [0.7%]  surface glycoprotein, S12F</title>
	<circle cx="1255.6" cy="405.1" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G21600T  North America=8 [3.2%]  surface glycoprotein, S13I</title>
	<circle cx="1255.6" cy="405.0" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G21600T  North America=8 [3.2%] Europe=4 [0.2%]  surface glycoprotein, S13I</title>
	<circle cx="1255.6" cy="405.0" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C21614T  Europe=139 [6.1%]  surface glycoprotein, L18F</title>
	<circle cx="1255.6" cy="404.6" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C21621T  Europe=5 [0.2%]  surface glycoprotein, T20I</title>
	<circle cx="1255.6" cy="404.4" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C21638T  North America=3 [1.2%]  surface glycoprotein, P26S</title>
	<circle cx="1255.7" cy="403.9" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C21707T  Europe=10 [0.4%]  surface glycoprotein, H49Y</title>
	<circle cx="1255.8" cy="401.8" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C21762T  Europe=3 [0.1%]  surface glycoprotein, A67V</title>
	<circle cx="1255.9" cy="400.1" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C21846T  Europe=7 [0.3%]  surface glycoprotein, T95I</title>
	<circle cx="1256.1" cy="397.5" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C21855T  Europe=170 [7.5%]  surface glycoprotein, S98F</title>
	<circle cx="1256.1" cy="397.2" r="3.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G21974T  Europe=3 [0.1%]  surface glycoprotein, D138Y</title>
	<circle cx="1256.4" cy="393.6" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G21989T  Europe=57 [2.5%]  surface glycoprotein, V143F</title>
	<circle cx="1256.4" cy="393.1" r="2.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  ATTA21993A  Europe=25 [1.1%]  surface glycoprotein, Y145H</title>
	<circle cx="1256.4" cy="393.0" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G22018T  North America=8 [3.2%]  surface glycoprotein, W152C</title>
	<circle cx="1256.5" cy="392.2" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G22018T  North America=8 [3.2%] Europe=3 [0.1%]  surface glycoprotein, W152C</title>
	<circle cx="1256.5" cy="392.2" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  T22020C  Europe=3 [0.1%]  surface glycoprotein, M153T</title>
	<circle cx="1256.5" cy="392.2" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C22079A  North America=3 [1.2%]  surface glycoprotein, Q173K</title>
	<circle cx="1256.6" cy="390.3" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C22088T  Europe=7 [0.3%]  surface glycoprotein, L176F</title>
	<circle cx="1256.6" cy="390.1" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G22103C  Europe=3 [0.1%]  surface glycoprotein, G181R</title>
	<circle cx="1256.7" cy="389.6" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C22127T  Europe=3 [0.1%]  surface glycoprotein, L189F</title>
	<circle cx="1256.7" cy="388.9" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  ATTA22190A  Europe=10 [0.4%]  surface glycoprotein, I210N</title>
	<circle cx="1256.9" cy="386.9" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G22203T  Europe=4 [0.2%]  surface glycoprotein, R214L</title>
	<circle cx="1256.9" cy="386.5" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G22205C  Europe=4 [0.2%]  surface glycoprotein, D215H</title>
	<circle cx="1256.9" cy="386.5" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C22227T  Europe=1343 [58.9%]  surface glycoprotein, A222V</title>
	<circle cx="1256.9" cy="385.8" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A22259G  Europe=38 [1.7%]  surface glycoprotein, I233V</title>
	<circle cx="1257.0" cy="384.8" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A22320G  Europe=3 [0.1%]  surface glycoprotein, D253G</title>
	<circle cx="1257.1" cy="382.9" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G22346T  Europe=19 [0.8%]  surface glycoprotein, A262S</title>
	<circle cx="1257.2" cy="382.2" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C22377T  Europe=15 [0.7%]  surface glycoprotein, P272L</title>
	<circle cx="1257.3" cy="381.2" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C22879A  Asia=6 [54.5%]  surface glycoprotein, N439K</title>
	<circle cx="1258.3" cy="365.8" r="7.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C22879A  Europe=257 [11.3%]  surface glycoprotein, N439K</title>
	<circle cx="1258.3" cy="365.8" r="4.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  T22917G  North America=8 [3.2%]  surface glycoprotein, L452R</title>
	<circle cx="1258.4" cy="364.6" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  T22917G  North America=8 [3.2%] Europe=6 [0.3%]  surface glycoprotein, L452R</title>
	<circle cx="1258.4" cy="364.6" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G22992A  Europe=277 [12.1%]  surface glycoprotein, S477N</title>
	<circle cx="1258.6" cy="362.3" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C22993G  Europe=19 [0.8%]  surface glycoprotein, S477R</title>
	<circle cx="1258.6" cy="362.3" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  T23042C  North America=3 [1.2%]  surface glycoprotein, S494P</title>
	<circle cx="1258.7" cy="360.8" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A23063T  Europe=16 [0.7%]  surface glycoprotein, N501Y</title>
	<circle cx="1258.7" cy="360.1" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A23064C  North America=4 [1.6%]  surface glycoprotein, N501T</title>
	<circle cx="1258.7" cy="360.1" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C23271A  Europe=15 [0.7%]  surface glycoprotein, A570D</title>
	<circle cx="1259.2" cy="353.8" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A23403G  North America=251 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1259.5" cy="349.7" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A23403G  North America=251 [100.0%] Asia=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1259.5" cy="349.7" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A23403G  North America=251 [100.0%] Asia=11 [100.0%] Oceania=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1259.5" cy="349.7" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A23403G  North America=251 [100.0%] Asia=11 [100.0%] Oceania=3 [100.0%] Europe=2276 [99.8%]  surface glycoprotein, D614G</title>
	<circle cx="1259.5" cy="349.7" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G23438T  Europe=5 [0.2%]  surface glycoprotein, A626S</title>
	<circle cx="1259.5" cy="348.6" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C23481T  Europe=3 [0.1%]  surface glycoprotein, S640F</title>
	<circle cx="1259.6" cy="347.3" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G23522C  Europe=5 [0.2%]  surface glycoprotein, E654Q</title>
	<circle cx="1259.7" cy="346.1" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G23580C  Europe=20 [0.9%]  surface glycoprotein, S673T</title>
	<circle cx="1259.8" cy="344.3" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G23587T  Europe=3 [0.1%]  surface glycoprotein, Q675H</title>
	<circle cx="1259.9" cy="344.1" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G23587C  North America=3 [1.2%]  surface glycoprotein, Q675H</title>
	<circle cx="1259.9" cy="344.1" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G23593T  North America=10 [4.0%]  surface glycoprotein, Q677H</title>
	<circle cx="1259.9" cy="343.9" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G23593T  North America=10 [4.0%] Europe=27 [1.2%]  surface glycoprotein, Q677H</title>
	<circle cx="1259.9" cy="343.9" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G23593C  North America=5 [2.0%]  surface glycoprotein, Q677H</title>
	<circle cx="1259.9" cy="343.9" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  T23599A  Europe=21 [0.9%]  surface glycoprotein, N679K</title>
	<circle cx="1259.9" cy="343.7" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C23604A  North America=12 [4.8%]  surface glycoprotein, P681H</title>
	<circle cx="1259.9" cy="343.5" r="3.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C23604A  North America=12 [4.8%] Europe=27 [1.2%]  surface glycoprotein, P681H</title>
	<circle cx="1259.9" cy="343.5" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C23604G  Asia=7 [63.6%]  surface glycoprotein, P681R</title>
	<circle cx="1259.9" cy="343.5" r="7.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C23604G  Europe=3 [0.1%]  surface glycoprotein, P681R</title>
	<circle cx="1259.9" cy="343.5" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C23625T  Europe=12 [0.5%]  surface glycoprotein, A688V</title>
	<circle cx="1259.9" cy="342.9" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C23709T  Europe=19 [0.8%]  surface glycoprotein, T716I</title>
	<circle cx="1260.1" cy="340.3" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A23756G  North America=4 [1.6%]  surface glycoprotein, T732A</title>
	<circle cx="1260.2" cy="338.9" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G23868T  North America=3 [1.2%]  surface glycoprotein, G769V</title>
	<circle cx="1260.5" cy="335.4" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G23876A  Europe=3 [0.1%]  surface glycoprotein, V772I</title>
	<circle cx="1260.5" cy="335.2" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G24000T  Europe=26 [1.1%]  surface glycoprotein, S813I</title>
	<circle cx="1260.7" cy="331.4" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C24138T  North America=3 [1.2%]  surface glycoprotein, T859I</title>
	<circle cx="1261.0" cy="327.1" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C24138T  North America=3 [1.2%] Europe=7 [0.3%]  surface glycoprotein, T859I</title>
	<circle cx="1261.0" cy="327.1" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C24374T  Europe=3 [0.1%]  surface glycoprotein, L938F</title>
	<circle cx="1261.5" cy="319.9" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C24378T  Europe=14 [0.6%]  surface glycoprotein, S939F</title>
	<circle cx="1261.6" cy="319.8" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  T24506G  Europe=15 [0.7%]  surface glycoprotein, S982A</title>
	<circle cx="1261.8" cy="315.9" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G24620T  Europe=31 [1.4%]  surface glycoprotein, A1020S</title>
	<circle cx="1262.1" cy="312.4" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C24767T  Europe=3 [0.1%]  surface glycoprotein, P1069S</title>
	<circle cx="1262.4" cy="307.8" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A24774T  Europe=5 [0.2%]  surface glycoprotein, Q1071L</title>
	<circle cx="1262.4" cy="307.6" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A24780C  Europe=47 [2.1%]  surface glycoprotein, K1073T</title>
	<circle cx="1262.4" cy="307.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G24794T  Europe=47 [2.1%]  surface glycoprotein, A1078S</title>
	<circle cx="1262.4" cy="307.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G24816C  Europe=7 [0.3%]  surface glycoprotein, G1085A</title>
	<circle cx="1262.5" cy="306.3" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G24821T  Europe=3 [0.1%]  surface glycoprotein, A1087S</title>
	<circle cx="1262.5" cy="306.2" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G24914C  Europe=15 [0.7%]  surface glycoprotein, D1118H</title>
	<circle cx="1262.7" cy="303.3" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G24926T  Europe=4 [0.2%]  surface glycoprotein, V1122L</title>
	<circle cx="1262.7" cy="303.0" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25046T  Europe=18 [0.8%]  surface glycoprotein, P1162S</title>
	<circle cx="1263.0" cy="299.3" r="1.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25047G  Europe=3 [0.1%]  surface glycoprotein, P1162R</title>
	<circle cx="1263.0" cy="299.2" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25049T  Europe=17 [0.7%]  surface glycoprotein, D1163Y</title>
	<circle cx="1263.0" cy="299.2" r="1.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25166C  Europe=8 [0.4%]  surface glycoprotein, E1202Q</title>
	<circle cx="1263.2" cy="295.6" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25217T  Europe=36 [1.6%]  surface glycoprotein, G1219C</title>
	<circle cx="1263.4" cy="294.0" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25218T  Europe=5 [0.2%]  surface glycoprotein, G1219V</title>
	<circle cx="1263.4" cy="294.0" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25229A  Europe=4 [0.2%]  surface glycoprotein, G1223S</title>
	<circle cx="1263.4" cy="293.7" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25244T  North America=6 [2.4%]  surface glycoprotein, V1228L</title>
	<circle cx="1263.4" cy="293.2" r="2.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25244T  North America=6 [2.4%] Europe=3 [0.1%]  surface glycoprotein, V1228L</title>
	<circle cx="1263.4" cy="293.2" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25317T  Europe=4 [0.2%]  surface glycoprotein, S1252F</title>
	<circle cx="1263.6" cy="291.0" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25352T  Europe=7 [0.3%]  surface glycoprotein, V1264L</title>
	<circle cx="1263.6" cy="289.9" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25433T  Europe=3 [0.1%]  ORF3a protein, T14I</title>
	<circle cx="1263.8" cy="287.4" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25437T  Europe=5 [0.2%]  ORF3a protein, L15F</title>
	<circle cx="1263.8" cy="287.3" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A25450G  Europe=71 [3.1%]  ORF3a protein, I20V</title>
	<circle cx="1263.9" cy="286.9" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25459T  Europe=5 [0.2%]  ORF3a protein, A23S</title>
	<circle cx="1263.9" cy="286.6" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25460T  Europe=4 [0.2%]  ORF3a protein, A23V</title>
	<circle cx="1263.9" cy="286.6" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25471T  Europe=33 [1.4%]  ORF3a protein, D27Y</title>
	<circle cx="1263.9" cy="286.2" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25487T  Europe=3 [0.1%]  ORF3a protein, T32I</title>
	<circle cx="1263.9" cy="285.7" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25489T  Europe=3 [0.1%]  ORF3a protein, A33S</title>
	<circle cx="1263.9" cy="285.7" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A25505G  Europe=153 [6.7%]  ORF3a protein, Q38R</title>
	<circle cx="1264.0" cy="285.2" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25552T  Europe=4 [0.2%]  ORF3a protein, A54S</title>
	<circle cx="1264.1" cy="283.7" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25563T  Asia=10 [90.9%]  ORF3a protein, Q57H</title>
	<circle cx="1264.1" cy="283.4" r="7.9" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25563T  North America=179 [71.3%]  ORF3a protein, Q57H</title>
	<circle cx="1264.1" cy="283.4" r="7.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25563T  Europe=289 [12.7%]  ORF3a protein, Q57H</title>
	<circle cx="1264.1" cy="283.4" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25583T  Europe=3 [0.1%]  ORF3a protein, T64I</title>
	<circle cx="1264.1" cy="282.8" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25606T  Europe=16 [0.7%]  ORF3a protein, A72S</title>
	<circle cx="1264.2" cy="282.1" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25613T  Europe=3 [0.1%]  ORF3a protein, S74F</title>
	<circle cx="1264.2" cy="281.9" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25621T  Europe=55 [2.4%]  ORF3a protein, V77F</title>
	<circle cx="1264.2" cy="281.6" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25624T  North America=5 [2.0%]  ORF3a protein, H78Y</title>
	<circle cx="1264.2" cy="281.5" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25624T  North America=5 [2.0%] Europe=4 [0.2%]  ORF3a protein, H78Y</title>
	<circle cx="1264.2" cy="281.5" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25647T  Europe=94 [4.1%]  ORF3a protein, L85F</title>
	<circle cx="1264.3" cy="280.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25690T  Europe=3 [0.1%]  ORF3a protein, G100C</title>
	<circle cx="1264.4" cy="279.5" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25708T  Europe=7 [0.3%]  ORF3a protein, L106F</title>
	<circle cx="1264.4" cy="279.0" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25714T  North America=9 [3.6%]  ORF3a protein, L108F</title>
	<circle cx="1264.4" cy="278.8" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25720T  Europe=31 [1.4%]  ORF3a protein, A110S</title>
	<circle cx="1264.4" cy="278.6" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  T25724C  Europe=29 [1.3%]  ORF3a protein, L111S</title>
	<circle cx="1264.4" cy="278.5" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25726T  North America=5 [2.0%]  ORF3a protein, V112F</title>
	<circle cx="1264.4" cy="278.4" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25757T  Europe=381 [16.7%]  ORF3a protein, R122I</title>
	<circle cx="1264.5" cy="277.5" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25777T  Europe=5 [0.2%]  ORF3a protein, L129F</title>
	<circle cx="1264.6" cy="276.8" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25785T  North America=3 [1.2%]  ORF3a protein, W131C</title>
	<circle cx="1264.6" cy="276.6" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25785T  North America=3 [1.2%] Europe=7 [0.3%]  ORF3a protein, W131C</title>
	<circle cx="1264.6" cy="276.6" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25810T  Europe=11 [0.5%]  ORF3a protein, L140F</title>
	<circle cx="1264.6" cy="275.8" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25844T  North America=13 [5.2%]  ORF3a protein, T151I</title>
	<circle cx="1264.7" cy="274.8" r="3.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25844T  Europe=3 [0.1%]  ORF3a protein, T151I</title>
	<circle cx="1264.7" cy="274.8" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25855T  North America=11 [4.4%]  ORF3a protein, D155Y</title>
	<circle cx="1264.7" cy="274.4" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25886T  Europe=12 [0.5%]  ORF3a protein, S165F</title>
	<circle cx="1264.8" cy="273.5" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25889T  North America=13 [5.2%]  ORF3a protein, S166L</title>
	<circle cx="1264.8" cy="273.4" r="3.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25889T  North America=13 [5.2%] Europe=8 [0.4%]  ORF3a protein, S166L</title>
	<circle cx="1264.8" cy="273.4" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25904T  Europe=5 [0.2%]  ORF3a protein, S171L</title>
	<circle cx="1264.8" cy="272.9" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25906T  Europe=4 [0.2%]  ORF3a protein, G172C</title>
	<circle cx="1264.8" cy="272.9" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25906C  Europe=153 [6.7%]  ORF3a protein, G172R</title>
	<circle cx="1264.8" cy="272.9" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25907T  North America=145 [57.8%]  ORF3a protein, G172V</title>
	<circle cx="1264.8" cy="272.8" r="7.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25907T  Europe=3 [0.1%]  ORF3a protein, G172V</title>
	<circle cx="1264.8" cy="272.8" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A25910G  Europe=8 [0.4%]  ORF3a protein, D173G</title>
	<circle cx="1264.8" cy="272.8" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25913A  Europe=51 [2.2%]  ORF3a protein, G174D</title>
	<circle cx="1264.8" cy="272.7" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C25916T  Europe=4 [0.2%]  ORF3a protein, T175I</title>
	<circle cx="1264.9" cy="272.6" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25947T  Europe=3 [0.1%]  ORF3a protein, Q185H</title>
	<circle cx="1264.9" cy="271.6" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G25996T  Europe=155 [6.8%]  ORF3a protein, V202L</title>
	<circle cx="1265.0" cy="270.1" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C26060A  Europe=5 [0.2%]  ORF3a protein, T223N</title>
	<circle cx="1265.2" cy="268.2" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C26060T  North America=11 [4.4%]  ORF3a protein, T223I</title>
	<circle cx="1265.2" cy="268.2" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C26060T  North America=11 [4.4%] Europe=40 [1.8%]  ORF3a protein, T223I</title>
	<circle cx="1265.2" cy="268.2" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G26062T  Europe=6 [0.3%]  ORF3a protein, G224C</title>
	<circle cx="1265.2" cy="268.1" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A26069G  North America=16 [6.4%]  ORF3a protein, E226G</title>
	<circle cx="1265.2" cy="267.9" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C26078T  Europe=6 [0.3%]  ORF3a protein, T229I</title>
	<circle cx="1265.2" cy="267.6" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C26110T  Europe=4 [0.2%]  ORF3a protein, P240S</title>
	<circle cx="1265.3" cy="266.6" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C26150T  Europe=49 [2.1%]  ORF3a protein, S253F</title>
	<circle cx="1265.4" cy="265.4" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C26195T  Europe=6 [0.3%]  ORF3a protein, T268M</title>
	<circle cx="1265.5" cy="264.0" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C26198T  Europe=7 [0.3%]  ORF3a protein, T269M</title>
	<circle cx="1265.5" cy="263.9" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G26217T  Europe=19 [0.8%]  ORF3a protein, L275F</title>
	<circle cx="1265.5" cy="263.3" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C26305T  Europe=5 [0.2%]  envelope protein, L21F</title>
	<circle cx="1265.7" cy="260.6" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A26530G  Europe=51 [2.2%]  membrane glycoprotein, D3G</title>
	<circle cx="1266.2" cy="253.7" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A26664G  North America=7 [2.8%]  membrane glycoprotein, I48V</title>
	<circle cx="1266.5" cy="249.6" r="2.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G26727T  Europe=3 [0.1%]  membrane glycoprotein, A69S</title>
	<circle cx="1266.6" cy="247.7" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C26895T  Europe=4 [0.2%]  membrane glycoprotein, H125Y</title>
	<circle cx="1267.0" cy="242.5" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  T27220C  Europe=4 [0.2%]  ORF6 protein, F7L</title>
	<circle cx="1267.7" cy="232.5" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C27434T  North America=9 [3.6%]  ORF7a protein, T14I</title>
	<circle cx="1268.1" cy="226.0" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C27434T  North America=9 [3.6%] Europe=27 [1.2%]  ORF7a protein, T14I</title>
	<circle cx="1268.1" cy="226.0" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G27463T  Europe=5 [0.2%]  ORF7a protein, V24F</title>
	<circle cx="1268.2" cy="225.1" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C27476T  Europe=4 [0.2%]  ORF7a protein, T28I</title>
	<circle cx="1268.2" cy="224.7" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C27527G  Europe=21 [0.9%]  ORF7a protein, P45R</title>
	<circle cx="1268.3" cy="223.1" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A27579T  Europe=26 [1.1%]  ORF7a protein, Q62H</title>
	<circle cx="1268.4" cy="221.5" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G27670T  North America=3 [1.2%]  ORF7a protein, V93F</title>
	<circle cx="1268.6" cy="218.7" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A27674T  Europe=3 [0.1%]  ORF7a protein, Q94L</title>
	<circle cx="1268.6" cy="218.6" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C27752T  Europe=3 [0.1%]  ORF7a protein, T120I</title>
	<circle cx="1268.8" cy="216.2" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  T27900C  Europe=19 [0.8%]  ORF8 protein, F3L</title>
	<circle cx="1269.1" cy="211.7" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G27915A  North America=5 [2.0%]  ORF8 protein, G8R</title>
	<circle cx="1269.1" cy="211.2" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C27945T  Europe=5 [0.2%]  ORF8 protein, Q18*</title>
	<circle cx="1269.2" cy="210.3" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C27964T  North America=149 [59.4%]  ORF8 protein, S24L</title>
	<circle cx="1269.2" cy="209.7" r="7.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C27964T  Europe=6 [0.3%]  ORF8 protein, S24L</title>
	<circle cx="1269.2" cy="209.7" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C27972T  Europe=15 [0.7%]  ORF8 protein, Q27*</title>
	<circle cx="1269.3" cy="209.5" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G27996T  Europe=33 [1.4%]  ORF8 protein, D35Y</title>
	<circle cx="1269.3" cy="208.7" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28011T  Europe=15 [0.7%]  ORF8 protein, H40Y</title>
	<circle cx="1269.3" cy="208.3" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28045T  Europe=10 [0.4%]  ORF8 protein, A51V</title>
	<circle cx="1269.4" cy="207.2" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G28048T  Europe=15 [0.7%]  ORF8 protein, R52I</title>
	<circle cx="1269.4" cy="207.1" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G28077T  Europe=7 [0.3%]  ORF8 protein, V62L</title>
	<circle cx="1269.5" cy="206.2" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G28083T  Europe=3 [0.1%]  ORF8 protein, E64*</title>
	<circle cx="1269.5" cy="206.1" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28087T  Europe=64 [2.8%]  ORF8 protein, A65V</title>
	<circle cx="1269.5" cy="205.9" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A28111G  Europe=14 [0.6%]  ORF8 protein, Y73C</title>
	<circle cx="1269.6" cy="205.2" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28292A  Europe=7 [0.3%]  nucleocapsid phosphoprotein, Q7K</title>
	<circle cx="1270.0" cy="199.6" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A28295T  Europe=26 [1.1%]  nucleocapsid phosphoprotein, N8Y</title>
	<circle cx="1270.0" cy="199.6" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28310T  Europe=5 [0.2%]  nucleocapsid phosphoprotein, P13S</title>
	<circle cx="1270.0" cy="199.1" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28310A  Europe=3 [0.1%]  nucleocapsid phosphoprotein, P13T</title>
	<circle cx="1270.0" cy="199.1" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28311T  North America=3 [1.2%]  nucleocapsid phosphoprotein, P13L</title>
	<circle cx="1270.0" cy="199.1" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G28346T  Europe=15 [0.7%]  nucleocapsid phosphoprotein, G25C</title>
	<circle cx="1270.1" cy="198.0" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  A28370G  Europe=50 [2.2%]  nucleocapsid phosphoprotein, S33G</title>
	<circle cx="1270.1" cy="197.2" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G28373T  Europe=5 [0.2%]  nucleocapsid phosphoprotein, G34W</title>
	<circle cx="1270.1" cy="197.2" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28472T  North America=146 [58.2%]  nucleocapsid phosphoprotein, P67S</title>
	<circle cx="1270.3" cy="194.1" r="7.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28472T  Europe=3 [0.1%]  nucleocapsid phosphoprotein, P67S</title>
	<circle cx="1270.3" cy="194.1" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G28580T  Europe=10 [0.4%]  nucleocapsid phosphoprotein, D103Y</title>
	<circle cx="1270.6" cy="190.8" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G28655T  Europe=12 [0.5%]  nucleocapsid phosphoprotein, D128Y</title>
	<circle cx="1270.7" cy="188.5" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G28690T  North America=6 [2.4%]  nucleocapsid phosphoprotein, L139F</title>
	<circle cx="1270.8" cy="187.4" r="2.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G28703T  Europe=4 [0.2%]  nucleocapsid phosphoprotein, D144Y</title>
	<circle cx="1270.8" cy="187.0" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28854T  Asia=3 [27.3%]  nucleocapsid phosphoprotein, S194L</title>
	<circle cx="1271.2" cy="182.4" r="5.8" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28854T  North America=33 [13.1%]  nucleocapsid phosphoprotein, S194L</title>
	<circle cx="1271.2" cy="182.4" r="4.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28854T  Europe=63 [2.8%]  nucleocapsid phosphoprotein, S194L</title>
	<circle cx="1271.2" cy="182.4" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28869T  North America=145 [57.8%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1271.2" cy="181.9" r="7.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28869T  Europe=155 [6.8%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1271.2" cy="181.9" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28887T  Asia=6 [54.5%]  nucleocapsid phosphoprotein, T205I</title>
	<circle cx="1271.2" cy="181.4" r="7.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28887T  North America=18 [7.2%]  nucleocapsid phosphoprotein, T205I</title>
	<circle cx="1271.2" cy="181.4" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28887T  Europe=8 [0.4%]  nucleocapsid phosphoprotein, T205I</title>
	<circle cx="1271.2" cy="181.4" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28890T  North America=3 [1.2%]  nucleocapsid phosphoprotein, S206F</title>
	<circle cx="1271.2" cy="181.3" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28892T  North America=4 [1.6%]  nucleocapsid phosphoprotein, P207S</title>
	<circle cx="1271.2" cy="181.2" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28932T  Europe=1338 [58.7%]  nucleocapsid phosphoprotein, A220V</title>
	<circle cx="1271.3" cy="180.0" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G28975T  Europe=10 [0.4%]  nucleocapsid phosphoprotein, M234I</title>
	<circle cx="1271.4" cy="178.7" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G28975C  Europe=221 [9.7%]  nucleocapsid phosphoprotein, M234I</title>
	<circle cx="1271.4" cy="178.7" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28977T  North America=4 [1.6%]  nucleocapsid phosphoprotein, S235F</title>
	<circle cx="1271.4" cy="178.6" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C28977T  North America=4 [1.6%] Europe=15 [0.7%]  nucleocapsid phosphoprotein, S235F</title>
	<circle cx="1271.4" cy="178.6" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G29000T  Europe=10 [0.4%]  nucleocapsid phosphoprotein, G243C</title>
	<circle cx="1271.5" cy="177.9" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G29140T  Europe=4 [0.2%]  nucleocapsid phosphoprotein, Q289H</title>
	<circle cx="1271.8" cy="173.6" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C29253T  Europe=5 [0.2%]  nucleocapsid phosphoprotein, S327L</title>
	<circle cx="1272.0" cy="170.1" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C29358T  North America=3 [1.2%]  nucleocapsid phosphoprotein, T362I</title>
	<circle cx="1272.2" cy="166.9" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C29358T  North America=3 [1.2%] Europe=6 [0.3%]  nucleocapsid phosphoprotein, T362I</title>
	<circle cx="1272.2" cy="166.9" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C29364T  North America=3 [1.2%]  nucleocapsid phosphoprotein, P364L</title>
	<circle cx="1272.3" cy="166.7" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C29366T  Europe=572 [25.1%]  nucleocapsid phosphoprotein, P365S</title>
	<circle cx="1272.3" cy="166.7" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C29370T  Europe=4 [0.2%]  nucleocapsid phosphoprotein, T366I</title>
	<circle cx="1272.3" cy="166.6" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G29399A  Europe=219 [9.6%]  nucleocapsid phosphoprotein, A376T</title>
	<circle cx="1272.3" cy="165.7" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G29402T  North America=72 [28.7%]  nucleocapsid phosphoprotein, D377Y</title>
	<circle cx="1272.3" cy="165.6" r="5.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G29402T  Europe=81 [3.6%]  nucleocapsid phosphoprotein, D377Y</title>
	<circle cx="1272.3" cy="165.6" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C29409T  North America=3 [1.2%]  nucleocapsid phosphoprotein, T379I</title>
	<circle cx="1272.3" cy="165.4" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C29420T  Europe=26 [1.1%]  nucleocapsid phosphoprotein, P383S</title>
	<circle cx="1272.4" cy="165.0" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G29427A  Europe=6 [0.3%]  nucleocapsid phosphoprotein, R385K</title>
	<circle cx="1272.4" cy="164.8" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C29445T  North America=6 [2.4%]  nucleocapsid phosphoprotein, T391I</title>
	<circle cx="1272.4" cy="164.3" r="2.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C29466T  Europe=9 [0.4%]  nucleocapsid phosphoprotein, A398V</title>
	<circle cx="1272.5" cy="163.6" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G29474T  Europe=24 [1.1%]  nucleocapsid phosphoprotein, D401Y</title>
	<circle cx="1272.5" cy="163.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G29511T  Europe=5 [0.2%]  nucleocapsid phosphoprotein, S413I</title>
	<circle cx="1272.6" cy="162.2" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  C29520T  Europe=9 [0.4%]  nucleocapsid phosphoprotein, S416L</title>
	<circle cx="1272.6" cy="162.0" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  TT29589T  Europe=47 [2.1%]  ORF10 protein, F11L</title>
	<circle cx="1272.7" cy="159.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-04  G29645T  Europe=1301 [57.1%]  ORF10 protein, V30L</title>
	<circle cx="1272.9" cy="158.1" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05 Europe: 59 samples</title>
	<line x1="1201.7" y1="1180.1" x2="1203.0" y2="1165.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-05 North America: 121 samples</title>
	<line x1="1203.0" y1="1165.9" x2="1204.4" y2="1149.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-05 Asia: 3 samples</title>
	<line x1="1204.4" y1="1149.3" x2="1204.9" y2="1144.5" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-05  C335T  Europe=6 [10.2%]  orf1ab polyprotein, R24C</title>
	<circle cx="1212.4" cy="1058.0" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C936T  North America=8 [6.6%]  orf1ab polyprotein, T224I</title>
	<circle cx="1214.0" cy="1039.5" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C1059T  North America=85 [70.2%]  orf1ab polyprotein, T265I</title>
	<circle cx="1214.4" cy="1035.8" r="7.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G1181T  North America=3 [2.5%]  orf1ab polyprotein, V306F</title>
	<circle cx="1214.7" cy="1032.0" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  T1578C  North America=3 [2.5%]  orf1ab polyprotein, V438A</title>
	<circle cx="1215.8" cy="1019.9" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G2258A  North America=5 [4.1%]  orf1ab polyprotein, V665I</title>
	<circle cx="1217.6" cy="999.0" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  A2342G  North America=7 [5.8%]  orf1ab polyprotein, I693V</title>
	<circle cx="1217.8" cy="996.4" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C2445T  North America=6 [5.0%]  orf1ab polyprotein, T727I</title>
	<circle cx="1218.1" cy="993.3" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G3259T  North America=7 [5.8%]  orf1ab polyprotein, Q998H</title>
	<circle cx="1220.3" cy="968.3" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C3267T  Europe=4 [6.8%]  orf1ab polyprotein, T1001I</title>
	<circle cx="1220.3" cy="968.1" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C3602T  Europe=11 [18.6%]  orf1ab polyprotein, H1113Y</title>
	<circle cx="1221.2" cy="957.8" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C3738T  North America=3 [2.5%]  orf1ab polyprotein, P1158L</title>
	<circle cx="1221.6" cy="953.6" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  A4040G  Europe=6 [10.2%]  orf1ab polyprotein, I1259V</title>
	<circle cx="1222.4" cy="944.4" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C5388A  Europe=4 [6.8%]  orf1ab polyprotein, A1708D</title>
	<circle cx="1226.0" cy="903.1" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C5622T  North America=6 [5.0%]  orf1ab polyprotein, P1786L</title>
	<circle cx="1226.6" cy="895.9" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  A6441G  North America=5 [4.1%]  orf1ab polyprotein, K2059R</title>
	<circle cx="1228.8" cy="870.8" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G6618A  North America=5 [4.1%]  orf1ab polyprotein, G2118D</title>
	<circle cx="1229.3" cy="865.4" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C6629T  North America=3 [2.5%]  orf1ab polyprotein, L2122F</title>
	<circle cx="1229.3" cy="865.0" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  T6954C  Europe=4 [6.8%]  orf1ab polyprotein, I2230T</title>
	<circle cx="1230.2" cy="855.1" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  T7767C  Europe=4 [6.8%]  orf1ab polyprotein, I2501T</title>
	<circle cx="1232.4" cy="830.2" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G8083A  North America=39 [32.2%]  orf1ab polyprotein, M2606I</title>
	<circle cx="1233.2" cy="820.5" r="6.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G8264T  North America=3 [2.5%]  orf1ab polyprotein, G2667C</title>
	<circle cx="1233.7" cy="814.9" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  A9204G  North America=5 [4.1%]  orf1ab polyprotein, D2980G</title>
	<circle cx="1236.2" cy="786.1" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G9526T  Europe=3 [5.1%]  orf1ab polyprotein, M3087I</title>
	<circle cx="1237.1" cy="776.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C9693T  Europe=4 [6.8%]  orf1ab polyprotein, A3143V</title>
	<circle cx="1237.5" cy="771.1" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G10265A  Europe=5 [8.5%]  orf1ab polyprotein, G3334S</title>
	<circle cx="1239.1" cy="753.6" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C10319T  North America=74 [61.2%]  orf1ab polyprotein, L3352F</title>
	<circle cx="1239.2" cy="751.9" r="7.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C10341T  North America=3 [2.5%]  orf1ab polyprotein, P3359L</title>
	<circle cx="1239.3" cy="751.3" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G11083T  Europe=4 [6.8%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1241.3" cy="728.5" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C11514T  North America=6 [5.0%]  orf1ab polyprotein, T3750I</title>
	<circle cx="1242.4" cy="715.3" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C11591T  North America=7 [5.8%]  orf1ab polyprotein, L3776F</title>
	<circle cx="1242.6" cy="712.9" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G11939A  North America=3 [2.5%]  orf1ab polyprotein, V3892I</title>
	<circle cx="1243.5" cy="702.3" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  A12878G  North America=4 [3.3%]  orf1ab polyprotein, I4205V</title>
	<circle cx="1246.1" cy="673.5" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G13993T  Europe=3 [5.1%]  orf1ab polyprotein, A4577S</title>
	<circle cx="1249.1" cy="639.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C14408T  North America=121 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1250.2" cy="626.6" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C14408T  North America=121 [100.0%] Europe=59 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1250.2" cy="626.6" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C14408T  North America=121 [100.0%] Europe=59 [100.0%] Asia=3 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1250.2" cy="626.6" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G14500T  North America=6 [5.0%]  orf1ab polyprotein, V4746L</title>
	<circle cx="1250.4" cy="623.8" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C15352T  North America=3 [2.5%]  orf1ab polyprotein, L5030F</title>
	<circle cx="1252.7" cy="597.7" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G15766T  Europe=3 [5.1%]  orf1ab polyprotein, V5168L</title>
	<circle cx="1253.8" cy="585.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  A16889G  Europe=3 [5.1%]  orf1ab polyprotein, K5542R</title>
	<circle cx="1256.8" cy="550.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G17014T  North America=6 [5.0%]  orf1ab polyprotein, D5584Y</title>
	<circle cx="1257.2" cy="546.7" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G17019T  Europe=3 [5.1%]  orf1ab polyprotein, E5585D</title>
	<circle cx="1257.2" cy="546.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C17104T  Europe=4 [6.8%]  orf1ab polyprotein, H5614Y</title>
	<circle cx="1257.4" cy="544.0" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G17122T  North America=8 [6.6%]  orf1ab polyprotein, A5620S</title>
	<circle cx="1257.4" cy="543.4" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G18255T  North America=4 [3.3%]  orf1ab polyprotein, M5997I</title>
	<circle cx="1260.5" cy="508.7" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  A18424G  North America=74 [61.2%]  orf1ab polyprotein, N6054D</title>
	<circle cx="1260.9" cy="503.5" r="7.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C18788T  Europe=3 [5.1%]  orf1ab polyprotein, T6175I</title>
	<circle cx="1261.9" cy="492.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C19718T  Europe=5 [8.5%]  orf1ab polyprotein, T6485I</title>
	<circle cx="1264.4" cy="463.8" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G19969A  North America=3 [2.5%]  orf1ab polyprotein, A6569T</title>
	<circle cx="1265.1" cy="456.1" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C21304T  North America=70 [57.9%]  orf1ab polyprotein, R7014C</title>
	<circle cx="1268.7" cy="415.2" r="7.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C21575T  North America=3 [2.5%]  surface glycoprotein, L5F</title>
	<circle cx="1269.4" cy="406.9" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C21597T  Europe=3 [5.1%]  surface glycoprotein, S12F</title>
	<circle cx="1269.4" cy="406.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G21600T  North America=6 [5.0%]  surface glycoprotein, S13I</title>
	<circle cx="1269.5" cy="406.1" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C21614T  Europe=14 [23.7%]  surface glycoprotein, L18F</title>
	<circle cx="1269.5" cy="405.7" r="5.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C21855T  Europe=11 [18.6%]  surface glycoprotein, S98F</title>
	<circle cx="1270.1" cy="398.3" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  ATTA21993A  Europe=4 [6.8%]  surface glycoprotein, Y145H</title>
	<circle cx="1270.5" cy="394.1" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G22018T  North America=6 [5.0%]  surface glycoprotein, W152C</title>
	<circle cx="1270.6" cy="393.3" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C22227T  Europe=22 [37.3%]  surface glycoprotein, A222V</title>
	<circle cx="1271.1" cy="386.9" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C22879A  Europe=4 [6.8%]  surface glycoprotein, N439K</title>
	<circle cx="1272.9" cy="366.9" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  T22917G  North America=6 [5.0%]  surface glycoprotein, L452R</title>
	<circle cx="1273.0" cy="365.8" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G22992A  Europe=4 [6.8%]  surface glycoprotein, S477N</title>
	<circle cx="1273.2" cy="363.5" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G23012A  North America=3 [2.5%]  surface glycoprotein, E484K</title>
	<circle cx="1273.2" cy="362.9" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  A23063T  Europe=4 [6.8%]  surface glycoprotein, N501Y</title>
	<circle cx="1273.4" cy="361.3" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C23271A  Europe=4 [6.8%]  surface glycoprotein, A570D</title>
	<circle cx="1273.9" cy="354.9" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  A23403G  North America=121 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1274.3" cy="350.9" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  A23403G  North America=121 [100.0%] Europe=59 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1274.3" cy="350.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  A23403G  North America=121 [100.0%] Europe=59 [100.0%] Asia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1274.3" cy="350.9" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G23593T  North America=12 [9.9%]  surface glycoprotein, Q677H</title>
	<circle cx="1274.8" cy="345.1" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C23604A  Europe=7 [11.9%]  surface glycoprotein, P681H</title>
	<circle cx="1274.8" cy="344.7" r="4.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C23604A  North America=7 [5.8%]  surface glycoprotein, P681H</title>
	<circle cx="1274.8" cy="344.7" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C23604G  North America=3 [2.5%]  surface glycoprotein, P681R</title>
	<circle cx="1274.8" cy="344.7" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C23709T  Europe=4 [6.8%]  surface glycoprotein, T716I</title>
	<circle cx="1275.1" cy="341.5" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G23868T  North America=3 [2.5%]  surface glycoprotein, G769V</title>
	<circle cx="1275.5" cy="336.6" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  T24506G  Europe=4 [6.8%]  surface glycoprotein, S982A</title>
	<circle cx="1277.2" cy="317.1" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G24914C  Europe=4 [6.8%]  surface glycoprotein, D1118H</title>
	<circle cx="1278.3" cy="304.6" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  A25505G  Europe=11 [18.6%]  ORF3a protein, Q38R</title>
	<circle cx="1279.9" cy="286.4" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G25563T  North America=82 [67.8%]  ORF3a protein, Q57H</title>
	<circle cx="1280.1" cy="284.7" r="7.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G25563T  Europe=4 [6.8%]  ORF3a protein, Q57H</title>
	<circle cx="1280.1" cy="284.7" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C25714T  North America=4 [3.3%]  ORF3a protein, L108F</title>
	<circle cx="1280.5" cy="280.0" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  A25859G  Europe=5 [8.5%]  ORF3a protein, Y156C</title>
	<circle cx="1280.9" cy="275.6" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G25906C  Europe=11 [18.6%]  ORF3a protein, G172R</title>
	<circle cx="1281.0" cy="274.2" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G25907T  North America=73 [60.3%]  ORF3a protein, G172V</title>
	<circle cx="1281.0" cy="274.1" r="7.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G25996T  Europe=11 [18.6%]  ORF3a protein, V202L</title>
	<circle cx="1281.2" cy="271.4" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C26060T  North America=3 [2.5%]  ORF3a protein, T223I</title>
	<circle cx="1281.4" cy="269.4" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  A26069G  North America=7 [5.8%]  ORF3a protein, E226G</title>
	<circle cx="1281.4" cy="269.2" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C27964T  North America=76 [62.8%]  ORF8 protein, S24L</title>
	<circle cx="1286.5" cy="211.1" r="7.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C27972T  Europe=4 [6.8%]  ORF8 protein, Q27*</title>
	<circle cx="1286.5" cy="210.8" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G28048T  Europe=4 [6.8%]  ORF8 protein, R52I</title>
	<circle cx="1286.7" cy="208.5" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  A28111G  Europe=4 [6.8%]  ORF8 protein, Y73C</title>
	<circle cx="1286.9" cy="206.6" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G28300C  Europe=5 [8.5%]  nucleocapsid phosphoprotein, Q9H</title>
	<circle cx="1287.4" cy="200.8" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C28310T  Europe=5 [8.5%]  nucleocapsid phosphoprotein, P13S</title>
	<circle cx="1287.4" cy="200.5" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C28311T  North America=6 [5.0%]  nucleocapsid phosphoprotein, P13L</title>
	<circle cx="1287.5" cy="200.4" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C28472T  North America=74 [61.2%]  nucleocapsid phosphoprotein, P67S</title>
	<circle cx="1287.9" cy="195.5" r="7.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G28628T  North America=3 [2.5%]  nucleocapsid phosphoprotein, A119S</title>
	<circle cx="1288.3" cy="190.7" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C28833T  North America=3 [2.5%]  nucleocapsid phosphoprotein, S187L</title>
	<circle cx="1288.9" cy="184.4" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G28851T  Europe=3 [5.1%]  nucleocapsid phosphoprotein, S193I</title>
	<circle cx="1288.9" cy="183.9" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C28854T  North America=23 [19.0%]  nucleocapsid phosphoprotein, S194L</title>
	<circle cx="1288.9" cy="183.8" r="5.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C28869T  North America=74 [61.2%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1288.9" cy="183.3" r="7.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C28869T  Europe=11 [18.6%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1288.9" cy="183.3" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C28887T  North America=7 [5.8%]  nucleocapsid phosphoprotein, T205I</title>
	<circle cx="1289.0" cy="182.8" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C28932T  Europe=22 [37.3%]  nucleocapsid phosphoprotein, A220V</title>
	<circle cx="1289.1" cy="181.4" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G28975T  North America=3 [2.5%]  nucleocapsid phosphoprotein, M234I</title>
	<circle cx="1289.2" cy="180.1" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G28975C  Europe=3 [5.1%]  nucleocapsid phosphoprotein, M234I</title>
	<circle cx="1289.2" cy="180.1" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C28977T  Europe=4 [6.8%]  nucleocapsid phosphoprotein, S235F</title>
	<circle cx="1289.2" cy="180.0" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G29399A  Europe=3 [5.1%]  nucleocapsid phosphoprotein, A376T</title>
	<circle cx="1290.4" cy="167.1" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G29402T  North America=29 [24.0%]  nucleocapsid phosphoprotein, D377Y</title>
	<circle cx="1290.4" cy="167.0" r="5.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C29445T  North America=7 [5.8%]  nucleocapsid phosphoprotein, T391I</title>
	<circle cx="1290.5" cy="165.7" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  C29625T  North America=3 [2.5%]  ORF10 protein, S23F</title>
	<circle cx="1291.0" cy="160.2" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-05  G29645T  Europe=21 [35.6%]  ORF10 protein, V30L</title>
	<circle cx="1291.0" cy="159.5" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06 Europe: 36 samples</title>
	<line x1="1202.1" y1="1180.1" x2="1203.4" y2="1167.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-06 North America: 163 samples</title>
	<line x1="1203.4" y1="1167.6" x2="1205.3" y2="1150.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-06 Africa: 4 samples</title>
	<line x1="1205.3" y1="1150.0" x2="1205.8" y2="1144.4" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-06  C335T  Europe=3 [8.3%]  orf1ab polyprotein, R24C</title>
	<circle cx="1214.9" cy="1058.2" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C344T  North America=24 [14.7%]  orf1ab polyprotein, L27F</title>
	<circle cx="1214.9" cy="1057.9" r="4.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C936T  North America=9 [5.5%]  orf1ab polyprotein, T224I</title>
	<circle cx="1216.8" cy="1039.8" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C1059T  North America=97 [59.5%]  orf1ab polyprotein, T265I</title>
	<circle cx="1217.2" cy="1036.0" r="7.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C1191T  North America=6 [3.7%]  orf1ab polyprotein, P309L</title>
	<circle cx="1217.7" cy="1032.0" r="2.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G2258A  North America=3 [1.8%]  orf1ab polyprotein, V665I</title>
	<circle cx="1221.1" cy="999.4" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A2342G  North America=9 [5.5%]  orf1ab polyprotein, I693V</title>
	<circle cx="1221.4" cy="996.8" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G3231T  North America=6 [3.7%]  orf1ab polyprotein, G989V</title>
	<circle cx="1224.2" cy="969.6" r="2.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G3259T  North America=9 [5.5%]  orf1ab polyprotein, Q998H</title>
	<circle cx="1224.3" cy="968.7" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C3261T  North America=3 [1.8%]  orf1ab polyprotein, T999I</title>
	<circle cx="1224.3" cy="968.7" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C3267T  Europe=12 [33.3%]  orf1ab polyprotein, T1001I</title>
	<circle cx="1224.3" cy="968.5" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C3602T  Europe=4 [11.1%]  orf1ab polyprotein, H1113Y</title>
	<circle cx="1225.4" cy="958.2" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A4040G  Europe=3 [8.3%]  orf1ab polyprotein, I1259V</title>
	<circle cx="1226.8" cy="944.8" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C4893T  Europe=3 [8.3%]  orf1ab polyprotein, T1543I</title>
	<circle cx="1229.6" cy="918.7" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A5011C  North America=3 [1.8%]  orf1ab polyprotein, Q1582H</title>
	<circle cx="1229.9" cy="915.1" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C5183T  Europe=3 [8.3%]  orf1ab polyprotein, P1640S</title>
	<circle cx="1230.5" cy="909.8" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C5388A  Europe=12 [33.3%]  orf1ab polyprotein, A1708D</title>
	<circle cx="1231.2" cy="903.6" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G5425T  North America=5 [3.1%]  orf1ab polyprotein, K1720N</title>
	<circle cx="1231.3" cy="902.4" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A5747G  North America=7 [4.3%]  orf1ab polyprotein, T1828A</title>
	<circle cx="1232.3" cy="892.6" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C6401T  North America=3 [1.8%]  orf1ab polyprotein, P2046S</title>
	<circle cx="1234.4" cy="872.6" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A6441G  North America=3 [1.8%]  orf1ab polyprotein, K2059R</title>
	<circle cx="1234.5" cy="871.3" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G6513A  Europe=3 [8.3%]  orf1ab polyprotein, S2083N</title>
	<circle cx="1234.8" cy="869.1" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G6618A  North America=27 [16.6%]  orf1ab polyprotein, G2118D</title>
	<circle cx="1235.1" cy="865.9" r="5.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  T6954C  Europe=12 [33.3%]  orf1ab polyprotein, I2230T</title>
	<circle cx="1236.2" cy="855.7" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  T7348A  North America=3 [1.8%]  orf1ab polyprotein, N2361K</title>
	<circle cx="1237.5" cy="843.6" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G8083A  North America=30 [18.4%]  orf1ab polyprotein, M2606I</title>
	<circle cx="1239.8" cy="821.1" r="5.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G8264T  North America=5 [3.1%]  orf1ab polyprotein, G2667C</title>
	<circle cx="1240.4" cy="815.6" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G9526T  Europe=9 [25.0%]  orf1ab polyprotein, M3087I</title>
	<circle cx="1244.5" cy="776.9" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G9928T  North America=10 [6.1%]  orf1ab polyprotein, M3221I</title>
	<circle cx="1245.8" cy="764.6" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C10029T  North America=3 [1.8%]  orf1ab polyprotein, T3255I</title>
	<circle cx="1246.1" cy="761.6" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C10319T  North America=67 [41.1%]  orf1ab polyprotein, L3352F</title>
	<circle cx="1247.0" cy="752.7" r="6.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A10323G  North America=4 [2.5%]  orf1ab polyprotein, K3353R</title>
	<circle cx="1247.0" cy="752.6" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C10448T  North America=25 [15.3%]  orf1ab polyprotein, P3395S</title>
	<circle cx="1247.4" cy="748.7" r="4.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G11083T  North America=4 [2.5%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1249.5" cy="729.3" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C11591T  North America=9 [5.5%]  orf1ab polyprotein, L3776F</title>
	<circle cx="1251.1" cy="713.8" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A12075G  Europe=3 [8.3%]  orf1ab polyprotein, N3937S</title>
	<circle cx="1252.7" cy="698.9" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C12525T  North America=6 [3.7%]  orf1ab polyprotein, T4087I</title>
	<circle cx="1254.1" cy="685.2" r="2.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C12809T  North America=3 [1.8%]  orf1ab polyprotein, L4182F</title>
	<circle cx="1255.0" cy="676.5" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A12878G  North America=6 [3.7%]  orf1ab polyprotein, I4205V</title>
	<circle cx="1255.2" cy="674.4" r="2.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C13335T  North America=3 [1.8%]  orf1ab polyprotein, A4357V</title>
	<circle cx="1256.7" cy="660.4" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C13694T  Europe=3 [8.3%]  orf1ab polyprotein, T4477I</title>
	<circle cx="1257.9" cy="649.4" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G13993T  Europe=9 [25.0%]  orf1ab polyprotein, A4577S</title>
	<circle cx="1258.8" cy="640.3" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C14318T  North America=3 [1.8%]  orf1ab polyprotein, T4685I</title>
	<circle cx="1259.9" cy="630.3" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C14408T  Europe=36 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1260.2" cy="627.6" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C14408T  Europe=36 [100.0%] Africa=4 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1260.2" cy="627.6" r="8.0" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C14408T  Europe=36 [100.0%] Africa=4 [100.0%] North America=161 [98.8%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1260.2" cy="627.6" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G15766T  Europe=9 [25.0%]  orf1ab polyprotein, V5168L</title>
	<circle cx="1264.5" cy="586.0" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  T16820C  North America=25 [15.3%]  orf1ab polyprotein, I5519T</title>
	<circle cx="1267.9" cy="553.7" r="4.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A16889G  Europe=9 [25.0%]  orf1ab polyprotein, K5542R</title>
	<circle cx="1268.1" cy="551.6" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G17014T  North America=8 [4.9%]  orf1ab polyprotein, D5584Y</title>
	<circle cx="1268.5" cy="547.8" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G17019T  Europe=9 [25.0%]  orf1ab polyprotein, E5585D</title>
	<circle cx="1268.6" cy="547.7" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G17122T  North America=9 [5.5%]  orf1ab polyprotein, A5620S</title>
	<circle cx="1268.9" cy="544.5" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C17135T  North America=4 [2.5%]  orf1ab polyprotein, P5624L</title>
	<circle cx="1268.9" cy="544.1" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G17259T  North America=7 [4.3%]  orf1ab polyprotein, E5665D</title>
	<circle cx="1269.3" cy="540.3" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A17615G  Europe=7 [19.4%]  orf1ab polyprotein, K5784R</title>
	<circle cx="1270.5" cy="529.4" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C17977T  North America=24 [14.7%]  orf1ab polyprotein, L5905F</title>
	<circle cx="1271.6" cy="518.3" r="4.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C18131T  North America=3 [1.8%]  orf1ab polyprotein, T5956I</title>
	<circle cx="1272.1" cy="513.6" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A18424G  North America=63 [38.7%]  orf1ab polyprotein, N6054D</title>
	<circle cx="1273.1" cy="504.7" r="6.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G19180T  North America=3 [1.8%]  orf1ab polyprotein, V6306L</title>
	<circle cx="1275.5" cy="481.5" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G19542T  North America=3 [1.8%]  orf1ab polyprotein, M6426I</title>
	<circle cx="1276.7" cy="470.4" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G20060T  Europe=3 [8.3%]  orf1ab polyprotein, S6599I</title>
	<circle cx="1278.3" cy="454.6" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C21304A  Europe=3 [8.3%]  orf1ab polyprotein, R7014S</title>
	<circle cx="1282.3" cy="416.5" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C21304T  North America=58 [35.6%]  orf1ab polyprotein, R7014C</title>
	<circle cx="1282.3" cy="416.5" r="6.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C21364T  North America=5 [3.1%]  orf1ab polyprotein, P7034S</title>
	<circle cx="1282.5" cy="414.7" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C21365T  Europe=3 [8.3%]  orf1ab polyprotein, P7034L</title>
	<circle cx="1282.5" cy="414.7" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C21431T  North America=5 [3.1%]  orf1ab polyprotein, A7056V</title>
	<circle cx="1282.8" cy="412.6" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C21575T  North America=8 [4.9%]  surface glycoprotein, L5F</title>
	<circle cx="1283.2" cy="408.2" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G21600T  North America=8 [4.9%]  surface glycoprotein, S13I</title>
	<circle cx="1283.3" cy="407.5" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C21621T  North America=3 [1.8%]  surface glycoprotein, T20I</title>
	<circle cx="1283.4" cy="406.8" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C21648T  North America=3 [1.8%]  surface glycoprotein, T29I</title>
	<circle cx="1283.5" cy="406.0" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C21855T  Europe=4 [11.1%]  surface glycoprotein, S98F</title>
	<circle cx="1284.1" cy="399.7" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  ATTA21993A  Europe=12 [33.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1284.6" cy="395.4" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G22018T  North America=8 [4.9%]  surface glycoprotein, W152C</title>
	<circle cx="1284.6" cy="394.7" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C22227T  Europe=6 [16.7%]  surface glycoprotein, A222V</title>
	<circle cx="1285.3" cy="388.3" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  T22917G  North America=8 [4.9%]  surface glycoprotein, L452R</title>
	<circle cx="1287.5" cy="367.2" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G22992A  Europe=9 [25.0%]  surface glycoprotein, S477N</title>
	<circle cx="1287.8" cy="364.9" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A23063T  Europe=12 [33.3%]  surface glycoprotein, N501Y</title>
	<circle cx="1288.0" cy="362.7" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A23063T  North America=4 [2.5%]  surface glycoprotein, N501Y</title>
	<circle cx="1288.0" cy="362.7" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A23064C  North America=5 [3.1%]  surface glycoprotein, N501T</title>
	<circle cx="1288.0" cy="362.7" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C23271A  Europe=12 [33.3%]  surface glycoprotein, A570D</title>
	<circle cx="1288.7" cy="356.3" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C23277T  North America=3 [1.8%]  surface glycoprotein, T572I</title>
	<circle cx="1288.7" cy="356.2" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A23403G  Europe=36 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1289.1" cy="352.3" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A23403G  Europe=36 [100.0%] Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1289.1" cy="352.3" r="8.0" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A23403G  Europe=36 [100.0%] Africa=4 [100.0%] North America=162 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="1289.1" cy="352.3" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G23593T  North America=8 [4.9%]  surface glycoprotein, Q677H</title>
	<circle cx="1289.7" cy="346.5" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G23593C  North America=3 [1.8%]  surface glycoprotein, Q677H</title>
	<circle cx="1289.7" cy="346.5" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C23604A  Europe=12 [33.3%]  surface glycoprotein, P681H</title>
	<circle cx="1289.7" cy="346.1" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C23604A  North America=33 [20.2%]  surface glycoprotein, P681H</title>
	<circle cx="1289.7" cy="346.1" r="5.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C23709T  Europe=12 [33.3%]  surface glycoprotein, T716I</title>
	<circle cx="1290.1" cy="342.9" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C24099T  Europe=3 [8.3%]  surface glycoprotein, A846V</title>
	<circle cx="1291.3" cy="331.0" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C24138T  North America=24 [14.7%]  surface glycoprotein, T859I</title>
	<circle cx="1291.5" cy="329.8" r="4.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  T24506G  Europe=12 [33.3%]  surface glycoprotein, S982A</title>
	<circle cx="1292.6" cy="318.5" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A24774T  North America=3 [1.8%]  surface glycoprotein, Q1071L</title>
	<circle cx="1293.5" cy="310.3" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G24914C  Europe=12 [33.3%]  surface glycoprotein, D1118H</title>
	<circle cx="1294.0" cy="306.1" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A25505G  Europe=3 [8.3%]  ORF3a protein, Q38R</title>
	<circle cx="1295.9" cy="288.0" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G25563T  North America=95 [58.3%]  ORF3a protein, Q57H</title>
	<circle cx="1296.0" cy="286.2" r="7.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G25563T  Europe=10 [27.8%]  ORF3a protein, Q57H</title>
	<circle cx="1296.0" cy="286.2" r="5.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C25624T  North America=3 [1.8%]  ORF3a protein, H78Y</title>
	<circle cx="1296.2" cy="284.3" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C25844T  North America=9 [5.5%]  ORF3a protein, T151I</title>
	<circle cx="1296.9" cy="277.6" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G25855T  North America=3 [1.8%]  ORF3a protein, D155Y</title>
	<circle cx="1297.0" cy="277.3" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C25889T  North America=5 [3.1%]  ORF3a protein, S166L</title>
	<circle cx="1297.1" cy="276.2" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G25906C  Europe=4 [11.1%]  ORF3a protein, G172R</title>
	<circle cx="1297.1" cy="275.7" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G25907T  North America=63 [38.7%]  ORF3a protein, G172V</title>
	<circle cx="1297.2" cy="275.7" r="6.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G25996T  Europe=4 [11.1%]  ORF3a protein, V202L</title>
	<circle cx="1297.4" cy="273.0" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C26060T  North America=6 [3.7%]  ORF3a protein, T223I</title>
	<circle cx="1297.6" cy="271.0" r="2.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G26062T  Europe=3 [8.3%]  ORF3a protein, G224C</title>
	<circle cx="1297.6" cy="270.9" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A26069G  North America=9 [5.5%]  ORF3a protein, E226G</title>
	<circle cx="1297.7" cy="270.7" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A26664G  North America=7 [4.3%]  membrane glycoprotein, I48V</title>
	<circle cx="1299.6" cy="252.5" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C26985T  North America=4 [2.5%]  membrane glycoprotein, H155Y</title>
	<circle cx="1300.6" cy="242.7" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C27964T  North America=66 [40.5%]  ORF8 protein, S24L</title>
	<circle cx="1303.8" cy="212.7" r="6.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C27972T  Europe=12 [33.3%]  ORF8 protein, Q27*</title>
	<circle cx="1303.8" cy="212.5" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G28048T  Europe=12 [33.3%]  ORF8 protein, R52I</title>
	<circle cx="1304.0" cy="210.2" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  A28111G  Europe=10 [27.8%]  ORF8 protein, Y73C</title>
	<circle cx="1304.2" cy="208.2" r="5.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G28300T  North America=4 [2.5%]  nucleocapsid phosphoprotein, Q9H</title>
	<circle cx="1304.8" cy="202.4" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C28472T  North America=63 [38.7%]  nucleocapsid phosphoprotein, P67S</title>
	<circle cx="1305.4" cy="197.2" r="6.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C28677T  North America=4 [2.5%]  nucleocapsid phosphoprotein, T135I</title>
	<circle cx="1306.1" cy="190.9" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G28690T  North America=3 [1.8%]  nucleocapsid phosphoprotein, L139F</title>
	<circle cx="1306.1" cy="190.5" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C28854T  North America=42 [25.8%]  nucleocapsid phosphoprotein, S194L</title>
	<circle cx="1306.6" cy="185.5" r="5.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C28869T  North America=64 [39.3%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1306.7" cy="185.0" r="6.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C28869T  Europe=4 [11.1%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1306.7" cy="185.0" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C28887T  North America=18 [11.0%]  nucleocapsid phosphoprotein, T205I</title>
	<circle cx="1306.7" cy="184.5" r="4.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C28890T  North America=5 [3.1%]  nucleocapsid phosphoprotein, S206F</title>
	<circle cx="1306.7" cy="184.4" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C28893T  North America=3 [1.8%]  nucleocapsid phosphoprotein, P207L</title>
	<circle cx="1306.8" cy="184.3" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C28932T  Europe=6 [16.7%]  nucleocapsid phosphoprotein, A220V</title>
	<circle cx="1306.9" cy="183.1" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G28975T  North America=10 [6.1%]  nucleocapsid phosphoprotein, M234I</title>
	<circle cx="1307.0" cy="181.8" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G28975C  Europe=9 [25.0%]  nucleocapsid phosphoprotein, M234I</title>
	<circle cx="1307.0" cy="181.8" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C28977T  Europe=12 [33.3%]  nucleocapsid phosphoprotein, S235F</title>
	<circle cx="1307.0" cy="181.7" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C28977T  North America=3 [1.8%]  nucleocapsid phosphoprotein, S235F</title>
	<circle cx="1307.0" cy="181.7" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C29366T  Europe=3 [8.3%]  nucleocapsid phosphoprotein, P365S</title>
	<circle cx="1308.3" cy="169.8" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G29399A  Europe=9 [25.0%]  nucleocapsid phosphoprotein, A376T</title>
	<circle cx="1308.4" cy="168.8" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G29402T  North America=19 [11.7%]  nucleocapsid phosphoprotein, D377Y</title>
	<circle cx="1308.4" cy="168.7" r="4.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  C29445T  North America=4 [2.5%]  nucleocapsid phosphoprotein, T391I</title>
	<circle cx="1308.5" cy="167.4" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-06  G29645T  Europe=6 [16.7%]  ORF10 protein, V30L</title>
	<circle cx="1309.2" cy="161.3" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07 Europe: 23 samples</title>
	<line x1="1202.4" y1="1180.1" x2="1203.8" y2="1169.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-07 North America: 103 samples</title>
	<line x1="1203.8" y1="1169.2" x2="1205.7" y2="1153.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-07 Asia: 3 samples</title>
	<line x1="1205.7" y1="1153.2" x2="1206.3" y2="1148.4" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-07  C335T  Europe=7 [30.4%]  orf1ab polyprotein, R24C</title>
	<circle cx="1217.4" cy="1058.5" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C1059T  North America=73 [70.9%]  orf1ab polyprotein, T265I</title>
	<circle cx="1220.1" cy="1036.4" r="7.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G2258A  North America=5 [4.9%]  orf1ab polyprotein, V665I</title>
	<circle cx="1224.6" cy="999.7" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G3231T  North America=3 [2.9%]  orf1ab polyprotein, G989V</title>
	<circle cx="1228.2" cy="970.0" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C3267T  Europe=3 [13.0%]  orf1ab polyprotein, T1001I</title>
	<circle cx="1228.4" cy="968.9" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G3527A  North America=4 [3.9%]  orf1ab polyprotein, D1088N</title>
	<circle cx="1229.3" cy="961.0" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C3602T  Europe=7 [30.4%]  orf1ab polyprotein, H1113Y</title>
	<circle cx="1229.6" cy="958.7" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  A4040G  Europe=7 [30.4%]  orf1ab polyprotein, I1259V</title>
	<circle cx="1231.3" cy="945.3" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G5015A  North America=4 [3.9%]  orf1ab polyprotein, V1584M</title>
	<circle cx="1234.9" cy="915.6" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C5183T  Europe=3 [13.0%]  orf1ab polyprotein, P1640S</title>
	<circle cx="1235.6" cy="910.4" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C5388A  Europe=3 [13.0%]  orf1ab polyprotein, A1708D</title>
	<circle cx="1236.3" cy="904.2" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  A5877G  North America=4 [3.9%]  orf1ab polyprotein, N1871S</title>
	<circle cx="1238.2" cy="889.2" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  A6441G  North America=5 [4.9%]  orf1ab polyprotein, K2059R</title>
	<circle cx="1240.3" cy="872.0" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  T6954C  Europe=3 [13.0%]  orf1ab polyprotein, I2230T</title>
	<circle cx="1242.2" cy="856.3" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  T7348A  North America=3 [2.9%]  orf1ab polyprotein, N2361K</title>
	<circle cx="1243.7" cy="844.3" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G8083A  North America=25 [24.3%]  orf1ab polyprotein, M2606I</title>
	<circle cx="1246.4" cy="821.9" r="5.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G8264T  North America=4 [3.9%]  orf1ab polyprotein, G2667C</title>
	<circle cx="1247.1" cy="816.3" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  A9204G  North America=5 [4.9%]  orf1ab polyprotein, D2980G</title>
	<circle cx="1250.6" cy="787.6" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G9526T  Europe=5 [21.7%]  orf1ab polyprotein, M3087I</title>
	<circle cx="1251.8" cy="777.8" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G9928T  North America=5 [4.9%]  orf1ab polyprotein, M3221I</title>
	<circle cx="1253.3" cy="765.5" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C10319T  North America=54 [52.4%]  orf1ab polyprotein, L3352F</title>
	<circle cx="1254.8" cy="753.6" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C10641T  North America=4 [3.9%]  orf1ab polyprotein, T3459M</title>
	<circle cx="1256.0" cy="743.7" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G11083T  North America=7 [6.8%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1257.7" cy="730.2" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C12525T  North America=3 [2.9%]  orf1ab polyprotein, T4087I</title>
	<circle cx="1263.1" cy="686.2" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  A12878G  North America=8 [7.8%]  orf1ab polyprotein, I4205V</title>
	<circle cx="1264.4" cy="675.4" r="3.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G13993T  Europe=5 [21.7%]  orf1ab polyprotein, A4577S</title>
	<circle cx="1268.6" cy="641.4" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C14408T  North America=103 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1270.1" cy="628.7" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C14408T  North America=103 [100.0%] Europe=23 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1270.1" cy="628.7" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C14408T  North America=103 [100.0%] Europe=23 [100.0%] Asia=3 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1270.1" cy="628.7" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G15766T  Europe=5 [21.7%]  orf1ab polyprotein, V5168L</title>
	<circle cx="1275.2" cy="587.2" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G15766T  North America=4 [3.9%]  orf1ab polyprotein, V5168L</title>
	<circle cx="1275.2" cy="587.2" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  A16889G  Europe=5 [21.7%]  orf1ab polyprotein, K5542R</title>
	<circle cx="1279.5" cy="552.9" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G17014T  North America=10 [9.7%]  orf1ab polyprotein, D5584Y</title>
	<circle cx="1279.9" cy="549.1" r="4.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G17019T  Europe=5 [21.7%]  orf1ab polyprotein, E5585D</title>
	<circle cx="1279.9" cy="549.0" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C17285T  North America=3 [2.9%]  orf1ab polyprotein, S5674L</title>
	<circle cx="1280.9" cy="540.8" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C18131T  North America=3 [2.9%]  orf1ab polyprotein, T5956I</title>
	<circle cx="1284.1" cy="515.0" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  A18424G  North America=52 [50.5%]  orf1ab polyprotein, N6054D</title>
	<circle cx="1285.2" cy="506.0" r="6.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G18538T  North America=4 [3.9%]  orf1ab polyprotein, V6092L</title>
	<circle cx="1285.6" cy="502.6" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G19969A  North America=4 [3.9%]  orf1ab polyprotein, A6569T</title>
	<circle cx="1291.0" cy="458.9" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C21304T  North America=52 [50.5%]  orf1ab polyprotein, R7014C</title>
	<circle cx="1296.0" cy="418.1" r="6.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C21364T  North America=4 [3.9%]  orf1ab polyprotein, P7034S</title>
	<circle cx="1296.2" cy="416.3" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C21575T  North America=3 [2.9%]  surface glycoprotein, L5F</title>
	<circle cx="1297.0" cy="409.8" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G21600T  North America=10 [9.7%]  surface glycoprotein, S13I</title>
	<circle cx="1297.1" cy="409.0" r="4.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C21621T  North America=3 [2.9%]  surface glycoprotein, T20I</title>
	<circle cx="1297.2" cy="408.4" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C21855T  Europe=7 [30.4%]  surface glycoprotein, S98F</title>
	<circle cx="1298.1" cy="401.3" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  ATTA21993A  Europe=3 [13.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1298.6" cy="397.0" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G22018T  North America=10 [9.7%]  surface glycoprotein, W152C</title>
	<circle cx="1298.7" cy="396.3" r="4.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C22227T  Europe=7 [30.4%]  surface glycoprotein, A222V</title>
	<circle cx="1299.5" cy="389.9" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  T22917G  North America=10 [9.7%]  surface glycoprotein, L452R</title>
	<circle cx="1302.1" cy="368.8" r="4.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G22992A  Europe=5 [21.7%]  surface glycoprotein, S477N</title>
	<circle cx="1302.3" cy="366.5" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  A23063T  Europe=4 [17.4%]  surface glycoprotein, N501Y</title>
	<circle cx="1302.6" cy="364.4" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  A23064C  North America=4 [3.9%]  surface glycoprotein, N501T</title>
	<circle cx="1302.6" cy="364.3" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C23271A  Europe=3 [13.0%]  surface glycoprotein, A570D</title>
	<circle cx="1303.4" cy="358.0" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  A23403G  Europe=23 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1303.9" cy="354.0" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  A23403G  Europe=23 [100.0%] Asia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1303.9" cy="354.0" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  A23403G  Europe=23 [100.0%] Asia=3 [100.0%] North America=102 [99.0%]  surface glycoprotein, D614G</title>
	<circle cx="1303.9" cy="354.0" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G23593T  North America=5 [4.9%]  surface glycoprotein, Q677H</title>
	<circle cx="1304.6" cy="348.2" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C23604A  Europe=3 [13.0%]  surface glycoprotein, P681H</title>
	<circle cx="1304.6" cy="347.8" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C23604A  North America=3 [2.9%]  surface glycoprotein, P681H</title>
	<circle cx="1304.6" cy="347.8" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C23709T  Europe=4 [17.4%]  surface glycoprotein, T716I</title>
	<circle cx="1305.0" cy="344.6" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G24095T  North America=4 [3.9%]  surface glycoprotein, A845S</title>
	<circle cx="1306.5" cy="332.9" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C24099T  Europe=3 [13.0%]  surface glycoprotein, A846V</title>
	<circle cx="1306.5" cy="332.7" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  T24506G  Europe=3 [13.0%]  surface glycoprotein, S982A</title>
	<circle cx="1308.0" cy="320.3" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G24914C  Europe=3 [13.0%]  surface glycoprotein, D1118H</title>
	<circle cx="1309.5" cy="307.8" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  A25505G  Europe=7 [30.4%]  ORF3a protein, Q38R</title>
	<circle cx="1311.8" cy="289.8" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G25563T  North America=78 [75.7%]  ORF3a protein, Q57H</title>
	<circle cx="1312.0" cy="288.0" r="7.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G25563T  Europe=6 [26.1%]  ORF3a protein, Q57H</title>
	<circle cx="1312.0" cy="288.0" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C25714T  North America=4 [3.9%]  ORF3a protein, L108F</title>
	<circle cx="1312.5" cy="283.4" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G25855T  North America=7 [6.8%]  ORF3a protein, D155Y</title>
	<circle cx="1313.1" cy="279.1" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G25906C  Europe=7 [30.4%]  ORF3a protein, G172R</title>
	<circle cx="1313.3" cy="277.5" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G25907T  North America=52 [50.5%]  ORF3a protein, G172V</title>
	<circle cx="1313.3" cy="277.5" r="6.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  T25930C  North America=4 [3.9%]  ORF3a protein, S180P</title>
	<circle cx="1313.4" cy="276.8" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G25996T  Europe=7 [30.4%]  ORF3a protein, V202L</title>
	<circle cx="1313.6" cy="274.8" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C26060T  North America=4 [3.9%]  ORF3a protein, T223I</title>
	<circle cx="1313.8" cy="272.8" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C27434T  North America=4 [3.9%]  ORF7a protein, T14I</title>
	<circle cx="1319.0" cy="230.9" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C27964T  North America=54 [52.4%]  ORF8 protein, S24L</title>
	<circle cx="1321.0" cy="214.7" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C27972T  Europe=3 [13.0%]  ORF8 protein, Q27*</title>
	<circle cx="1321.0" cy="214.4" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G28048T  Europe=3 [13.0%]  ORF8 protein, R52I</title>
	<circle cx="1321.3" cy="212.1" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C28472T  North America=52 [50.5%]  nucleocapsid phosphoprotein, P67S</title>
	<circle cx="1322.9" cy="199.2" r="6.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C28854T  North America=21 [20.4%]  nucleocapsid phosphoprotein, S194L</title>
	<circle cx="1324.3" cy="187.5" r="5.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C28869T  North America=53 [51.5%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1324.4" cy="187.1" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C28869T  Europe=7 [30.4%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1324.4" cy="187.1" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C28887T  North America=13 [12.6%]  nucleocapsid phosphoprotein, T205I</title>
	<circle cx="1324.4" cy="186.5" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C28890T  North America=3 [2.9%]  nucleocapsid phosphoprotein, S206F</title>
	<circle cx="1324.5" cy="186.4" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C28932T  Europe=5 [21.7%]  nucleocapsid phosphoprotein, A220V</title>
	<circle cx="1324.6" cy="185.1" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G28975T  North America=6 [5.8%]  nucleocapsid phosphoprotein, M234I</title>
	<circle cx="1324.8" cy="183.8" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G28975C  Europe=5 [21.7%]  nucleocapsid phosphoprotein, M234I</title>
	<circle cx="1324.8" cy="183.8" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C28977T  Europe=3 [13.0%]  nucleocapsid phosphoprotein, S235F</title>
	<circle cx="1324.8" cy="183.8" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G29384T  North America=3 [2.9%]  nucleocapsid phosphoprotein, D371Y</title>
	<circle cx="1326.3" cy="171.3" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G29399A  Europe=5 [21.7%]  nucleocapsid phosphoprotein, A376T</title>
	<circle cx="1326.4" cy="170.9" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G29402T  North America=15 [14.6%]  nucleocapsid phosphoprotein, D377Y</title>
	<circle cx="1326.4" cy="170.8" r="4.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  A29439T  North America=4 [3.9%]  nucleocapsid phosphoprotein, Q389L</title>
	<circle cx="1326.5" cy="169.6" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  C29445T  North America=8 [7.8%]  nucleocapsid phosphoprotein, T391I</title>
	<circle cx="1326.5" cy="169.5" r="3.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-07  G29645T  Europe=5 [21.7%]  ORF10 protein, V30L</title>
	<circle cx="1327.3" cy="163.4" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08 Europe: 28 samples</title>
	<line x1="1202.8" y1="1180.2" x2="1204.4" y2="1168.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-08 North America: 87 samples</title>
	<line x1="1204.4" y1="1168.6" x2="1206.6" y2="1153.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-08 Oceania: 3 samples</title>
	<line x1="1206.6" y1="1153.2" x2="1207.2" y2="1148.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-08  C335T  Europe=5 [17.9%]  orf1ab polyprotein, R24C</title>
	<circle cx="1219.8" cy="1058.8" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C936T  North America=5 [5.7%]  orf1ab polyprotein, T224I</title>
	<circle cx="1222.4" cy="1040.5" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C1059T  Oceania=3 [100.0%]  orf1ab polyprotein, T265I</title>
	<circle cx="1222.9" cy="1036.7" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C1059T  North America=57 [65.5%]  orf1ab polyprotein, T265I</title>
	<circle cx="1222.9" cy="1036.7" r="7.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  T1578C  North America=3 [3.4%]  orf1ab polyprotein, V438A</title>
	<circle cx="1225.2" cy="1020.9" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G2258A  North America=5 [5.7%]  orf1ab polyprotein, V665I</title>
	<circle cx="1228.1" cy="1000.2" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  A2342G  North America=5 [5.7%]  orf1ab polyprotein, I693V</title>
	<circle cx="1228.4" cy="997.7" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G3259T  North America=5 [5.7%]  orf1ab polyprotein, Q998H</title>
	<circle cx="1232.4" cy="969.7" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G3527A  North America=4 [4.6%]  orf1ab polyprotein, D1088N</title>
	<circle cx="1233.5" cy="961.5" r="3.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C3602T  Europe=5 [17.9%]  orf1ab polyprotein, H1113Y</title>
	<circle cx="1233.8" cy="959.3" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  A4040G  Europe=5 [17.9%]  orf1ab polyprotein, I1259V</title>
	<circle cx="1235.7" cy="945.9" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G5015A  North America=4 [4.6%]  orf1ab polyprotein, V1584M</title>
	<circle cx="1239.9" cy="916.2" r="3.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  A5877G  North America=4 [4.6%]  orf1ab polyprotein, N1871S</title>
	<circle cx="1243.6" cy="889.9" r="3.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  A6441G  North America=5 [5.7%]  orf1ab polyprotein, K2059R</title>
	<circle cx="1246.0" cy="872.8" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C6539T  North America=3 [3.4%]  orf1ab polyprotein, H2092Y</title>
	<circle cx="1246.4" cy="869.8" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G6618A  North America=5 [5.7%]  orf1ab polyprotein, G2118D</title>
	<circle cx="1246.7" cy="867.4" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G8083A  North America=17 [19.5%]  orf1ab polyprotein, M2606I</title>
	<circle cx="1253.0" cy="822.7" r="5.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  A9204G  North America=4 [4.6%]  orf1ab polyprotein, D2980G</title>
	<circle cx="1257.8" cy="788.6" r="3.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G9738C  North America=4 [4.6%]  orf1ab polyprotein, S3158T</title>
	<circle cx="1260.1" cy="772.3" r="3.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G9928T  North America=3 [3.4%]  orf1ab polyprotein, M3221I</title>
	<circle cx="1260.9" cy="766.5" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C10319T  North America=46 [52.9%]  orf1ab polyprotein, L3352F</title>
	<circle cx="1262.6" cy="754.6" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  A11451G  North America=4 [4.6%]  orf1ab polyprotein, Q3729R</title>
	<circle cx="1267.4" cy="720.1" r="3.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C11591T  North America=5 [5.7%]  orf1ab polyprotein, L3776F</title>
	<circle cx="1268.0" cy="715.8" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  A12878G  North America=4 [4.6%]  orf1ab polyprotein, I4205V</title>
	<circle cx="1273.6" cy="676.6" r="3.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C14408T  North America=87 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1280.1" cy="630.0" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C14408T  North America=87 [100.0%] Europe=28 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1280.1" cy="630.0" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C14408T  North America=87 [100.0%] Europe=28 [100.0%] Oceania=3 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1280.1" cy="630.0" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C16394T  North America=4 [4.6%]  orf1ab polyprotein, P5377L</title>
	<circle cx="1288.6" cy="569.5" r="3.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G17014T  North America=8 [9.2%]  orf1ab polyprotein, D5584Y</title>
	<circle cx="1291.3" cy="550.6" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G17122T  North America=5 [5.7%]  orf1ab polyprotein, A5620S</title>
	<circle cx="1291.7" cy="547.3" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  A18424G  North America=45 [51.7%]  orf1ab polyprotein, N6054D</title>
	<circle cx="1297.3" cy="507.6" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C20132T  North America=3 [3.4%]  orf1ab polyprotein, A6623V</title>
	<circle cx="1304.6" cy="455.6" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C21304T  North America=44 [50.6%]  orf1ab polyprotein, R7014C</title>
	<circle cx="1309.6" cy="419.9" r="6.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G21600T  North America=8 [9.2%]  surface glycoprotein, S13I</title>
	<circle cx="1310.9" cy="410.9" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C21614T  Europe=13 [46.4%]  surface glycoprotein, L18F</title>
	<circle cx="1311.0" cy="410.4" r="6.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C21638T  North America=3 [3.4%]  surface glycoprotein, P26S</title>
	<circle cx="1311.1" cy="409.7" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C21855T  Europe=5 [17.9%]  surface glycoprotein, S98F</title>
	<circle cx="1312.0" cy="403.1" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G22018T  North America=8 [9.2%]  surface glycoprotein, W152C</title>
	<circle cx="1312.7" cy="398.1" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C22227T  Europe=18 [64.3%]  surface glycoprotein, A222V</title>
	<circle cx="1313.6" cy="391.8" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G22335T  North America=3 [3.4%]  surface glycoprotein, W258L</title>
	<circle cx="1314.1" cy="388.5" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  T22917G  North America=7 [8.0%]  surface glycoprotein, L452R</title>
	<circle cx="1316.5" cy="370.7" r="3.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  A23403G  North America=87 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1318.6" cy="355.9" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  A23403G  North America=87 [100.0%] Europe=28 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1318.6" cy="355.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  A23403G  North America=87 [100.0%] Europe=28 [100.0%] Oceania=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1318.6" cy="355.9" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  A23592C  North America=4 [4.6%]  surface glycoprotein, Q677P</title>
	<circle cx="1319.4" cy="350.2" r="3.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C23604A  North America=6 [6.9%]  surface glycoprotein, P681H</title>
	<circle cx="1319.5" cy="349.8" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C25317T  Europe=3 [10.7%]  surface glycoprotein, S1252F</title>
	<circle cx="1326.8" cy="297.6" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  A25505G  Europe=5 [17.9%]  ORF3a protein, Q38R</title>
	<circle cx="1327.6" cy="291.9" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G25563T  Oceania=3 [100.0%]  ORF3a protein, Q57H</title>
	<circle cx="1327.9" cy="290.1" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G25563T  North America=52 [59.8%]  ORF3a protein, Q57H</title>
	<circle cx="1327.9" cy="290.1" r="7.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G25563T  Europe=3 [10.7%]  ORF3a protein, Q57H</title>
	<circle cx="1327.9" cy="290.1" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C25714T  North America=4 [4.6%]  ORF3a protein, L108F</title>
	<circle cx="1328.5" cy="285.5" r="3.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C25844T  North America=3 [3.4%]  ORF3a protein, T151I</title>
	<circle cx="1329.1" cy="281.5" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G25855T  North America=5 [5.7%]  ORF3a protein, D155Y</title>
	<circle cx="1329.1" cy="281.2" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C25889T  North America=3 [3.4%]  ORF3a protein, S166L</title>
	<circle cx="1329.3" cy="280.2" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G25906C  Europe=5 [17.9%]  ORF3a protein, G172R</title>
	<circle cx="1329.3" cy="279.7" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G25907T  North America=45 [51.7%]  ORF3a protein, G172V</title>
	<circle cx="1329.3" cy="279.6" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G25996T  Europe=5 [17.9%]  ORF3a protein, V202L</title>
	<circle cx="1329.7" cy="276.9" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C26060T  North America=3 [3.4%]  ORF3a protein, T223I</title>
	<circle cx="1330.0" cy="275.0" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  A26069G  North America=5 [5.7%]  ORF3a protein, E226G</title>
	<circle cx="1330.0" cy="274.7" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C27434T  North America=4 [4.6%]  ORF7a protein, T14I</title>
	<circle cx="1335.9" cy="233.1" r="3.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C27964T  North America=46 [52.9%]  ORF8 protein, S24L</title>
	<circle cx="1338.2" cy="217.0" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C28087T  North America=4 [4.6%]  ORF8 protein, A65V</title>
	<circle cx="1338.7" cy="213.2" r="3.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C28311T  North America=3 [3.4%]  nucleocapsid phosphoprotein, P13L</title>
	<circle cx="1339.6" cy="206.4" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C28472T  North America=45 [51.7%]  nucleocapsid phosphoprotein, P67S</title>
	<circle cx="1340.3" cy="201.5" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C28854T  North America=21 [24.1%]  nucleocapsid phosphoprotein, S194L</title>
	<circle cx="1342.0" cy="189.8" r="5.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C28854T  Europe=3 [10.7%]  nucleocapsid phosphoprotein, S194L</title>
	<circle cx="1342.0" cy="189.8" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C28869T  North America=45 [51.7%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1342.0" cy="189.4" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C28869T  Europe=5 [17.9%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1342.0" cy="189.4" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C28887T  North America=11 [12.6%]  nucleocapsid phosphoprotein, T205I</title>
	<circle cx="1342.1" cy="188.8" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C28932T  Europe=17 [60.7%]  nucleocapsid phosphoprotein, A220V</title>
	<circle cx="1342.3" cy="187.5" r="7.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G29384T  North America=3 [3.4%]  nucleocapsid phosphoprotein, D371Y</title>
	<circle cx="1344.2" cy="173.7" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G29402T  North America=11 [12.6%]  nucleocapsid phosphoprotein, D377Y</title>
	<circle cx="1344.3" cy="173.1" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  C29445T  North America=6 [6.9%]  nucleocapsid phosphoprotein, T391I</title>
	<circle cx="1344.5" cy="171.8" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-08  G29645T  Europe=17 [60.7%]  ORF10 protein, V30L</title>
	<circle cx="1345.4" cy="165.7" r="7.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09 Europe: 23 samples</title>
	<line x1="1203.1" y1="1180.2" x2="1204.9" y2="1169.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-09 North America: 21 samples</title>
	<line x1="1204.9" y1="1169.3" x2="1206.5" y2="1158.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-09 Oceania: 3 samples</title>
	<line x1="1206.5" y1="1158.7" x2="1207.3" y2="1154.0" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-09 Asia: 6 samples</title>
	<line x1="1207.3" y1="1154.0" x2="1208.3" y2="1147.3" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-09  C335T  Europe=5 [21.7%]  orf1ab polyprotein, R24C</title>
	<circle cx="1222.3" cy="1059.2" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  C1059T  North America=18 [85.7%]  orf1ab polyprotein, T265I</title>
	<circle cx="1225.8" cy="1037.2" r="7.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  C3602T  Europe=5 [21.7%]  orf1ab polyprotein, H1113Y</title>
	<circle cx="1238.0" cy="959.9" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  A4040G  Europe=5 [21.7%]  orf1ab polyprotein, I1259V</title>
	<circle cx="1240.1" cy="946.6" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  G8083A  North America=7 [33.3%]  orf1ab polyprotein, M2606I</title>
	<circle cx="1259.6" cy="823.7" r="6.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  C10319T  North America=16 [76.2%]  orf1ab polyprotein, L3352F</title>
	<circle cx="1270.4" cy="755.8" r="7.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  C14408T  Europe=23 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1290.0" cy="631.5" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  C14408T  Europe=23 [100.0%] North America=21 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1290.0" cy="631.5" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  C14408T  Europe=23 [100.0%] North America=21 [100.0%] Asia=6 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1290.0" cy="631.5" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  C14408T  Europe=23 [100.0%] North America=21 [100.0%] Asia=6 [100.0%] Oceania=3 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1290.0" cy="631.5" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  A18424G  North America=16 [76.2%]  orf1ab polyprotein, N6054D</title>
	<circle cx="1309.4" cy="509.4" r="7.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  C21304T  North America=15 [71.4%]  orf1ab polyprotein, R7014C</title>
	<circle cx="1323.2" cy="421.9" r="7.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  C21614T  Europe=6 [26.1%]  surface glycoprotein, L18F</title>
	<circle cx="1324.7" cy="412.5" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  C21855T  Europe=5 [21.7%]  surface glycoprotein, S98F</title>
	<circle cx="1325.9" cy="405.2" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  C22227T  Europe=16 [69.6%]  surface glycoprotein, A222V</title>
	<circle cx="1327.7" cy="393.9" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  A23403G  Europe=23 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1333.3" cy="358.1" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  A23403G  Europe=23 [100.0%] North America=21 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1333.3" cy="358.1" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  A23403G  Europe=23 [100.0%] North America=21 [100.0%] Asia=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1333.3" cy="358.1" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  A23403G  Europe=23 [100.0%] North America=21 [100.0%] Asia=6 [100.0%] Oceania=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1333.3" cy="358.1" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  A25505G  Europe=5 [21.7%]  ORF3a protein, Q38R</title>
	<circle cx="1343.5" cy="294.2" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  G25563T  North America=18 [85.7%]  ORF3a protein, Q57H</title>
	<circle cx="1343.7" cy="292.5" r="7.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  G25906C  Europe=5 [21.7%]  ORF3a protein, G172R</title>
	<circle cx="1345.4" cy="282.1" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  G25907T  North America=16 [76.2%]  ORF3a protein, G172V</title>
	<circle cx="1345.4" cy="282.0" r="7.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  G25996T  Europe=5 [21.7%]  ORF3a protein, V202L</title>
	<circle cx="1345.8" cy="279.3" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  C27964T  North America=16 [76.2%]  ORF8 protein, S24L</title>
	<circle cx="1355.3" cy="219.5" r="7.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  C28472T  North America=16 [76.2%]  nucleocapsid phosphoprotein, P67S</title>
	<circle cx="1357.7" cy="204.1" r="7.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  C28869T  North America=16 [76.2%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1359.6" cy="192.0" r="7.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  C28869T  Europe=5 [21.7%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1359.6" cy="192.0" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  C28932T  Europe=15 [65.2%]  nucleocapsid phosphoprotein, A220V</title>
	<circle cx="1360.0" cy="190.1" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  G29402T  North America=4 [19.0%]  nucleocapsid phosphoprotein, D377Y</title>
	<circle cx="1362.2" cy="175.8" r="5.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-09  G29645T  Europe=16 [69.6%]  ORF10 protein, V30L</title>
	<circle cx="1363.4" cy="168.4" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-10 North America: 5 samples</title>
	<line x1="1203.5" y1="1180.3" x2="1204.6" y2="1174.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-10 Oceania: 4 samples</title>
	<line x1="1204.6" y1="1174.2" x2="1205.5" y2="1168.7" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-10 Asia: 4 samples</title>
	<line x1="1205.5" y1="1168.7" x2="1206.5" y2="1163.2" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-10  C3768T  Asia=3 [75.0%]  orf1ab polyprotein, T1168I</title>
	<circle cx="1243.1" cy="955.6" r="7.5" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-10  C14408T  North America=5 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1300.0" cy="633.1" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-10  C14408T  North America=5 [100.0%] Oceania=4 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1300.0" cy="633.1" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-10  C14408T  North America=5 [100.0%] Oceania=4 [100.0%] Asia=4 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1300.0" cy="633.1" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-10  C22879A  Asia=3 [75.0%]  surface glycoprotein, N439K</title>
	<circle cx="1345.2" cy="376.5" r="7.5" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-10  A23403G  North America=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1348.0" cy="360.6" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-10  A23403G  North America=5 [100.0%] Oceania=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1348.0" cy="360.6" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-10  A23403G  North America=5 [100.0%] Oceania=4 [100.0%] Asia=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1348.0" cy="360.6" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-10  C23604G  Asia=3 [75.0%]  surface glycoprotein, P681R</title>
	<circle cx="1349.1" cy="354.5" r="7.5" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-10  G25563T  Asia=3 [75.0%]  ORF3a protein, Q57H</title>
	<circle cx="1359.6" cy="295.1" r="7.5" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-10  C28887T  Asia=3 [75.0%]  nucleocapsid phosphoprotein, T205I</title>
	<circle cx="1377.3" cy="194.4" r="7.5" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11 Europe: 825 samples</title>
	<line x1="1203.8" y1="1180.4" x2="1208.3" y2="1157.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-11 North America: 24 samples</title>
	<line x1="1208.3" y1="1157.5" x2="1210.4" y2="1146.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-11  C335T  Europe=28 [3.4%]  orf1ab polyprotein, R24C</title>
	<circle cx="1227.2" cy="1060.0" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C593T  Europe=8 [1.0%]  orf1ab polyprotein, H110Y</title>
	<circle cx="1228.7" cy="1052.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A605C  Europe=10 [1.2%]  orf1ab polyprotein, I114L</title>
	<circle cx="1228.8" cy="1051.9" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C690T  Europe=29 [3.5%]  orf1ab polyprotein, S142L</title>
	<circle cx="1229.3" cy="1049.3" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A761G  Europe=28 [3.4%]  orf1ab polyprotein, S166G</title>
	<circle cx="1229.7" cy="1047.2" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C815T  Europe=4 [0.5%]  orf1ab polyprotein, R184C</title>
	<circle cx="1230.0" cy="1045.5" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C882T  Europe=22 [2.7%]  orf1ab polyprotein, A206V</title>
	<circle cx="1230.4" cy="1043.5" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C884T  Europe=8 [1.0%]  orf1ab polyprotein, R207C</title>
	<circle cx="1230.4" cy="1043.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C936T  North America=3 [12.5%]  orf1ab polyprotein, T224I</title>
	<circle cx="1230.7" cy="1041.9" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C1059T  North America=13 [54.2%]  orf1ab polyprotein, T265I</title>
	<circle cx="1231.5" cy="1038.2" r="7.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C1190T  Europe=3 [0.4%]  orf1ab polyprotein, P309S</title>
	<circle cx="1232.2" cy="1034.2" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C1191T  Europe=11 [1.3%]  orf1ab polyprotein, P309L</title>
	<circle cx="1232.2" cy="1034.2" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C1218T  Europe=5 [0.6%]  orf1ab polyprotein, S318L</title>
	<circle cx="1232.4" cy="1033.4" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C1469T  Europe=3 [0.4%]  orf1ab polyprotein, R402C</title>
	<circle cx="1233.9" cy="1025.8" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C1473T  Europe=6 [0.7%]  orf1ab polyprotein, T403I</title>
	<circle cx="1233.9" cy="1025.7" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C1593T  Europe=3 [0.4%]  orf1ab polyprotein, S443F</title>
	<circle cx="1234.6" cy="1022.0" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C1887T  Europe=8 [1.0%]  orf1ab polyprotein, A541V</title>
	<circle cx="1236.3" cy="1013.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A2015G  Europe=5 [0.6%]  orf1ab polyprotein, M584V</title>
	<circle cx="1237.1" cy="1009.3" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G2081A  Europe=4 [0.5%]  orf1ab polyprotein, V606I</title>
	<circle cx="1237.5" cy="1007.3" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C2106T  Europe=4 [0.5%]  orf1ab polyprotein, T614I</title>
	<circle cx="1237.6" cy="1006.5" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C2334T  Europe=10 [1.2%]  orf1ab polyprotein, A690V</title>
	<circle cx="1238.9" cy="999.7" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A2342G  North America=3 [12.5%]  orf1ab polyprotein, I693V</title>
	<circle cx="1239.0" cy="999.4" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G2369T  Europe=5 [0.6%]  orf1ab polyprotein, A702S</title>
	<circle cx="1239.1" cy="998.6" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G2447T  Europe=15 [1.8%]  orf1ab polyprotein, G728C</title>
	<circle cx="1239.6" cy="996.2" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A2510G  Europe=8 [1.0%]  orf1ab polyprotein, T749A</title>
	<circle cx="1240.0" cy="994.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C2667T  Europe=5 [0.6%]  orf1ab polyprotein, A801V</title>
	<circle cx="1240.9" cy="989.6" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C3177T  Europe=15 [1.8%]  orf1ab polyprotein, P971L</title>
	<circle cx="1243.9" cy="974.2" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G3239T  Europe=22 [2.7%]  orf1ab polyprotein, D992Y</title>
	<circle cx="1244.3" cy="972.3" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G3259T  North America=3 [12.5%]  orf1ab polyprotein, Q998H</title>
	<circle cx="1244.4" cy="971.7" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C3267T  Europe=39 [4.7%]  orf1ab polyprotein, T1001I</title>
	<circle cx="1244.4" cy="971.5" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C3311T  Europe=52 [6.3%]  orf1ab polyprotein, L1016F</title>
	<circle cx="1244.7" cy="970.1" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A3329G  Europe=14 [1.7%]  orf1ab polyprotein, T1022A</title>
	<circle cx="1244.8" cy="969.6" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C3411T  Europe=3 [0.4%]  orf1ab polyprotein, A1049V</title>
	<circle cx="1245.3" cy="967.1" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C3602T  Europe=80 [9.7%]  orf1ab polyprotein, H1113Y</title>
	<circle cx="1246.4" cy="961.4" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C3653T  Europe=15 [1.8%]  orf1ab polyprotein, L1130F</title>
	<circle cx="1246.7" cy="959.8" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C3828T  Europe=4 [0.5%]  orf1ab polyprotein, S1188L</title>
	<circle cx="1247.7" cy="954.5" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G3871T  Europe=5 [0.6%]  orf1ab polyprotein, K1202N</title>
	<circle cx="1248.0" cy="953.2" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C4002T  Europe=5 [0.6%]  orf1ab polyprotein, T1246I</title>
	<circle cx="1248.7" cy="949.3" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A4040G  Europe=22 [2.7%]  orf1ab polyprotein, I1259V</title>
	<circle cx="1249.0" cy="948.1" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C4068T  Europe=10 [1.2%]  orf1ab polyprotein, A1268V</title>
	<circle cx="1249.1" cy="947.3" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C4206T  Europe=3 [0.4%]  orf1ab polyprotein, A1314V</title>
	<circle cx="1249.9" cy="943.1" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G4474T  Europe=9 [1.1%]  orf1ab polyprotein, Q1403H</title>
	<circle cx="1251.5" cy="935.0" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G4486T  Europe=14 [1.7%]  orf1ab polyprotein, K1407N</title>
	<circle cx="1251.6" cy="934.7" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C4893T  Europe=35 [4.2%]  orf1ab polyprotein, T1543I</title>
	<circle cx="1254.0" cy="922.4" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G4913T  Europe=16 [1.9%]  orf1ab polyprotein, V1550F</title>
	<circle cx="1254.1" cy="921.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  T4917C  Europe=18 [2.2%]  orf1ab polyprotein, I1551T</title>
	<circle cx="1254.1" cy="921.6" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C5183T  Europe=11 [1.3%]  orf1ab polyprotein, P1640S</title>
	<circle cx="1255.7" cy="913.6" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C5388A  Europe=38 [4.6%]  orf1ab polyprotein, A1708D</title>
	<circle cx="1256.9" cy="907.4" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C5526T  Europe=14 [1.7%]  orf1ab polyprotein, T1754I</title>
	<circle cx="1257.7" cy="903.2" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C5672T  Europe=8 [1.0%]  orf1ab polyprotein, P1803S</title>
	<circle cx="1258.5" cy="898.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C5730T  Europe=4 [0.5%]  orf1ab polyprotein, T1822I</title>
	<circle cx="1258.9" cy="897.1" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A5949G  Europe=52 [6.3%]  orf1ab polyprotein, K1895R</title>
	<circle cx="1260.2" cy="890.5" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G5950T  Europe=13 [1.6%]  orf1ab polyprotein, K1895N</title>
	<circle cx="1260.2" cy="890.4" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C6027T  Europe=5 [0.6%]  orf1ab polyprotein, P1921L</title>
	<circle cx="1260.6" cy="888.1" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G6080A  Europe=8 [1.0%]  orf1ab polyprotein, D1939N</title>
	<circle cx="1260.9" cy="886.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C6539T  Europe=34 [4.1%]  orf1ab polyprotein, H2092Y</title>
	<circle cx="1263.6" cy="872.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C6936T  Europe=3 [0.4%]  orf1ab polyprotein, S2224F</title>
	<circle cx="1266.0" cy="860.7" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  T6954C  Europe=38 [4.6%]  orf1ab polyprotein, I2230T</title>
	<circle cx="1266.1" cy="860.1" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G7059A  Europe=3 [0.4%]  orf1ab polyprotein, G2265D</title>
	<circle cx="1266.7" cy="856.9" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C7224T  Europe=33 [4.0%]  orf1ab polyprotein, A2320V</title>
	<circle cx="1267.7" cy="852.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C7482T  Europe=4 [0.5%]  orf1ab polyprotein, S2406L</title>
	<circle cx="1269.2" cy="844.2" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C7728T  Europe=5 [0.6%]  orf1ab polyprotein, S2488F</title>
	<circle cx="1270.6" cy="836.7" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  T7767C  Europe=99 [12.0%]  orf1ab polyprotein, I2501T</title>
	<circle cx="1270.8" cy="835.6" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A8072G  Europe=6 [0.7%]  orf1ab polyprotein, N2603D</title>
	<circle cx="1272.6" cy="826.3" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G8083A  North America=3 [12.5%]  orf1ab polyprotein, M2606I</title>
	<circle cx="1272.7" cy="826.0" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G8131T  Europe=6 [0.7%]  orf1ab polyprotein, K2622N</title>
	<circle cx="1273.0" cy="824.6" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C8139T  Europe=12 [1.5%]  orf1ab polyprotein, S2625F</title>
	<circle cx="1273.0" cy="824.3" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C8327T  Europe=14 [1.7%]  orf1ab polyprotein, L2688F</title>
	<circle cx="1274.1" cy="818.6" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G8648A  Europe=5 [0.6%]  orf1ab polyprotein, V2795I</title>
	<circle cx="1276.0" cy="808.9" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G8720A  Europe=31 [3.8%]  orf1ab polyprotein, D2819N</title>
	<circle cx="1276.4" cy="806.8" r="2.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G8872C  Europe=8 [1.0%]  orf1ab polyprotein, L2869F</title>
	<circle cx="1277.3" cy="802.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C9120T  Europe=3 [0.4%]  orf1ab polyprotein, T2952I</title>
	<circle cx="1278.8" cy="794.7" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G9526T  Europe=93 [11.3%]  orf1ab polyprotein, M3087I</title>
	<circle cx="1281.2" cy="782.4" r="4.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C9693T  Europe=9 [1.1%]  orf1ab polyprotein, A3143V</title>
	<circle cx="1282.1" cy="777.4" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G10097A  Europe=5 [0.6%]  orf1ab polyprotein, G3278S</title>
	<circle cx="1284.5" cy="765.2" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G10097T  Europe=26 [3.2%]  orf1ab polyprotein, G3278C</title>
	<circle cx="1284.5" cy="765.2" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G10265A  Europe=8 [1.0%]  orf1ab polyprotein, G3334S</title>
	<circle cx="1285.5" cy="760.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C10319T  North America=6 [25.0%]  orf1ab polyprotein, L3352F</title>
	<circle cx="1285.8" cy="758.5" r="5.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A10323G  Europe=7 [0.8%]  orf1ab polyprotein, K3353R</title>
	<circle cx="1285.8" cy="758.4" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C10376T  Europe=4 [0.5%]  orf1ab polyprotein, P3371S</title>
	<circle cx="1286.2" cy="756.8" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C10449T  Europe=3 [0.4%]  orf1ab polyprotein, P3395L</title>
	<circle cx="1286.6" cy="754.6" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C10641T  Europe=4 [0.5%]  orf1ab polyprotein, T3459M</title>
	<circle cx="1287.7" cy="748.8" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G10793T  Europe=22 [2.7%]  orf1ab polyprotein, V3510F</title>
	<circle cx="1288.6" cy="744.2" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  TT11083T  Europe=6 [0.7%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1290.3" cy="735.4" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G11083T  Europe=7 [0.8%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1290.3" cy="735.4" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G11132T  Europe=4 [0.5%]  orf1ab polyprotein, A3623S</title>
	<circle cx="1290.6" cy="733.9" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G11230T  Europe=3 [0.4%]  orf1ab polyprotein, M3655I</title>
	<circle cx="1291.2" cy="731.0" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G11557T  Europe=3 [0.4%]  orf1ab polyprotein, E3764D</title>
	<circle cx="1293.1" cy="721.1" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C11591T  North America=3 [12.5%]  orf1ab polyprotein, L3776F</title>
	<circle cx="1293.3" cy="720.1" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A11991G  Europe=3 [0.4%]  orf1ab polyprotein, E3909G</title>
	<circle cx="1295.6" cy="708.0" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A12075G  Europe=5 [0.6%]  orf1ab polyprotein, N3937S</title>
	<circle cx="1296.1" cy="705.4" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  T12134C  Europe=78 [9.5%]  orf1ab polyprotein, F3957L</title>
	<circle cx="1296.5" cy="703.7" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C12455T  Europe=45 [5.5%]  orf1ab polyprotein, L4064F</title>
	<circle cx="1298.4" cy="694.0" r="3.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C12513T  Europe=11 [1.3%]  orf1ab polyprotein, T4083M</title>
	<circle cx="1298.7" cy="692.2" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G12988T  Europe=66 [8.0%]  orf1ab polyprotein, M4241I</title>
	<circle cx="1301.5" cy="677.9" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C13176T  Europe=6 [0.7%]  orf1ab polyprotein, T4304I</title>
	<circle cx="1302.6" cy="672.2" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C13197T  Europe=22 [2.7%]  orf1ab polyprotein, T4311I</title>
	<circle cx="1302.7" cy="671.6" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C13517T  Europe=6 [0.7%]  orf1ab polyprotein, T4418I</title>
	<circle cx="1304.6" cy="661.9" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C13862T  Europe=6 [0.7%]  orf1ab polyprotein, T4533I</title>
	<circle cx="1306.6" cy="651.5" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G13993T  Europe=93 [11.3%]  orf1ab polyprotein, A4577S</title>
	<circle cx="1307.4" cy="647.5" r="4.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C14117T  Europe=3 [0.4%]  orf1ab polyprotein, T4618M</title>
	<circle cx="1308.1" cy="643.8" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C14230T  Europe=10 [1.2%]  orf1ab polyprotein, P4656S</title>
	<circle cx="1308.8" cy="640.4" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C14408T  Europe=824 [99.9%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1309.8" cy="635.0" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C14408T  Europe=824 [99.9%] North America=23 [95.8%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1309.8" cy="635.0" r="7.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A15337G  Europe=4 [0.5%]  orf1ab polyprotein, M5025V</title>
	<circle cx="1315.3" cy="606.9" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G15598A  Europe=66 [8.0%]  orf1ab polyprotein, V5112I</title>
	<circle cx="1316.8" cy="599.0" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G15766T  Europe=93 [11.3%]  orf1ab polyprotein, V5168L</title>
	<circle cx="1317.8" cy="594.0" r="4.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G15906T  Europe=9 [1.1%]  orf1ab polyprotein, Q5214H</title>
	<circle cx="1318.6" cy="589.7" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A16085G  Europe=22 [2.7%]  orf1ab polyprotein, H5274R</title>
	<circle cx="1319.7" cy="584.3" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C16349T  Europe=5 [0.6%]  orf1ab polyprotein, S5362L</title>
	<circle cx="1321.2" cy="576.3" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C16394T  Europe=5 [0.6%]  orf1ab polyprotein, P5377L</title>
	<circle cx="1321.5" cy="575.0" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G16528T  Europe=4 [0.5%]  orf1ab polyprotein, V5422F</title>
	<circle cx="1322.3" cy="570.9" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A16889G  Europe=92 [11.2%]  orf1ab polyprotein, K5542R</title>
	<circle cx="1324.4" cy="560.0" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G17014T  North America=3 [12.5%]  orf1ab polyprotein, D5584Y</title>
	<circle cx="1325.1" cy="556.3" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G17019T  Europe=93 [11.3%]  orf1ab polyprotein, E5585D</title>
	<circle cx="1325.2" cy="556.1" r="4.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G17058T  Europe=5 [0.6%]  orf1ab polyprotein, M5598I</title>
	<circle cx="1325.4" cy="554.9" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C17104T  Europe=99 [12.0%]  orf1ab polyprotein, H5614Y</title>
	<circle cx="1325.7" cy="553.5" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G17122T  North America=3 [12.5%]  orf1ab polyprotein, A5620S</title>
	<circle cx="1325.8" cy="553.0" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G17122A  Europe=26 [3.2%]  orf1ab polyprotein, A5620T</title>
	<circle cx="1325.8" cy="553.0" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G17259T  Europe=3 [0.4%]  orf1ab polyprotein, E5665D</title>
	<circle cx="1326.6" cy="548.9" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C17440T  Europe=9 [1.1%]  orf1ab polyprotein, P5726S</title>
	<circle cx="1327.6" cy="543.4" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G17572T  Europe=52 [6.3%]  orf1ab polyprotein, A5770S</title>
	<circle cx="1328.4" cy="539.4" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A17615G  Europe=9 [1.1%]  orf1ab polyprotein, K5784R</title>
	<circle cx="1328.7" cy="538.1" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C17747A  Europe=5 [0.6%]  orf1ab polyprotein, P5828H</title>
	<circle cx="1329.4" cy="534.1" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C17999T  Europe=3 [0.4%]  orf1ab polyprotein, T5912I</title>
	<circle cx="1330.9" cy="526.5" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G18028T  Europe=65 [7.9%]  orf1ab polyprotein, A5922S</title>
	<circle cx="1331.1" cy="525.6" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C18032T  Europe=3 [0.4%]  orf1ab polyprotein, T5923I</title>
	<circle cx="1331.1" cy="525.5" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G18186T  Europe=5 [0.6%]  orf1ab polyprotein, M5974I</title>
	<circle cx="1332.0" cy="520.9" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A18424G  North America=5 [20.8%]  orf1ab polyprotein, N6054D</title>
	<circle cx="1333.4" cy="513.7" r="5.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C18458T  Europe=3 [0.4%]  orf1ab polyprotein, P6065L</title>
	<circle cx="1333.6" cy="512.6" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G18498T  Europe=4 [0.5%]  orf1ab polyprotein, M6078I</title>
	<circle cx="1333.8" cy="511.4" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C18508T  Europe=7 [0.8%]  orf1ab polyprotein, L6082F</title>
	<circle cx="1333.9" cy="511.1" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G18951T  Europe=12 [1.5%]  orf1ab polyprotein, K6229N</title>
	<circle cx="1336.5" cy="497.8" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C19018T  Europe=5 [0.6%]  orf1ab polyprotein, P6252S</title>
	<circle cx="1336.9" cy="495.7" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C19273T  Europe=52 [6.3%]  orf1ab polyprotein, P6337S</title>
	<circle cx="1338.4" cy="488.0" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G19542T  Europe=3 [0.4%]  orf1ab polyprotein, M6426I</title>
	<circle cx="1340.0" cy="479.9" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G19648T  Europe=13 [1.6%]  orf1ab polyprotein, V6462L</title>
	<circle cx="1340.6" cy="476.7" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C19718T  Europe=8 [1.0%]  orf1ab polyprotein, T6485I</title>
	<circle cx="1341.0" cy="474.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G19732T  Europe=5 [0.6%]  orf1ab polyprotein, V6490F</title>
	<circle cx="1341.1" cy="474.2" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G19816T  Europe=3 [0.4%]  orf1ab polyprotein, V6518L</title>
	<circle cx="1341.6" cy="471.6" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G20102T  Europe=7 [0.8%]  orf1ab polyprotein, S6613I</title>
	<circle cx="1343.3" cy="463.0" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C20233T  Europe=3 [0.4%]  orf1ab polyprotein, P6657S</title>
	<circle cx="1344.0" cy="459.0" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G20238T  Europe=4 [0.5%]  orf1ab polyprotein, R6658S</title>
	<circle cx="1344.1" cy="458.9" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G20995T  Europe=4 [0.5%]  orf1ab polyprotein, G6911C</title>
	<circle cx="1348.5" cy="436.0" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A21137G  Europe=4 [0.5%]  orf1ab polyprotein, K6958R</title>
	<circle cx="1349.3" cy="431.7" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G21220T  Europe=7 [0.8%]  orf1ab polyprotein, A6986S</title>
	<circle cx="1349.8" cy="429.2" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C21304T  North America=5 [20.8%]  orf1ab polyprotein, R7014C</title>
	<circle cx="1350.3" cy="426.7" r="5.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C21365T  Europe=33 [4.0%]  orf1ab polyprotein, P7034L</title>
	<circle cx="1350.7" cy="424.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C21575T  North America=3 [12.5%]  surface glycoprotein, L5F</title>
	<circle cx="1351.9" cy="418.5" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C21575T  Europe=18 [2.2%]  surface glycoprotein, L5F</title>
	<circle cx="1351.9" cy="418.5" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C21597T  Europe=5 [0.6%]  surface glycoprotein, S12F</title>
	<circle cx="1352.0" cy="417.8" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G21600T  North America=3 [12.5%]  surface glycoprotein, S13I</title>
	<circle cx="1352.1" cy="417.7" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C21614T  Europe=23 [2.8%]  surface glycoprotein, L18F</title>
	<circle cx="1352.1" cy="417.3" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C21707T  Europe=4 [0.5%]  surface glycoprotein, H49Y</title>
	<circle cx="1352.7" cy="414.5" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C21855T  Europe=91 [11.0%]  surface glycoprotein, S98F</title>
	<circle cx="1353.6" cy="410.0" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G21989T  Europe=26 [3.2%]  surface glycoprotein, V143F</title>
	<circle cx="1354.3" cy="406.0" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  ATTA21993A  Europe=40 [4.8%]  surface glycoprotein, Y145H</title>
	<circle cx="1354.4" cy="405.9" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G22018T  North America=3 [12.5%]  surface glycoprotein, W152C</title>
	<circle cx="1354.5" cy="405.1" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  ATTA22190A  Europe=4 [0.5%]  surface glycoprotein, I210N</title>
	<circle cx="1355.5" cy="399.9" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C22227T  Europe=427 [51.8%]  surface glycoprotein, A222V</title>
	<circle cx="1355.7" cy="398.8" r="6.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A22259G  Europe=10 [1.2%]  surface glycoprotein, I233V</title>
	<circle cx="1355.9" cy="397.8" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G22346T  Europe=20 [2.4%]  surface glycoprotein, A262S</title>
	<circle cx="1356.4" cy="395.2" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C22377T  Europe=13 [1.6%]  surface glycoprotein, P272L</title>
	<circle cx="1356.6" cy="394.3" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C22879A  Europe=100 [12.1%]  surface glycoprotein, N439K</title>
	<circle cx="1359.6" cy="379.1" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  T22917G  North America=3 [12.5%]  surface glycoprotein, L452R</title>
	<circle cx="1359.8" cy="378.0" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G22992A  Europe=115 [13.9%]  surface glycoprotein, S477N</title>
	<circle cx="1360.2" cy="375.7" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A23063T  Europe=38 [4.6%]  surface glycoprotein, N501Y</title>
	<circle cx="1360.6" cy="373.6" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A23064C  North America=3 [12.5%]  surface glycoprotein, N501T</title>
	<circle cx="1360.6" cy="373.5" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C23271A  Europe=38 [4.6%]  surface glycoprotein, A570D</title>
	<circle cx="1361.9" cy="367.3" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A23403G  Europe=824 [99.9%]  surface glycoprotein, D614G</title>
	<circle cx="1362.6" cy="363.3" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A23403G  Europe=824 [99.9%] North America=23 [95.8%]  surface glycoprotein, D614G</title>
	<circle cx="1362.6" cy="363.3" r="7.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C23481T  Europe=10 [1.2%]  surface glycoprotein, S640F</title>
	<circle cx="1363.1" cy="360.9" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G23593T  Europe=9 [1.1%]  surface glycoprotein, Q677H</title>
	<circle cx="1363.8" cy="357.6" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C23604A  Europe=44 [5.3%]  surface glycoprotein, P681H</title>
	<circle cx="1363.8" cy="357.2" r="3.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C23604G  Europe=3 [0.4%]  surface glycoprotein, P681R</title>
	<circle cx="1363.8" cy="357.2" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C23709T  Europe=41 [5.0%]  surface glycoprotein, T716I</title>
	<circle cx="1364.4" cy="354.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C23987T  Europe=4 [0.5%]  surface glycoprotein, P809S</title>
	<circle cx="1366.1" cy="345.7" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G24000T  Europe=5 [0.6%]  surface glycoprotein, S813I</title>
	<circle cx="1366.1" cy="345.3" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C24099T  Europe=10 [1.2%]  surface glycoprotein, A846V</title>
	<circle cx="1366.7" cy="342.3" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C24138T  Europe=6 [0.7%]  surface glycoprotein, T859I</title>
	<circle cx="1367.0" cy="341.1" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C24378T  Europe=12 [1.5%]  surface glycoprotein, S939F</title>
	<circle cx="1368.4" cy="333.8" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  T24506G  Europe=38 [4.6%]  surface glycoprotein, S982A</title>
	<circle cx="1369.1" cy="330.0" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G24620T  Europe=6 [0.7%]  surface glycoprotein, A1020S</title>
	<circle cx="1369.8" cy="326.5" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A24780C  Europe=24 [2.9%]  surface glycoprotein, K1073T</title>
	<circle cx="1370.7" cy="321.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G24794T  Europe=15 [1.8%]  surface glycoprotein, A1078S</title>
	<circle cx="1370.8" cy="321.3" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G24914C  Europe=38 [4.6%]  surface glycoprotein, D1118H</title>
	<circle cx="1371.5" cy="317.7" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G24926T  Europe=3 [0.4%]  surface glycoprotein, V1122L</title>
	<circle cx="1371.6" cy="317.3" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C25046T  Europe=6 [0.7%]  surface glycoprotein, P1162S</title>
	<circle cx="1372.3" cy="313.7" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G25049T  Europe=4 [0.5%]  surface glycoprotein, D1163Y</title>
	<circle cx="1372.3" cy="313.6" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G25166C  Europe=7 [0.8%]  surface glycoprotein, E1202Q</title>
	<circle cx="1373.0" cy="310.0" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G25217T  Europe=25 [3.0%]  surface glycoprotein, G1219C</title>
	<circle cx="1373.3" cy="308.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G25218T  Europe=3 [0.4%]  surface glycoprotein, G1219V</title>
	<circle cx="1373.3" cy="308.5" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A25450G  Europe=52 [6.3%]  ORF3a protein, I20V</title>
	<circle cx="1374.7" cy="301.5" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G25471T  Europe=8 [1.0%]  ORF3a protein, D27Y</title>
	<circle cx="1374.8" cy="300.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A25505G  Europe=80 [9.7%]  ORF3a protein, Q38R</title>
	<circle cx="1375.0" cy="299.8" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G25563T  North America=13 [54.2%]  ORF3a protein, Q57H</title>
	<circle cx="1375.3" cy="298.1" r="7.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G25563T  Europe=112 [13.6%]  ORF3a protein, Q57H</title>
	<circle cx="1375.3" cy="298.1" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G25606T  Europe=3 [0.4%]  ORF3a protein, A72S</title>
	<circle cx="1375.6" cy="296.8" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G25621T  Europe=16 [1.9%]  ORF3a protein, V77F</title>
	<circle cx="1375.7" cy="296.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G25647T  Europe=52 [6.3%]  ORF3a protein, L85F</title>
	<circle cx="1375.8" cy="295.5" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C25708T  Europe=8 [1.0%]  ORF3a protein, L106F</title>
	<circle cx="1376.2" cy="293.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G25720T  Europe=11 [1.3%]  ORF3a protein, A110S</title>
	<circle cx="1376.2" cy="293.3" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  T25724C  Europe=6 [0.7%]  ORF3a protein, L111S</title>
	<circle cx="1376.3" cy="293.2" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G25757T  Europe=126 [15.3%]  ORF3a protein, R122I</title>
	<circle cx="1376.5" cy="292.2" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G25906C  Europe=79 [9.6%]  ORF3a protein, G172R</title>
	<circle cx="1377.3" cy="287.7" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G25907T  North America=5 [20.8%]  ORF3a protein, G172V</title>
	<circle cx="1377.3" cy="287.7" r="5.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A25910G  Europe=3 [0.4%]  ORF3a protein, D173G</title>
	<circle cx="1377.4" cy="287.6" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G25913A  Europe=22 [2.7%]  ORF3a protein, G174D</title>
	<circle cx="1377.4" cy="287.5" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G25996T  Europe=81 [9.8%]  ORF3a protein, V202L</title>
	<circle cx="1377.9" cy="285.0" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C26060T  Europe=5 [0.6%]  ORF3a protein, T223I</title>
	<circle cx="1378.2" cy="283.0" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G26062T  Europe=4 [0.5%]  ORF3a protein, G224C</title>
	<circle cx="1378.3" cy="283.0" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A26069G  North America=3 [12.5%]  ORF3a protein, E226G</title>
	<circle cx="1378.3" cy="282.8" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C26150T  Europe=16 [1.9%]  ORF3a protein, S253F</title>
	<circle cx="1378.8" cy="280.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C26305T  Europe=4 [0.5%]  envelope protein, L21F</title>
	<circle cx="1379.7" cy="275.6" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A26530G  Europe=22 [2.7%]  membrane glycoprotein, D3G</title>
	<circle cx="1381.0" cy="268.8" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C26895T  Europe=7 [0.8%]  membrane glycoprotein, H125Y</title>
	<circle cx="1383.1" cy="257.8" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  T27220C  Europe=4 [0.5%]  ORF6 protein, F7L</title>
	<circle cx="1385.0" cy="248.0" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C27434T  Europe=13 [1.6%]  ORF7a protein, T14I</title>
	<circle cx="1386.3" cy="241.5" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G27463T  Europe=13 [1.6%]  ORF7a protein, V24F</title>
	<circle cx="1386.5" cy="240.7" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C27527G  Europe=12 [1.5%]  ORF7a protein, P45R</title>
	<circle cx="1386.9" cy="238.7" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A27579T  Europe=5 [0.6%]  ORF7a protein, Q62H</title>
	<circle cx="1387.2" cy="237.2" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A27674T  Europe=3 [0.4%]  ORF7a protein, Q94L</title>
	<circle cx="1387.7" cy="234.3" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C27964T  North America=6 [25.0%]  ORF8 protein, S24L</title>
	<circle cx="1389.4" cy="225.5" r="5.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C27972T  Europe=38 [4.6%]  ORF8 protein, Q27*</title>
	<circle cx="1389.5" cy="225.3" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G27996T  Europe=8 [1.0%]  ORF8 protein, D35Y</title>
	<circle cx="1389.6" cy="224.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G28048T  Europe=38 [4.6%]  ORF8 protein, R52I</title>
	<circle cx="1389.9" cy="223.0" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G28077T  Europe=3 [0.4%]  ORF8 protein, V62L</title>
	<circle cx="1390.1" cy="222.1" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C28087T  Europe=27 [3.3%]  ORF8 protein, A65V</title>
	<circle cx="1390.1" cy="221.8" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A28111G  Europe=38 [4.6%]  ORF8 protein, Y73C</title>
	<circle cx="1390.3" cy="221.1" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A28295T  Europe=5 [0.6%]  nucleocapsid phosphoprotein, N8Y</title>
	<circle cx="1391.4" cy="215.5" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  A28370G  Europe=20 [2.4%]  nucleocapsid phosphoprotein, S33G</title>
	<circle cx="1391.8" cy="213.3" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C28472T  North America=5 [20.8%]  nucleocapsid phosphoprotein, P67S</title>
	<circle cx="1392.4" cy="210.2" r="5.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G28655T  Europe=3 [0.4%]  nucleocapsid phosphoprotein, D128Y</title>
	<circle cx="1393.5" cy="204.7" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C28854T  Europe=17 [2.1%]  nucleocapsid phosphoprotein, S194L</title>
	<circle cx="1394.6" cy="198.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C28866T  Europe=3 [0.4%]  nucleocapsid phosphoprotein, T198I</title>
	<circle cx="1394.7" cy="198.3" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C28869T  North America=8 [33.3%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1394.7" cy="198.2" r="6.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C28869T  Europe=79 [9.6%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1394.7" cy="198.2" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C28887T  North America=5 [20.8%]  nucleocapsid phosphoprotein, T205I</title>
	<circle cx="1394.8" cy="197.7" r="5.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C28887T  Europe=5 [0.6%]  nucleocapsid phosphoprotein, T205I</title>
	<circle cx="1394.8" cy="197.7" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C28932T  Europe=423 [51.3%]  nucleocapsid phosphoprotein, A220V</title>
	<circle cx="1395.1" cy="196.3" r="6.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G28975C  Europe=93 [11.3%]  nucleocapsid phosphoprotein, M234I</title>
	<circle cx="1395.4" cy="195.0" r="4.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C28977T  Europe=38 [4.6%]  nucleocapsid phosphoprotein, S235F</title>
	<circle cx="1395.4" cy="194.9" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C29366T  Europe=201 [24.4%]  nucleocapsid phosphoprotein, P365S</title>
	<circle cx="1397.6" cy="183.2" r="5.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C29370T  Europe=8 [1.0%]  nucleocapsid phosphoprotein, T366I</title>
	<circle cx="1397.7" cy="183.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G29399A  Europe=93 [11.3%]  nucleocapsid phosphoprotein, A376T</title>
	<circle cx="1397.8" cy="182.2" r="4.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G29402T  Europe=27 [3.3%]  nucleocapsid phosphoprotein, D377Y</title>
	<circle cx="1397.9" cy="182.1" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C29420T  Europe=5 [0.6%]  nucleocapsid phosphoprotein, P383S</title>
	<circle cx="1398.0" cy="181.6" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C29451T  Europe=4 [0.5%]  nucleocapsid phosphoprotein, T393I</title>
	<circle cx="1398.1" cy="180.6" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G29474T  Europe=7 [0.8%]  nucleocapsid phosphoprotein, D401Y</title>
	<circle cx="1398.3" cy="179.9" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C29520T  Europe=3 [0.4%]  nucleocapsid phosphoprotein, S416L</title>
	<circle cx="1398.6" cy="178.5" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  TT29589T  Europe=16 [1.9%]  ORF10 protein, F11L</title>
	<circle cx="1399.0" cy="176.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  G29645T  Europe=419 [50.8%]  ORF10 protein, V30L</title>
	<circle cx="1399.3" cy="174.8" r="6.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-11  C29666T  Europe=6 [0.7%]  ORF10 protein, L37F</title>
	<circle cx="1399.4" cy="174.1" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12 Europe: 8 samples</title>
	<line x1="1204.2" y1="1180.4" x2="1205.7" y2="1173.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-12 Asia: 3 samples</title>
	<line x1="1205.7" y1="1173.0" x2="1206.7" y2="1168.3" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-12  C335T  Europe=3 [37.5%]  orf1ab polyprotein, R24C</title>
	<circle cx="1229.6" cy="1060.5" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  C3267T  Europe=3 [37.5%]  orf1ab polyprotein, T1001I</title>
	<circle cx="1248.4" cy="972.3" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  C3602T  Europe=4 [50.0%]  orf1ab polyprotein, H1113Y</title>
	<circle cx="1250.5" cy="962.2" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  A4040G  Europe=3 [37.5%]  orf1ab polyprotein, I1259V</title>
	<circle cx="1253.3" cy="949.0" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  C5388A  Europe=3 [37.5%]  orf1ab polyprotein, A1708D</title>
	<circle cx="1262.0" cy="908.5" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  C14408T  Europe=8 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1319.7" cy="637.0" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  C14408T  Europe=8 [100.0%] Asia=3 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1319.7" cy="637.0" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  C21855T  Europe=4 [50.0%]  surface glycoprotein, S98F</title>
	<circle cx="1367.3" cy="412.8" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  A23063T  Europe=3 [37.5%]  surface glycoprotein, N501Y</title>
	<circle cx="1375.0" cy="376.5" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  C23271A  Europe=3 [37.5%]  surface glycoprotein, A570D</title>
	<circle cx="1376.4" cy="370.2" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  A23403G  Europe=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1377.2" cy="366.3" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  A23403G  Europe=8 [100.0%] Asia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1377.2" cy="366.3" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  C23604A  Europe=3 [37.5%]  surface glycoprotein, P681H</title>
	<circle cx="1378.5" cy="360.2" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  C23709T  Europe=3 [37.5%]  surface glycoprotein, T716I</title>
	<circle cx="1379.2" cy="357.0" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  T24506G  Europe=3 [37.5%]  surface glycoprotein, S982A</title>
	<circle cx="1384.3" cy="333.1" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  G24914C  Europe=3 [37.5%]  surface glycoprotein, D1118H</title>
	<circle cx="1386.9" cy="320.8" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  A25505G  Europe=4 [50.0%]  ORF3a protein, Q38R</title>
	<circle cx="1390.7" cy="303.0" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  G25906C  Europe=4 [50.0%]  ORF3a protein, G172R</title>
	<circle cx="1393.2" cy="290.9" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  G25996T  Europe=4 [50.0%]  ORF3a protein, V202L</title>
	<circle cx="1393.8" cy="288.2" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  C27972T  Europe=3 [37.5%]  ORF8 protein, Q27*</title>
	<circle cx="1406.4" cy="228.7" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  G28048T  Europe=3 [37.5%]  ORF8 protein, R52I</title>
	<circle cx="1406.9" cy="226.5" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  A28111G  Europe=3 [37.5%]  ORF8 protein, Y73C</title>
	<circle cx="1407.3" cy="224.6" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  C28869T  Europe=4 [50.0%]  nucleocapsid phosphoprotein, P199L</title>
	<circle cx="1412.2" cy="201.7" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-12  C28977T  Europe=3 [37.5%]  nucleocapsid phosphoprotein, S235F</title>
	<circle cx="1412.9" cy="198.5" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-13 Europe: 3 samples</title>
	<line x1="1204.5" y1="1180.5" x2="1205.6" y2="1175.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-13 Asia: 5 samples</title>
	<line x1="1205.6" y1="1175.8" x2="1207.0" y2="1169.8" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-13  G11083T  Asia=3 [60.0%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1306.5" cy="738.8" r="7.1" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-13  C14408T  Asia=5 [100.0%]  orf1ab polyprotein, P4715L</title>
	<circle cx="1329.5" cy="639.2" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-13  A23403G  Asia=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1391.7" cy="369.5" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2021-01-13  G25563T  Asia=4 [80.0%]  ORF3a protein, Q57H</title>
	<circle cx="1406.7" cy="304.7" r="7.6" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<rect x="1865" y="140" width="500" height="135" rx="15" style="fill:gainsboro;stroke-width:0;fill-opacity:0.15;" />
<text font-size="1.8em" x="1880" y="170" fill="white">Data from 6 continents</text>
<text font-size="1.8em" x="1880" y="200" fill="white">Genomes/year≥100  Genomes/day≥3</text>
<text font-size="1.8em" x="1880" y="230" fill="white">566 distinct missense variants mapped</text>
<text font-size="1.8em" x="1880" y="260" fill="white">Updated 2021-01-21</text>
</svg>
